<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Ressources de Gowling WLG - Produit RSS</title><link>https://gowlingwlg.com/ecaapi/fr-fr/rss/resource?service=Brevets</link><description>Ressources de Gowling WLG - Produit RSS</description><item><guid isPermaLink="false">84679c11-aba5-4ca5-b1e8-f39a5a6a5a2a</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2026/restoring-patent-priority-in-canada</link><title>Restoring patent priority in Canada</title><description>Learn how restoration of priority can help patent applicants in Canada protect an earlier filing date.</description><pubDate>Mon, 24 Aug 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5c120633-18b8-4a3b-be44-9c083c2c3aa8</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2026/a-guide-to-ai-inventions-in-singapore-and-canada</link><title>Bridging the AI frontier: A guide to AI inventions in Singapore and Canada</title><description>This article provides a comparative analysis of Singapore (IPOS) and Canada (CIPO) patent landscapes, offering actionable drafting and prosecution strategies for maximising portfolio value in both jurisdictions.</description><pubDate>Mon, 27 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1ad2bda1-c1bc-49f7-aab7-989cbdd78191</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2026/gowling-wlg-successfully-represents-jempak-ulc-in-complex-patent-trial</link><title>Gowling WLG successfully represents Jempak ULC in complex patent trial</title><description>Gowling WLG successfully represented Jempak ULC in a complex patent infringement action before the Federal Court of Canada, resulting in the dismissal of all infringement claims advanced by Gemak Trust.</description><pubDate>Tue, 21 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8d72c88d-8ca5-45f9-b060-735d440f7184</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2026/pharmascience-v-janssen-supreme-court</link><title>Skill, judgment, and the syringe: &#x3C;em&#x3E;Pharmascience v Janssen&#x3C;/em&#x3E; at the Supreme Court</title><description>The Supreme Court of Canada&#x2019;s first patent decision since 2017 provides new guidance on when methods of medical treatment may be patentable.</description><pubDate>Fri, 17 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4f32f008-25ab-46d4-acf8-8402c9aa949c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2026/ai-transforming-patent-what-businesses-need-to-know</link><title>How AI is transforming patent practice and what your business needs to know</title><description>AI is fundamentally changing how companies invent, file, and protect their intellectual property. The efficiency gains are substantial, but so are the risks.</description><pubDate>Tue, 07 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8413bc3d-712d-4d74-85a9-b674ca6575c3</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2026/how-foreign-companies-face-canadian-patent-liability</link><title>Borders not an escape: How foreign companies face Canadian patent liability</title><description>Can a company working outside of Canada infringe a Canadian patent? The answer may surprise you.</description><pubDate>Thu, 02 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">30dd4909-bd48-46b9-b845-0b219699d7bc</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2026/patentability-and-the-supreme-court</link><title>Patentability and the Supreme Court: Conundrums surrounding methods of medical treatment</title><description>A highly anticipated Supreme Court of Canada decision could bring new clarity to how Canadian patent law treats methods of medical treatment.</description><pubDate>Thu, 02 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7ec849e0-f000-493e-81d3-dd20e5b36b20</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2026/china-2026-trademark-law-revision</link><title>China&#x27;s 2026 Trademark Law revision - 10 changes reshaping brand protection</title><description>China&#x27;s trademark reforms mark a decisive move towards stronger enforcement and real commercial use. For businesses with China exposure, the implications are significant. Read our latest insight to see how to prepare before the changes take effect.</description><pubDate>Wed, 01 Jul 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c7efa8e2-f1a5-4597-9e9c-5db1ed9ade41</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2026/from-neurodata-to-the-no-fakes-act</link><title>From neurodata to the NO FAKES Act: Recognising human contributions in the algorithmic age</title><description>The Nurture Originals, Foster Art, and Keep Entertainment Safe Act of 2026 (the so-called NO FAKES Act) creates a federal intellectual property right in an individual&#x27;s voice and visual likeness. The new development signals that the idea of treating personal human data as a protectable asset is gaining legislative worldwide traction.</description><pubDate>Tue, 02 Jun 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">45deb591-1899-46dd-998f-c2067bb9568b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2026/new-pmac-model-clauses</link><title>New PMAC model clauses: position your IP agreements for the UPC era</title><description>The UPC&#x2019;s Patent Mediation and Arbitration Centre has published model ADR clauses, completing its framework. The development shows why drafting now matters for enforcement, leverage and outcomes under the UPC for patent&#x2011;critical SEP and FRAND agreements. Find out more.</description><pubDate>Tue, 05 May 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9d09a15f-6caa-4931-b902-0853c1da0123</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2026/protecting-pharmaceutical-and-medical-device-patents-in-saudi-arabia</link><title>Protecting pharmaceutical and medical device patents in Saudi Arabia: the two-step process every innovator must know</title><description>Saudi Arabia&#x2019;s fast-growing pharma market under Vision 2030 creates real opportunity, but patents alone won&#x2019;t stop generics. Rights holders must also register products and notify the Saudi Food and Drug Authority. Get the protection strategy right before launch.</description><pubDate>Tue, 21 Apr 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">81f30dd0-0812-4d81-83dd-6cffe0037806</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2026/changing-life-sciences-patent-landscape</link><title>Changing Life Sciences&#x27; patent landscape: It&#x27;s time to talk about efficient licensing</title><description>Life sciences has transformed and the patent landscape is transforming with it. The question the industry must confront is whether the licensing models inherited from an earlier era can still deliver life-saving innovation to patients efficiently, or if something new is required?</description><pubDate>Wed, 25 Mar 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7155e508-8117-4b2f-9f3a-03aaa1c0866f</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2026/fifa-world-cup-trademark-copyright-and-enforcement-considerations</link><title>The 2026 FIFA World Cup&#x26;trade;: Trademark, copyright and enforcement considerations</title><description>This overview explains how Canada&#x2019;s existing IP framework will govern use of FIFA World Cup-related marks, content and marketing, and the practical steps businesses can take to avoid missteps before the tournament begins.</description><pubDate>Tue, 17 Mar 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a7ccbae9-9a61-4ece-9bf3-432b7b5ec761</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2026/legal-side-ip-backed-lending</link><title>Smoke detectors and domino effects: The legal side of IP-backed lending</title><description>IP-backed deals require a different kind of legal architecture than traditional asset-based lending&#x2014;one that reflects the unique characteristics of intangible collateral.</description><pubDate>Tue, 17 Mar 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">61c3e65c-9672-4119-85bc-a42ca782b694</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2026/ip-protection-canadian-firms-in-sa</link><title>IP protection for Canadian firms working in South America&#x27;s burgeoning mining sector</title><description>We explore the key considerations for Canadian mining companies to secure, safeguard and manage their IP rights effectively.</description><pubDate>Fri, 06 Feb 2026 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3bfe55d8-a5da-46ae-b830-dafb50891763</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/how-to-assess-patentable-subject-matter-eligibility</link><title>How to assess patentable subject matter eligibility? &#x3C;em&#x3E;Dusome&#x3C;/em&#x3E; continues a trend, SCC to follow</title><description>On the heels of the Supreme Court of Canada&#x2019;s (&#x201C;SCC&#x201D;) hearing in Pharmascience Inc. v. Janssen Inc., et al. regarding subject matter eligibility of methods of medical treatment, the Federal Court issued a subject matter eligibility decision in Dusome v. Canada (Attorney General).</description><pubDate>Tue, 09 Dec 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">600aeb01-6a0a-4982-91a0-a881938e9570</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/uk-asa-rules-unqualified-sustainable-fashion-google-ads-misleading</link><title>UK ASA rules unqualified &#x22;sustainable&#x22; fashion Google ads misleading: what brands must do now</title><description>Are your sustainability claims putting your brand at risk? Find out how recent ASA rulings on &#x22;sustainable&#x22; fashion ads highlight the need for clear, evidence-based messaging, and what all brands should do next.</description><pubDate>Mon, 08 Dec 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d67f081d-9fce-4e99-99e9-6574154a117f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2025/upc-case-win-for-molecular-instruments</link><title>Life Sciences team helps secure success for Molecular Instruments in its patent litigation case in the Unified Patent Court</title><description>Our Life Sciences UPC Litigation team is proud to announce that, together with teams at patent attorney firm Boult and Dutch lawyers at De Brauw Blackstone Westbroek, they have secured a victory for US company Molecular Instruments in a patent litigation case before the Unified Patent Court (UPC), Local Division of the Hague.</description><pubDate>Thu, 04 Dec 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e8dda82d-f745-4f0f-bc8f-5257269f4377</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/chinese-version-of-your-brand</link><title>Do you really need a Chinese version of your brand? Not always&#x2014;and here&#x27;s the smarter alternative IP move</title><description>Do you need to use a Chinese name in branding? Do you need to secure a Chinese brand name in IP? The real question is whether you control your Chinese name.</description><pubDate>Thu, 27 Nov 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">85cce640-633b-4526-b290-77a93b2d013f</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/budget-2025-a-measured-step-up-for-ip-and-innovation</link><title>Budget 2025: A measured step up for intellectual property and innovation</title><description>Budget 2025 introduces new tax incentives, expanded R&#x26;D supports, and major investments in AI and IP programs to strengthen Canada&#x2019;s innovation ecosystem. Overall, the budget aims to make it easier for businesses, especially those developing intellectual property, to innovate, grow, and keep their IP in Canada.</description><pubDate>Wed, 26 Nov 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4aa5ba66-110e-4780-aa6b-7e1e9b3ef680</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/recovering-from-canadas-patent-office-delays</link><title>Recovering from Canada&#x2019;s Patent Office delays with the Patent Term Adjustment Process</title><description>As delays continue with Canada&#x2019;s Patent Office, patentees should consider if Canada&#x2019;s recently introduced Patent Term Adjustment (PTA) system can provide some recovery of otherwise lost patent term. With the Patent Office&#x2019;s service standards now significantly extended, a greater number of patents may qualify for PTA than was the case when PTA was first proposed.</description><pubDate>Wed, 26 Nov 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f086c6bb-ff30-4e92-93f0-79f52e416efe</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/retailers-and-brands-face-a-deluge-of-new-challenges-as-cma-intensifies-action-on-drip-pricing</link><title>Retailers and brands face a deluge of new challenges, as CMA intensifies action on drip pricing</title><description>Consumer law dominates compliance in 2025 as the Competition and Markets Authority gains new powers under the Digital Markets Competition and Consumers Act. Actions target fake reviews, price transparency, drip pricing, enforcement against eight businesses, and guidance for 100 others.</description><pubDate>Thu, 20 Nov 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1ecee06f-f71c-4ca2-a557-6724f462e273</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/femtech-in-canada-guide-to-patents-trademarks-and-ip-strategy</link><title>Femtech in Canada: A practical guide to patents, trademarks and IP strategy</title><description>Femtech&#x2014;technology and innovation focused on women&#x2019;s health&#x2014;has rapidly grown from a niche sector into a central pillar of the modern healthcare economy. As the market expands, strategic intellectual property protection is essential, with patents and trademarks creating defensible moats that safeguard innovation, build consumer trust, and support long-term commercial success.</description><pubDate>Tue, 18 Nov 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fc1832d4-d289-4e43-bca8-36d322f2b935</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/stability-ai-defeats-getty-images-in-landmark-copyright-case</link><title>Stability AI defeats Getty Images in landmark copyright case</title><description>Stability AI largely wins Getty Images case, clarifying UK law on AI and copyright. Getty drops main claims but urges government support for content creators. The judgment addresses secondary infringement and AI&#x2019;s legal context.</description><pubDate>Wed, 05 Nov 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3dcbb433-a30b-419e-a50f-c7d3454566bb</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/hidden-costs-chinese-ip-strategy-wrong</link><title>The hidden costs of getting your Chinese IP strategy wrong</title><description>Here are five of the most common blind spots and how you can avoid them while there&#x2019;s still time.</description><pubDate>Wed, 29 Oct 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d0414f76-0fde-40c4-9555-04f3ef6f4f9d</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/uk-court-of-appeal-clarifies-redaction-test-in-optis-v-apple-frand-licensing-dispute</link><title>UK Court of Appeal clarifies redaction test in Optis v Apple FRAND licensing dispute</title><description>The Court of Appeal&#x2019;s latest decision in Optis v Apple clarifies when UK courts will redact confidential information in judgments.</description><pubDate>Thu, 23 Oct 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f5781957-cf93-48f5-83d4-10191b02d6bc</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/canada-patent-maintenance-fee</link><title>Un aper&#xE7;u de l&#x2019;exigence canadienne relative aux taxes de maintien en &#xE9;tat de brevets</title><description>Cet article donne un aper&#xE7;u des obligations d&#x2019;un brevet&#xE9; qui souhaite prot&#xE9;ger ses demandes de brevet et ses brevets canadiens.</description><pubDate>Wed, 22 Oct 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b9e0d681-e67d-4040-84f4-2d6966e2a3d0</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/federal-court-of-appeal-clarifies-patent-deadlines</link><title>Pr&#xE9;cision de la Cour d&#x2019;appel f&#xE9;d&#xE9;rale : chaque partie concern&#xE9;e par un brevet doit veiller au respect des d&#xE9;lais</title><description>Si les taxes requises pour le maintien en &#xE9;tat d&#x2019;un brevet ou les surtaxes ne sont pas pay&#xE9;es &#xE0; temps, le r&#xE9;tablissement du brevet n&#x2019;est alors possible que si toutes les parties concern&#xE9;es peuvent d&#xE9;montrer qu&#x2019;elles ont agi comme l&#x2019;aurait fait toute personne raisonnablement prudente.</description><pubDate>Tue, 07 Oct 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">24de14c2-584b-4541-9c70-d491952cbfcc</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/crispr-patent-landscape</link><title>Fragmented and shifting CRISPR patent landscape: Global proceedings and the patent pool solution</title><description>In this article we summarize the current state of the CRISPR patent landscape, including major disputes and proceedings in key jurisdictions, and more.</description><pubDate>Wed, 24 Sep 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8fcef619-d091-4b38-9eb2-dc03840f1329</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/neurodata-in-the-algorithmic-age</link><title>The data beneath the skull: Neurodata in the algorithmic age</title><description>In today&#x27;s algorithmic age, neurodata is no longer just a medical curiosity&#x2014;it has become a critical resource powering personalized medicine, adaptive technologies, and even targeted advertising.</description><pubDate>Wed, 24 Sep 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f8b66cdf-2084-4382-ad1d-7ae1564927af</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/your-step-by-step-guide-to-the-uks-important-design-law-consultation</link><title>Your step by step guide to the UK&#x27;s important design law consultation</title><description>The UK government is consulting on reforms to modernise design law, creating a framework tailored for the digital age to better support UK innovation and creativity.</description><pubDate>Thu, 04 Sep 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c57f47ce-ff36-4ebd-9289-6eeb417a736e</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/ai-impact-ip-rights-enforcement</link><title>AI&#x27;s impact on intellectual property rights and enforcement</title><description>AI is both a source of new creative tools and a disruptive force challenging long-standing business models and requiring that we develop new legal standards and norms.</description><pubDate>Thu, 28 Aug 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f7b7a39a-4435-4b1e-af7d-2c338058174f</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/safeguarding-trademarks-brands-globalized-market</link><title>Safeguarding trademarks and brands in a globalized market</title><description>As companies push to expand their market reach, safeguarding trademarks and branding becomes a legal necessity and a strategic imperative.</description><pubDate>Mon, 25 Aug 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ff3deb65-faa6-4c2e-ae13-d078b4d791d3</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/cultural-heritage-sustainability-ip-assets</link><title>Cultural heritage and sustainability as intellectual property assets</title><description>The protection and sustainable use of cultural heritage are not only matters of preservation but also of innovation and economic opportunity which has become both an asset and a responsibility.</description><pubDate>Fri, 15 Aug 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b826b25d-5ee3-4ec0-bb56-459c9066abfb</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/ip-ownership-of-the-human-cell-atlas</link><title>Could IP ownership of the Human Cell Atlas turn into a legal headache for researchers?</title><description>Let&#x2019;s unpack the legal implications of this ambitious international project.</description><pubDate>Fri, 15 Aug 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f18f9925-fe7a-40ae-82d2-0cf61e0b36dc</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/can-us-differences-in-patent-prosecution</link><title>Canada and the U.S.: Differences in patent prosecution</title><description>The patent prosecution processes in Canada and the United States have evolved in distinct ways, resulting in notable procedural and substantive differences.</description><pubDate>Tue, 12 Aug 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d49e43dc-cc0d-4dc2-b589-69b440721400</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/why-computer-software-is-too-vague-for-trademark-protection-and-why-it-matters</link><title>Why Computer Software is too vague for trademark protection - and why it matters</title><description>In the EU, vague trademark claims like &#x201C;computer software&#x201D; persist despite the Court of Justice of the European Union rulings requiring clarity. Unlike NFTs, software lacks specificity, risking unjust monopolies. Courts now limit such claims, urging applicants to be precise to ensure fair competition.</description><pubDate>Tue, 05 Aug 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c064f433-401b-4988-86ba-98505a207139</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/navigating-virtual-patent-marking-in-china</link><title>Navigating virtual patent marking in China: Key compliance insights</title><description>Virtual patent marking in China is complex due to the lack of explicit regulations. Companies must comply with general patent laws, detailing patent categories and numbers in Chinese to ensure proper protection and showcasing of intellectual property.</description><pubDate>Tue, 27 May 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5446c849-ac1b-4317-8b86-7c17844f4e04</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/eu-courts-can-overreach-in-foreign-patent-disputes</link><title>EU courts can overreach in foreign patent disputes: the arm is very long and not confined to infringement</title><description>The Court of Justice of the European Union (CJEU) has ruled in BSH v Electrolux case that courts of EU Member States may hear claims for infringement of foreign patents when seised by domicile. We explore the scope of the reasoning and inconsistencies in the court&#x27;s position.</description><pubDate>Mon, 19 May 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">67a3f663-4f95-4239-a7f1-4360f907c2cb</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/ip-assets-guide-to-maximizing-your-portfolio-value</link><title>IP assets: A guide to maximizing your portfolio&#x27;s value</title><description>Intellectual property can be a central asset for your business, but are you maximizing its value? Read on for a guide to understanding the types of IP available in Canada, how your business can best utilize its IP portfolio, and best practices for maximizing IP as a business asset.</description><pubDate>Tue, 06 May 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ef063a2d-545d-4e4a-b2c9-46dc5ec21c28</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/from-ad-law-to-influencers</link><title>From ad law to influencers</title><description>This year&#x27;s INTA Annual Meeting is once again almost upon us. The event is now global benchmark on the IP industry calendar. This year&#x27;s no different with more than 10,000 delegates set to descend on the San Diego Convention Center, for five days of meetings, presentations and networking.</description><pubDate>Tue, 08 Apr 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3e3d4a13-092f-4ddf-9542-be48d2c2146d</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/can-you-benefit-from-more-ip-protection</link><title>Can you benefit from more than one form of IP protection?</title><description>In this article, we will discuss three different forms of intellectual property protection in Canada: patents, trademarks and industrial designs.</description><pubDate>Thu, 03 Apr 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">74e4135d-a744-4d7b-9457-f015eaed5814</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/ip-complaints-trade-fairs-china</link><title>How to make intellectual property complaints at trade fairs in China</title><description>Given China&#x27;s vast market size and manufacturing capabilities, large-scale trade fairs are held regularly. Among them, the Canton Fair is one of the largest and most comprehensive in the world.</description><pubDate>Wed, 05 Mar 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">43605e81-4a62-46a1-a8f7-ab55fc45b2f4</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/what-does-the-upcs-dusseldorf-courts-long-arm-mean-for-global-patent-disputes</link><title>What does the UPC&#x27;s long arm mean for global patent disputes?</title><description>We explore the Fujifilm v Kodak case, as the UPC D&#xFC;sseldorf court&#x27;s recent decision to rule on a UK patent, despite the UK not being part of the UPC system, highlights the court&#x27;s jurisdictional reach and its implications for global patent disputes.</description><pubDate>Mon, 24 Feb 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8398eaf1-0f48-4f0d-a242-5f7563e745a1</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/updates-to-canadian-patent-office-practices-in-2025</link><title>Pratiques du Bureau des brevets canadien : les mises &#xE0; jour de 2025</title><description>Des modifications aux R&#xE8;gles sur les brevets du Canada sont entr&#xE9;es en vigueur le 1er janvier 2025.</description><pubDate>Fri, 21 Feb 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">92cd9fb2-83c5-4abb-9774-ddf437721c96</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/beware-overreach-by-eu-courts-in-foreign-patent-disputes</link><title>Beware overreach by EU courts in foreign patent disputes</title><description>Why should companies be wary of overreach by EU courts in foreign patent disputes? We explore the BSH v Electrolux and Fujifilm v Kodak cases that raise critical questions about the jurisdiction of courts of EU Member States and the UPC.</description><pubDate>Thu, 30 Jan 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">27ca84b9-669c-477c-a38f-3cacbf291c6a</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2025/beyond-the-standard-patent-term</link><title>Beyond the standard patent term: Canada&#x27;s new patent term adjustment framework</title><description>Beginning January 1, 2025, patent term adjustment is available to protect patent owners from diminished patent terms in Canada.</description><pubDate>Thu, 09 Jan 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0210b8d6-0364-471d-b73a-b2c5cae6c59a</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2025/canadian-patent-law-2024-in-review</link><title>Canadian patent law: 2024 in review</title><description>Prepare for the year ahead with our 2024 summary of notable Canadian patent law developments.</description><pubDate>Wed, 08 Jan 2025 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">927e6ac1-9fab-4670-866c-109e381b29f2</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2024/transparency-in-litigation-part-three</link><title>Transparency in litigation - transparency before the court of France (part 3)</title><description>In the final article of our three-part series on transparency in litigation, we take a look at transparency issues from the perspective of the courts of France.</description><pubDate>Thu, 25 Jul 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9140b0f7-875a-4201-979e-c1e81e668669</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2024/transparency-in-litigation-part-two</link><title>Transparency in litigation - the courts of England &#x26; Wales (part 2)</title><description>In part two of our series on transparency in litigation, we take a look at the litigation documents that non-parties can obtain in the courts of England and Wales, and the principles underlying document requests.</description><pubDate>Thu, 18 Jul 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0a5db28a-191e-43e3-a118-b9a1a2e95a9a</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2024/transparency-in-litigation</link><title>Transparency in litigation - The Unified Patent Court, the courts of England &#x26; Wales and the French courts (part 1)</title><description>In our three-part series &#x27;Transparency in Litigation&#x27; we take a look at the documents that non-parties can obtain in the Unified Patent Court (part one), the courts of England &#x26; Wales (part two) and the French courts, with a deep dive into the principles underlying requests for documents (part three). Read the first article here.</description><pubDate>Fri, 12 Jul 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7e8d0437-a86f-43c6-923c-d88c7b3a4cd8</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2024/canadas-proposed-patent-term-adjustment-framework</link><title>Canada&#x27;s proposed Patent Term Adjustment framework excludes cases of unreasonable delay by the Patent Office</title><description>Canada&#x27;s Patent Term Adjustment framework, set to take effect in January 2025, promises to address unreasonable delays. However, the proposed regulations may fall short, potentially excluding many patents from receiving adequate term adjustments. Learn more about the implications for patentees and how to voice your concerns.</description><pubDate>Wed, 12 Jun 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">03586957-7cfc-4135-afb0-306e6fda05fa</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2024/claims-for-patent-infringement-in-alberta</link><title>Alberta patent infringement claims: Two-year and not a six-year limitation period - Seriously? Comments on the recent &#x3C;em&#x3E;JL Energy Transportation&#x3C;/em&#x3E; decision</title><description>Claims for patent infringement in Alberta have only a two-year and not a six-year limitation period as set out in the Patent Act. Seriously? Comments on the recent Alberta Court of Kings Bench decision in JL Energy Transportation Inc. v. Alliance Pipeline Limited Partnership</description><pubDate>Tue, 07 May 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c44e9465-ac98-47b2-b40c-b9b0c820803a</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2024/protecting-canadian-innovation-cleantech-sector</link><title>Technologies propres : prot&#xE9;ger les innovations canadiennes</title><description>Les technologies &#xE9;mergentes visant &#xE0; r&#xE9;gler des probl&#xE8;mes environnementaux ou &#xE0; en att&#xE9;nuer les cons&#xE9;quences sont mieux connues sous le nom de &#xAB; technologies propres &#xBB; ou &#xAB; cleantech &#xBB;. Elles incarnent une possibilit&#xE9; de croissance potentiellement foudroyante pour l&#x27;innovation canadienne.</description><pubDate>Wed, 17 Apr 2024 12:21:00 Z</pubDate></item><item><guid isPermaLink="false">97beb504-500b-4ed0-99f0-559f243a7563</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2024/trade-secret-tactics-10-strategies-counsel</link><title>Conseillers juridiques en entreprise : 10 mesures &#xE0; int&#xE9;grer &#xE0; votre strat&#xE9;gie de secrets commerciaux</title><description>Les secrets commerciaux jouent un r&#xF4;le primordial dans l&#x27;&#xE9;cosyst&#xE8;me de l&#x2019;innovation. Compte tenu de la vitesse &#xE0; laquelle elle modifie les technologies r&#xE9;centes, les rendant redondantes voire obsol&#xE8;tes, il peut s&#x27;av&#xE9;rer inappropri&#xE9; ou peu rentable de s&#x27;appuyer uniquement sur la protection par brevet pour prot&#xE9;ger sa propri&#xE9;t&#xE9; intellectuelle.</description><pubDate>Tue, 26 Mar 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">94622cf9-cf74-4c3d-a046-e8230d639acc</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2024/the-whole-truth-and-nothing-but-the-truth</link><title>Toute la v&#xE9;rit&#xE9;, rien que la v&#xE9;rit&#xE9; : ne pas porter &#xE0; la connaissance du Juge autorisant une saisie-contrefa&#xE7;on toutes les informations utiles peut &#xEA;tre lourd de cons&#xE9;quences</title><description>In France a saisie is the instrument par excellence needed for when proving infringement.&#xA0;Although highly effective, it is strictly regulated due to its invasive nature and the fact that the procedure for obtaining it is in principle non-adversarial. In France, in addition to an ad hoc legal framework, case law, and particularly the Cour de cassation (French Supreme Court) has, over the years, laid down obligations that the applicant is required to comply with.</description><pubDate>Wed, 13 Mar 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2124af50-7f52-4f38-b0fe-87f02cb6f0c6</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/white-papers/2024/26th-annual-patent-case-law-review</link><title>26e revue annuelle des d&#xE9;cisions cl&#xE9;s en mati&#xE8;re de brevets (EN Anglais)</title><description>We recently held our 26th Annual Patent Case Law Review where our IP lawyers explored key topics, including ongoing developments in the SEP/FRAND case law, a review of UPC cases and what to watch out for in 2024. Explore our Annual Review to find out more.</description><pubDate>Wed, 28 Feb 2024 12:07:00 Z</pubDate></item><item><guid isPermaLink="false">d12c035a-2ca7-43ce-beb5-e024fa5fc797</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/white-papers/2025/annual-patent-case-law-review</link><title>26e revue annuelle des d&#xE9;cisions cl&#xE9;s en mati&#xE8;re de brevets (EN Anglais)</title><description>Our annual patent case law review took place at the start of July 2025. As always, a lot of ground was covered, including in-depth and interactive breakout sessions.</description><pubDate>Wed, 28 Feb 2024 12:07:00 Z</pubDate></item><item><guid isPermaLink="false">870552e3-3a7a-4661-8084-fea9cf8fc905</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2024/patentability-of-methods-of-medical-treatment</link><title>Federal Court of Appeal addresses patentability of methods of medical treatment in Canada</title><description>Methods of medical treatment are considered to be an exception to patentable subject matter in Canada. However, it is acknowledged that the exception has no explicit statutory basis, and the supporting jurisprudence is both unclear and contradictory.</description><pubDate>Fri, 23 Feb 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">dba816a0-5042-4bec-82ed-f35d2301ca68</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2024/patentability-of-ai</link><title>Patentability of AI: Emotional Perception vs the UK IPO</title><description>Recent High Court ruling challenges patent eligibility for AI inventions in the UK. The UK Intellectual Property Office (IPO) is appealing the decision and we take a look at the issues under appeal and the possible consequences for the patentability of AI inventions in the UK.</description><pubDate>Mon, 12 Feb 2024 08:41:00 Z</pubDate></item><item><guid isPermaLink="false">7fbc0f61-11a0-4c20-b9bd-a1be3c60b72a</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2024/cjeu-assessed-compliance-with-eu-law</link><title>La CJUE appr&#xE9;cie la responsabilit&#xE9; sans faute de la partie ex&#xE9;cutant une mesure provisoire sur la base d&#x27;un titre cons&#xE9;cutivement annul&#xE9;</title><description>Titulaires de brevets, ex&#xE9;cuter une mesure provisoire vous expose &#xE0; devoir indemniser la partie adverse en cas d&#x27;annulation de votre titre. Bien &#xE9;valuer sa validit&#xE9; pr&#xE9;alablement est donc essentiel. Notre nouvel article revient sur la d&#xE9;cision rendue en la mati&#xE8;re par la Cour de justice de l&#x27;Union europ&#xE9;enne le 11 janvier 2024, sur son incidence en France et en Allemagne, et sur la fa&#xE7;on dont cette probl&#xE9;matique est trait&#xE9;e au Canada, au Royaume-Uni, et en Chine.</description><pubDate>Mon, 12 Feb 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1a46ace0-758c-4f18-a9da-98bedaa2094c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2024/new-costs-cap-under-the-shorter-trial-scheme</link><title>Will the new costs cap under the Shorter Trial Scheme bring a rise in mid-tier patent litigation?</title><description>For patent and registered design right cases in England and Wales, a new costs cap has been introduced under the Shorter Trials Scheme procedure in the High Court&#x27;s Patents Court. What does the change mean and how will it impact cost recovery? Here we provide a summary of the key points to note and the wider implications of this change in terms of the options for resolving disputes through the courts.</description><pubDate>Wed, 31 Jan 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4e81b151-01c7-4b23-addd-2c7bc9e2b16b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2024/qatar-patent-applications</link><title>Qatar joins Bahrain and Kuwait as third national patent office to refer patent applications to GCCPO</title><description>In 2023, Qatar became the third country to begin referring the filing and examination of national patent applications to the GCCPO. We provide a summary of what this change means.</description><pubDate>Wed, 24 Jan 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2e5b5cf6-47c7-446a-9964-f9b1bbe2956e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2024/new-official-fees-for-uae-patent-applications</link><title>New official fees for UAE patent applications effective from January 2024</title><description>A new Ministerial Decision no. 112 of 2023 was issued by the UAE Cabinet in November 2023, which introduces changes to the official fees for UAE patent applications, utility models and industrial design applications, amending the official fees associated with Federal law no. 11 of 2021. The Decision was published in the UAE&#x2019;s Official Gazette on November 15, 2023 and these changes came into effect on January 15, 2024. In this article, we examine those changes and how they affect patent applications filed in the UAE.</description><pubDate>Mon, 22 Jan 2024 08:32:00 Z</pubDate></item><item><guid isPermaLink="false">b4896e33-d00c-4f63-a6f5-84e368615509</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2024/canadian-patent-law-2023-year-in-review</link><title>Droit canadien en mati&#xE8;re de brevets &#x2013; Faits saillants de 2023 (en anglais)</title><description>Canadian courts issued many patent-related decisions in 2023. This article summarizes a number of the more notable court decisions.</description><pubDate>Tue, 16 Jan 2024 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">971ddd34-0385-4525-933a-aae9ba0d8878</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2024/patent-applications-must-identify-human-inventors</link><title>Supreme Court rules that patent applications must identify human inventors</title><description>UK Supreme Court rules in Thaler case: a patent application must identify a human inventor. The judgment leaves open for later cases the possibility of patents for inventions made by humans involving the use of AI. Our legal experts explore this topic in our latest insight.</description><pubDate>Wed, 03 Jan 2024 10:54:00 Z</pubDate></item><item><guid isPermaLink="false">2d9340d9-b186-4d04-bf2b-1c0138ca5d7e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2023/upc-and-the-definition-of-same-parties</link><title>The party season is upon us but what does a party look like to the Unified Patent Court?</title><description>The Unified Patent Court&#x27;s (UPC&#x27;s) decision in a recent case has raised a significant point in relation to the definition of &#x27;same parties&#x27; in the context of parallel revocation and infringement claims. Our IP experts do a deep dive and consider what it means for future claims brought before the UPC.</description><pubDate>Wed, 20 Dec 2023 08:26:00 Z</pubDate></item><item><guid isPermaLink="false">d4ccafe5-7301-4811-b8aa-69f948aa4f7c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2023/rational-reaction-to-emotional-perception</link><title>Rational reaction to Emotional Perception?</title><description>The UK Intellectual Property Office (IPO) has changed its patenting guidelines for AI inventions. Two recent announcements from the IPO have shed some light on the issue, but questions remain. We take a look at what the IPO said and what it will do.</description><pubDate>Mon, 04 Dec 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ea825db5-8827-49f9-a76f-8a94cf3a20d0</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2023/get-ready-for-patents-for-ai</link><title>Get ready for patents for AI: UK court says Artificial Neural Networks are patentable</title><description>Can you get a patent for AI? The UK High Court has recently issued its first judgment on this topic, Emotional Perception AI v Comptroller-General of Patents [2023] EWHC 2948 (Ch) and has said &#x27;yes&#x27;. In this article, we discuss the eligibility, implications and key takeaways.</description><pubDate>Mon, 27 Nov 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1b19a2a0-7a35-44c4-ad2e-4837f7d97e03</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2023/trade-secrets-non-competes-ndas</link><title>Protection du secret commercial &#xE0; l&#x27;&#xE9;chelle mondiale : particularit&#xE9;s des clauses de non-concurrence et des accords de non-divulgation (en anglais)</title><description>As one method of safeguarding trade secrets and shielding them from misappropriation, companies often use non-competes and non-disclosure agreements (NDAs). The problem, however, is that such agreements may not always be legally enforceable, thus falling short of delivering the intended protection.</description><pubDate>Fri, 10 Nov 2023 13:50:00 Z</pubDate></item><item><guid isPermaLink="false">cd9de36d-8472-4802-b42d-79130cdd445c</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2023/new-trade-secrets-directive-in-germany</link><title>Trade Secrets Directive - effective business framework</title><description>The Act relating to safeguarding trade secrets (GeschGehG) entered into force on 26 April 2019 and fundamentally changed the protection of trade secrets in Germany. Find out key details about the Act and its wider impact in our article.</description><pubDate>Tue, 24 Oct 2023 14:01:00 Z</pubDate></item><item><guid isPermaLink="false">2d0aa896-96f9-4f3f-862c-52f046b45d7e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/guides/2023/the-legal-500-ip-country-comparative-guide-2023</link><title>The essential guide to intellectual property laws and regulations: understanding IP across multiple jurisdictions</title><description>It is important to understand intellectual property on an international level in order for businesses to protect their brands globally. Take a look at our insights in the latest edition of The Legal 500: Intellectual Property Country Comparative Guide.</description><pubDate>Tue, 24 Oct 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">69c73497-ad60-450b-b162-4e58979a9d1d</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2023/recording-assignments-with-the-epo</link><title>Recording assignments with the EPO &#x2013; time called on using electronic signatures</title><description>The European Patent Office has confirmed its return to requiring handwritten signatures for the assignment of legal documents. Our intellectual property lawyers discuss the background to the decision and what organisations need to consider when making future applications to the EPO.</description><pubDate>Thu, 12 Oct 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d90bcc61-4369-449b-bbf8-6c59de18c56a</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2023/distinction-confidential-information-know-how</link><title>Renseignements confidentiels, savoir-faire et secrets commerciaux : L&#x2019;importance de la d&#xE9;finition dans l&#x2019;&#xE9;valuation de la valeur</title><description>Qu&#x2019;est-ce qu&#x2019;un savoir-faire? Qu&#x2019;est-ce qu&#x2019;un secret commercial? Un savoir-faire est-il toujours un secret commercial? Tous les savoir-faire sont-ils confidentiels?</description><pubDate>Tue, 12 Sep 2023 12:07:00 Z</pubDate></item><item><guid isPermaLink="false">2e0c023d-8e9b-4d96-aede-ddf6530d47ca</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2023/how-reula-will-impact-ip-law-in-the-uk</link><title>REULA&#x27;s end of supremacy of EU law will impact IP law in the UK from 2024, explains High Court</title><description>The Retained EU Law (Revocation and Reform) Act 2023 (REULA) is now on the statute books. As has been reported widely, it revokes, at the end of 2023, a long list of retained direct and subordinate legislation derived from EU legislation. This will impact intellectual property law in the UK as the UK separates further from the EU.</description><pubDate>Mon, 04 Sep 2023 11:13:00 Z</pubDate></item><item><guid isPermaLink="false">8e6dd9a7-5908-462c-a1dc-c1df9545748a</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2023/prior-art-and-patentability-canada</link><title>Prior art and patentability: Canada</title><description>This Note provides information useful for patent counsel with responsibility for a global patent portfolio to help them understand the legal analytical framework in Canada for determining the potential patentability of an invention, which a patent applicant may seek to cover.</description><pubDate>Tue, 22 Aug 2023 19:37:00 Z</pubDate></item><item><guid isPermaLink="false">1f6c2940-038a-497a-82a2-ff7263dc21a0</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2023/federal-court-of-appeal-subject-matter-eligibility</link><title>Cour d&#x27;appel f&#xE9;d&#xE9;rale : rejet du cadre propos&#xE9; pour d&#xE9;terminer la brevetabilit&#xE9; (en anglais)</title><description>Last summer, the Federal Court proposed a new framework when considering an appeal that arose from the Canadian Intellectual Property Office (CIPO)&#x27;s rejection of two Canadian patent applications for being directed at ineligible subject matter.</description><pubDate>Thu, 10 Aug 2023 21:29:00 Z</pubDate></item><item><guid isPermaLink="false">e562e750-1d82-4f19-b7e3-1dc5deb66449</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2023/significant-cipo-trademark-fee-increase</link><title>Augmentation importante des frais de l&#x2019;OPIC d&#xE8;s le 1er janvier 2024 : d&#xE9;posez sans plus tarder vos nouvelles demandes de marques de commerce!</title><description>Le 1er janvier 2024, l&#x2019;OPIC augmentera de 25 % la plupart de ses frais de marques de commerce, y compris les frais de demande d&#x2019;enregistrement pour chaque classe.</description><pubDate>Thu, 06 Jul 2023 14:51:00 Z</pubDate></item><item><guid isPermaLink="false">23381152-bc35-4539-8332-958847c61358</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2023/canadian-patent-fees-to-significantly-increase</link><title>Augmentation importante des taxes applicables aux brevets canadiens en 2024 : comment l&#x27;&#xE9;viter et r&#xE9;duire les d&#xE9;penses</title><description>En vertu des r&#xE9;centes modifications l&#xE9;gislatives port&#xE9;es aux R&#xE8;gles sur les brevets du Canada, le tarif des taxes officielles payables au Bureau canadien des brevets en lien avec les demandes de brevets et les brevets d&#xE9;livr&#xE9;s augmentera d&#xE8;s le 1er janvier 2024.</description><pubDate>Thu, 06 Jul 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7ec68e1c-dc7f-4f86-a95a-d0ad9183f53b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2023/unified-patent-court-system-in-europe</link><title>Lifecycle of a smart idea | Are you prepared for the new unified patent court system in Europe?</title><description>Our panellists examine the position of current and future patents in Europe, consider new options, and provide detailed, practical answers to important questions.</description><pubDate>Fri, 02 Jun 2023 15:18:00 Z</pubDate></item><item><guid isPermaLink="false">f5bf2384-3dc1-4dce-94c6-e4ebad3ef4c8</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2023/the-pmprb-controversy-and-suspense</link><title>Le Conseil d&#x27;examen du prix des m&#xE9;dicaments brevet&#xE9;s :&#x3C;br&#x3E;controverse et suspense (en anglais)</title><description>The Patented Medicines Prices Review Board (PMPRB) has seemingly courted controversy over the last 6 years. Through its pricing decisions and proposed regulatory amendments, the PMPRB took steps to expand its jurisdiction beyond its statutory domain.</description><pubDate>Tue, 25 Apr 2023 16:11:00 Z</pubDate></item><item><guid isPermaLink="false">c20c0060-d738-443c-a884-a39b6e18e9ec</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2023/strategically-using-chinese-utility-models</link><title>Strategically using Chinese utility models</title><description>Despite recent headlines emphasizing &#x22;nearshoring&#x22; and long-term demographic issues, China remains a manufacturing powerhouse and a large market. In view of this, non-Chinese companies commonly partner with Chinese companies to manufacture products for worldwide distribution and to gain access to the Chinese market.</description><pubDate>Tue, 25 Apr 2023 16:09:00 Z</pubDate></item><item><guid isPermaLink="false">c85d476b-22bb-494f-96ae-88dbb7df58e8</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/reports/2023/are-you-prepared-for-the-unitary-patent-system</link><title>The Unitary Patent System - Expectations, challenges, preparation</title><description>In 2015, Gowling WLG conducted an online survey of patent attorneys and solicitors in private practice and in-house roles, seeking their views on the introduction of the Unified Patent Court (UPC) and Unitary Patent (UP). The results then showed a strong degree of pessimism as to the necessity of the system and whether it would be a success.</description><pubDate>Mon, 24 Apr 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">439fe93f-afe3-400d-9c4a-4c24ca186bdb</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2023/patent-infringement-remedies-around-the-world</link><title>Cycle de vie d&#x27;une bonne id&#xE9;e | Tour du monde des recours en contrefa&#xE7;on de brevets (en anglais)</title><description>Our international panel of intellectual property (IP) professionals have hosted an informative session focusing on the remedies available for patent infringement in Canada, the US, the UK, France, China, as well as under the new Unified Patent Court.</description><pubDate>Wed, 05 Apr 2023 13:26:00 Z</pubDate></item><item><guid isPermaLink="false">e18cc69c-6986-4c88-8fa5-33521326149d</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2023/managing-software-and-ai-inventions-as-ip</link><title>Managing software and AI inventions as IP</title><description>Although AI has been around for some time, the rapid development and widespread application of AI technology over the last 10 years has resulted in a global AI &#x27;patent boom&#x27;.</description><pubDate>Tue, 04 Apr 2023 07:55:00 Z</pubDate></item><item><guid isPermaLink="false">a2e7dc29-f02d-43a7-84c9-0c282686c39f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/opting-out-of-the-upc</link><title>Vous souhaitez d&#xE9;roger &#xE0; la comp&#xE9;tence de la Juridiction Unifi&#xE9;e du Brevet ? Voici notre guide pour les titulaires de brevets</title><description>Alors que l&#x27;av&#xE8;nement de la Juridiction unifi&#xE9;e du brevet (JUB) approche, les subtilit&#xE9;s de son fonctionnement se pr&#xE9;cisent. Nos experts en propri&#xE9;t&#xE9; industrielle vous pr&#xE9;cisent ici la structure et le r&#xF4;le du nouveau tribunal, et apportent quelques pr&#xE9;cisions relatives &#xE0; la proc&#xE9;dure de d&#xE9;rogation (opt out) qui s&#x27;offre aux titulaires de brevets europ&#xE9;ens, de certificats compl&#xE9;mentaires de protection (CCP) et aux demandeurs de brevets.</description><pubDate>Wed, 15 Mar 2023 08:17:00 Z</pubDate></item><item><guid isPermaLink="false">21ffbc36-04e0-45be-a8ac-83ca03c21b8e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/what-will-litigation-in-front-of-the-upc-look-like</link><title>Comment les litiges seront-ils abord&#xE9;s devant la Juridiction Unifi&#xE9;e du Brevet ?</title><description>Dans cet article, nos avocats en propri&#xE9;t&#xE9; intellectuelle r&#xE9;sument les principaux m&#xE9;canismes et proc&#xE9;dures accessibles devant la JUB. Nous avons &#xE9;galement &#xE9;tabli une comparaison avec les r&#xE8;gles et proc&#xE9;dures en vigueur en Allemagne, en France et au Royaume-Uni.</description><pubDate>Wed, 15 Mar 2023 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4d525fce-82a5-4ea8-8b69-43eff60585a0</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2023/court-of-appeal-win-for-interdigital</link><title>Intellectual property team secures another Court of Appeal win for InterDigital in Lenovo dispute</title><description>The Intellectual Property team has secured another Court of Appeal win in 2023 for InterDigital, one of the world&#x27;s largest mobile and video technology research and development companies, in its litigation against Lenovo.</description><pubDate>Thu, 16 Feb 2023 09:24:00 Z</pubDate></item><item><guid isPermaLink="false">c8460c03-3ae6-4131-aac8-820fe1937c1b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2022/influencers-in-toronto</link><title>Influencers in Toronto</title><description>In this series, you will meet a number of practitioners in our Toronto office who have helped their clients overcome a variety of complex legal obstacles.</description><pubDate>Thu, 09 Feb 2023 18:59:00 Z</pubDate></item><item><guid isPermaLink="false">aee0185d-8588-42b1-a598-507d28f009c9</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/white-papers/2023/annual-patent-review-paper-2022</link><title>Annual patent review paper 2022: A Slightly Slippery Slope</title><description>Our annual review of UK patent judgments in 2022 comprehensively reviews the patent decisions of the courts of England and Wales, with comment and opinion on the big issues arising.</description><pubDate>Wed, 08 Feb 2023 12:07:00 Z</pubDate></item><item><guid isPermaLink="false">2ee8334c-f6b9-451d-a2cc-9271db027c3d</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2023/uk-and-uae-approach-to-patent-enforcement</link><title>Enforcing UAE patent rights: A comparative overview of the UK and UAE approach</title><description>In this article we look at some of the procedural differences between patent litigation in the UK and the UAE. First, we remind readers of the process for obtaining patent rights and utility models in the UAE.</description><pubDate>Mon, 30 Jan 2023 08:44:00 Z</pubDate></item><item><guid isPermaLink="false">1adeaef6-fd0c-4d9b-ad6f-85bf5b80a959</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2023/canadian-patent-law-2022-year-in-review</link><title>Droit canadien des brevets : faits saillants de 2022 (article en anglais)</title><description>Canadian Courts issued many patent-related decisions in 2022. This article summarizes a number of the more notable court decisions, as well as other patent-related developments from 2022.</description><pubDate>Thu, 12 Jan 2023 17:15:00 Z</pubDate></item><item><guid isPermaLink="false">3efff9fb-9848-4c72-a7ce-769ed5243309</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/gcc-patent-office-to-handle-new-applications</link><title>The GCC Patent Office to handle new applications from January 2023</title><description>In the latest Official Gazette issued by the GCC Patent Office, it was confirmed that from 1st January 2023 the GCC Patent Office will begin to handle national patent applications on behalf of the requesting GCC country. So far, two countries have confirmed to be referring their national applications from January 2023 to the GCC Patent Office to handle formality and substantive examination.</description><pubDate>Tue, 20 Dec 2022 09:14:00 Z</pubDate></item><item><guid isPermaLink="false">ab8edc47-3ac7-4188-9964-a2a4e4801540</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/changes-to-canadian-patent-rules</link><title>R&#xE9;centes modifications aux &#x3C;em&#x3E;R&#xE8;gles sur les brevets&#x3C;/em&#x3E; du Canada et enjeux pour les demandeurs</title><description>Alors que le pays s&#x27;appr&#xEA;te &#xE0; instaurer un r&#xE9;gime visant &#xE0; ajuster la dur&#xE9;e des brevets aux termes de l&#x27;Accord Canada-&#xC9;tats-Unis-Mexique (ACEUM), les R&#xE8;gles sur les brevets seront modifi&#xE9;es afin de simplifier le processus d&#x27;examen et ainsi &#xE9;viter les retards inutiles.</description><pubDate>Thu, 24 Nov 2022 22:07:00 Z</pubDate></item><item><guid isPermaLink="false">077ba475-634d-4ca6-ae01-6fbc6ccaff23</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/scc-upholds-usd644-million-award-for-patent-infringement</link><title>Supreme Court of Canada upholds $644-million award for patent infringement; provides fresh guidance for conducting an accounting of profits</title><description>In an 8 to 1 decision (2022 SCC 43), the Supreme Court of Canada has upheld the largest monetary award ever by a Canadian court for patent infringement: $644 million in favour of Dow Chemical for Nova Chemicals&#x27; infringement of Dow&#x27;s patent. In so doing, the Supreme Court provided fresh guidance and a preferred framework for conducting an accounting of profits.</description><pubDate>Fri, 18 Nov 2022 20:30:00 Z</pubDate></item><item><guid isPermaLink="false">759e3803-8338-44bc-ab49-b4b29ea25707</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/key-trademark-considerations-m-a-transactions</link><title>Marques et marques de commerce : consid&#xE9;rations cl&#xE9;s pour les op&#xE9;rations de F&#x26;A (article en anglais)</title><description>It is crucial that a buyer or seller of a company does not overlook trademarks and brands in business acquisitions, or any red flags that might get revealed. Luckily, there are solutions to overcome such complexities.</description><pubDate>Fri, 18 Nov 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">aabf5b35-01e6-4d68-b6a8-54ae907e380c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/international-licensors-licensees-business-china</link><title>Legal considerations for international licensors and licensees conducting business in China</title><description>Foreign licensors and licensees need to be aware of the key consequences of doing business in China. Taking proper account of these will also help them weigh up whether to follow through with litigation or to go down the route of arbitration in the event of a dispute.</description><pubDate>Thu, 17 Nov 2022 13:31:00 Z</pubDate></item><item><guid isPermaLink="false">e78490e3-c7da-4a77-ae2a-2c9f1ce5cd9f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/key-to-success-technology-transfer-tips-ip-manager</link><title>The key to success: Technology transfer tips for university and research IP managers</title><description>The role of the technology transfer office is crucial for getting products to market. Implementing well thought-out strategies will allow these to flourish in your organisation.</description><pubDate>Tue, 15 Nov 2022 14:38:00 Z</pubDate></item><item><guid isPermaLink="false">637e9ee9-b289-4535-8ce2-39630b8dbc4f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/guides/2022/protecting-your-inventions-in-china-patent-guide</link><title>Protecting your inventions in China: The China Patent Law Guide</title><description>Our China Patent Law Guide serves as an easy-to-read, searchable and continuously updated resource for IP practitioners who must learn to negotiate this legal landscape strategically.</description><pubDate>Thu, 10 Nov 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6a93963f-02da-4467-9aa6-5c161fed0dbe</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/client-work/2022/crocs-successfully-asserts-industrial-design</link><title>Crocs successfully asserts industrial design, awarded infringer&#x27;s profits</title><description>Crocs has successfully asserted an industrial design that covers its MAMMOTH line of clogs, establishing infringement by Double Diamond&#x27;s knock-off Fleece Dawgs products.</description><pubDate>Thu, 27 Oct 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">befe3712-2c2c-4b91-b2eb-f6094f4551b9</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/how-far-can-the-upc-reach</link><title>Quelle est la port&#xE9;e juridictionnelle de la JUB?</title><description>La JUB a r&#xE9;cemment propos&#xE9; une modification du R&#xE8;glement. Dans cet article, notre &#xE9;quipe de propri&#xE9;t&#xE9; intellectuelle examine ces changements et leurs implications.</description><pubDate>Fri, 21 Oct 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8930a02d-0d4a-4364-8faf-d09856b674bc</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2022/miovision-acquires-rapid-flow-technologies</link><title>Miovision acquires Rapid Flow Technologies</title><description>On October 11, 2022, Miovision Technologies Inc. announced that it had acquired Pittsburgh-based Rapid Flow Technologies.</description><pubDate>Tue, 11 Oct 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b8d0265b-cd24-4176-927b-a87ff28922ea</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/false-patent-marking-in-china</link><title>False patent marking in China &#x2013; How the courts are determining damages</title><description>In China, false patent marking is becoming more prevalent, so it is interesting that in June 2022, the Chinese Supreme People&#x27;s Court heard an appeal case that shed light on how damages should be determined in such cases. In this article, we explore the outcome of that case and how the approach to determining damages differs to that for patent infringement cases.</description><pubDate>Thu, 29 Sep 2022 10:34:00 Z</pubDate></item><item><guid isPermaLink="false">aa3cf212-bbaf-4dc2-8e27-832c1be97f55</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/the-cost-challenge</link><title>The Cost Challenge: How can UK courts remain competitive for patent litigation in a new era?</title><description>Gordon Harris&#x27; insightful article &#x27;The Cost Challenge: How can UK courts remain competitive for patent litigation in a new era&#x27; explores the success of costs reforms instigated in the last 30 years in England and Wales.</description><pubDate>Tue, 13 Sep 2022 13:11:00 Z</pubDate></item><item><guid isPermaLink="false">85c48bcb-7ff2-46a0-b25f-4fe91cb05d7b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/market-it-or-lose-it-a-cautionary-tale</link><title>Innovateurs, prenez garde : commercialisez vos inventions&#x3C;br&#x3E;ou vous perdrez vos privil&#xE8;ges (article en anglais)</title><description>In AbbVie Corporation v Canada (Health), 2022 FC 1209, Justice Fothergill of the Federal Court upheld the Minister of Health&#x27;s finding that innovator pharmaceutical companies must actively market their drugs in Canada in order to benefit from Canada&#x27;s patent linkage regime.</description><pubDate>Tue, 30 Aug 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5327db39-c471-4ed0-95cb-773430fec09f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/patent-ownership-when-your-r-d-staff-depart</link><title>D&#xE9;part du personnel de recherche&#x3C;br&#x3E;et d&#xE9;veloppement : &#xE0; qui appartiennent les droits de propri&#xE9;t&#xE9; intellectuelle? (article en anglais)</title><description>The success of IP transactions is rooted in the IP asset in play. But what if your company suddenly discovers it no longer actually owns the right, despite it being created by employees?</description><pubDate>Tue, 02 Aug 2022 14:38:00 Z</pubDate></item><item><guid isPermaLink="false">be731487-11b7-4f80-a27f-29565a2f65a5</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/be-proactive-about-ip-ownership</link><title>Prot&#xE9;gez vos droits de propri&#xE9;t&#xE9; intellectuelle de mani&#xE8;re proactive (article en anglais)</title><description>For patented or patentable inventions, it is best practice to execute an agreement for a patent assignment that compensates the employee for the invention separately from their usual employment compensation.</description><pubDate>Tue, 02 Aug 2022 14:36:00 Z</pubDate></item><item><guid isPermaLink="false">f0441588-2136-4be5-9a1f-899e26501fb5</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2022/going-global-with-your-patents-for-smes</link><title>Vos brevets &#xE0; l&#x27;&#xE9;chelle mondiale : risques et occasions pour les PME canadiennes (disponible en anglais)</title><description>Patent rights are the lifeblood of the global innovation economy and one of the most valuable corporate assets a growing business can have. With the right strategy, IP assets can be levered to secure finance for company growth, as well as attract and solidify partnerships.</description><pubDate>Wed, 20 Jul 2022 14:37:00 Z</pubDate></item><item><guid isPermaLink="false">aceff640-d48b-4918-ac5e-74b8fc7be602</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/how-does-the-upc-work</link><title>Comment fonctionne la Juridiction Unifi&#xE9;e du Brevet (JUB) ?</title><description>Notre &#xE9;quipe de propri&#xE9;t&#xE9; intellectuelle explique tout ce qu&#x27;il faut savoir sur la JUB, sa structure et son fonctionnement.</description><pubDate>Mon, 18 Jul 2022 12:49:00 Z</pubDate></item><item><guid isPermaLink="false">d56fef2c-00d8-48eb-ad8b-579d4bc991d1</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/new-export-control-provisions-for-uae-patents</link><title>UAE Patent Regulations introduce new &#x27;export control&#x27; type provisions for UAE patent applications with security and military applications</title><description>What do the new restrictions to the Implementing Regulations for the UAE Patent Law mean for companies and research organisations operating in the military defence or national security sectors? We discuss the new provisions for UAE patents with security or military application.</description><pubDate>Thu, 30 Jun 2022 13:21:00 Z</pubDate></item><item><guid isPermaLink="false">30f91ad1-33e9-4654-a835-152e4b136ce5</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/a-small-screen-patent-infringement-case</link><title>Violation de brevets au petit &#xE9;cran : paiement d&#x27;importantes redevances en jeu (article en anglais)</title><description>In Rovi v Videotron, 2022 FC 874, Rovi alleged infringement by Videotron of four patents with respect to interactive television program guides. Rovi sought an accounting of Videotron&#x27;s profits or, in the alternative, damages in the form of a royalty.</description><pubDate>Wed, 29 Jun 2022 16:43:00 Z</pubDate></item><item><guid isPermaLink="false">93790faf-6470-4a3b-b966-db39fa518ea9</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/eligibility-test-computer-implemented-inventions</link><title>C&#x27;est pratiquement possible : La Cour f&#xE9;d&#xE9;rale du Canada adopte un nouveau test pour analyser la brevetabilit&#xE9; des inventions mises en &#x153;uvre par ordinateur (article en anglais)</title><description>For the third time in a little over a decade, the Canadian Federal Court has disagreed with how the Canadian Intellectual Property Office determines eligibility of computer-implemented inventions.</description><pubDate>Mon, 20 Jun 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7295a317-3fdc-4d44-bd6d-105a3205cde0</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/middle-east-based-patent-filers-are-you-prepared</link><title>Middle East-based patent filers - the Unified Patent Court will open doors early 2023, are you prepared?</title><description>In this article we summarise everything Middle East-based European patent holders need to know about the major changes to the European patent system.</description><pubDate>Wed, 01 Jun 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8c1b84de-cfe3-41dc-9263-5dd58eb2acc1</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/patents-as-legal-firepower-evolusion-concepts</link><title>Patents as Legal Firepower: Evolusion Concepts, Inc. v HOC Events, Inc., 2022 WL 128577</title><description>Firearms with detachable magazines allow the user to quickly replace the magazine when it is depleted without disassembling the firearm action. In many shooting sports where scores are based on a combination of speed and accuracy, the ability to quickly replace an empty magazine can have a significant impact on a competitor&#x27;s ranking.</description><pubDate>Thu, 28 Apr 2022 15:43:00 Z</pubDate></item><item><guid isPermaLink="false">c9483e0c-552d-40d4-8d98-710be0ce8a3d</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/map-of-the-unified-patent-court-upc</link><title>La carte de la Juridiction unifi&#xE9;e du brevet (JUB)</title><description>L&#x27;introduction de la Juridiction unifi&#xE9;e du brevet offre une protection dans tous les &#xC9;tats participants membres de l&#x27;UE. Utilisez notre carte interactive pour comprendre le statut actuel de chaque juridiction.</description><pubDate>Thu, 21 Apr 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9929fe24-b1ff-44ea-9034-fdb6ad78b6ed</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/guide-to-the-unified-patent-court-upc</link><title>Guide relatif &#xE0; la Juridiction unifi&#xE9;e du brevet (JUB)</title><description>Toute personne impliqu&#xE9;e dans le domaine des brevets en Europe, que ce soit aux stades de l&#x27;application, de l&#x2019;octroi de licences ou de l&#x2019;&#xE9;valuation du risque de potentielles contrefa&#xE7;ons, doit comprendre comment le syst&#xE8;me de la JUB fonctionnera et se pr&#xE9;parer d&#xE8;s maintenant &#xE0; son lancement. Visitez notre centre de ressources sur la JUB et le brevet unitaire pour un guide facile &#xE0; suivre et des FAQ.</description><pubDate>Wed, 20 Apr 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d72ab2fe-0eee-4df7-b173-72b6d611b32b</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/ip-transactions-in-china-and-canada</link><title>Sciences de la vie et op&#xE9;rations de PI : transfert, partage et exclusivit&#xE9; des donn&#xE9;es en Chine et au Canada</title><description>Dans le cadre de nombreuses op&#xE9;rations de propri&#xE9;t&#xE9; intellectuelle (PI) dans le domaine des sciences de la vie, le transfert de donn&#xE9;es et de technologie joue un r&#xF4;le essentiel. Toutefois, on consacre g&#xE9;n&#xE9;ralement tr&#xE8;s peu de temps aux d&#xE9;tails des dispositions op&#xE9;rationnelles &#xE0; cet &#xE9;gard, et on n&#xE9;glige &#xE9;galement de se pencher sur les dispositions juridiques et r&#xE9;glementaires territoriales concernant le partage des donn&#xE9;es entre les autorit&#xE9;s r&#xE9;glementaires. Afin de pouvoir pr&#xE9;server les droits de PI d&#x27;une partie et les faire respecter, surtout en mati&#xE8;re de secrets commerciaux, les professionnels en sciences de la vie doivent absolument savoir de quelle fa&#xE7;on les donn&#xE9;es et la technologie sont trait&#xE9;es.</description><pubDate>Fri, 25 Mar 2022 17:33:00 Z</pubDate></item><item><guid isPermaLink="false">ca66a038-f24a-4e1c-83bd-f74a4eaed385</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/accelerate-patent-prosecution-in-asean-region</link><title>Comment acc&#xE9;l&#xE9;rer la poursuite des demandes de brevets dans la r&#xE9;gion de l&#x27;ANASE (article en anglais)</title><description>How can businesses accelerate patent prosecution in the ASEAN Region? In this article, our Singapore IP experts discuss the main international, regional, and national acceleration programmes in Association of Southeast Asian Nations (ASEAN) countries</description><pubDate>Thu, 24 Mar 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">00a58eff-319b-466e-93a2-d155873aac8d</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/exhaustion-of-patent-and-trademark-rights</link><title>L&#x27;&#xE9;puisement des droits de brevet et de marque de commerce au Canada</title><description>Si votre entreprise participe ou souhaite participer &#xE0; l&#x27;importation au Canada de marchandises prot&#xE9;g&#xE9;es par un droit de propri&#xE9;t&#xE9; intellectuelle, il vous faut comprendre les implications de la loi canadienne en ce qui a trait &#xE0; &#xAB;&#xA0;l&#x27;&#xE9;puisement&#xA0;&#xBB; du droit concern&#xE9;.</description><pubDate>Wed, 09 Mar 2022 14:54:00 Z</pubDate></item><item><guid isPermaLink="false">50b15b00-b4cb-4258-b84d-8d171b324d99</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/exhaustion-of-patent-and-trademarks-in-france</link><title>Exhaustion of patent and trademark rights in France</title><description>What is the law on &#x27;exhaustion&#x27; of intellectual property in France and the EU? Our global IP experts explore the development of the regime governing exhaustion in the country for patents and trademarks, and what this means for businesses.</description><pubDate>Wed, 09 Mar 2022 14:52:00 Z</pubDate></item><item><guid isPermaLink="false">5a7689a4-a4e4-4b6d-8ce6-727a356593a3</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/exhaustion-of-patent-trademark-rights-in-the-uk</link><title>Exhaustion of patent and trademark rights in the United Kingdom</title><description>Our global IP experts explore the UK&#x27;s &#x27;exhaustion&#x27; regime for patents and trademarks, how this governs the import of genuine IP-protected goods, and what it means for businesses.</description><pubDate>Wed, 09 Mar 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4248d321-5fec-41b1-a6af-ad73b82c001f</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/canadian-patent-law-2021-year-in-review</link><title>Droit canadien des brevets : Faits saillants de 2021</title><description>L&#x27;ann&#xE9;e&#xA0;2021 a &#xE9;t&#xE9; fort occup&#xE9;e pour les tribunaux f&#xE9;d&#xE9;raux en plus d&#x27;&#xEA;tre le th&#xE9;&#xE2;tre d&#x27;un certain nombre de changements au chapitre du droit canadien des brevets. Le pr&#xE9;sent article r&#xE9;sume les d&#xE9;cisions judiciaires notables en la mati&#xE8;re au Canada en&#xA0;2021.</description><pubDate>Wed, 02 Mar 2022 14:20:00 Z</pubDate></item><item><guid isPermaLink="false">31facd6e-06c9-46b4-8c50-d00db567e7c6</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/podcasts/2022/protecting-cleantech-inventions-in-canada</link><title>Protecting cleantech inventions in Canada</title><description>How do you commercialize an idea in Canada&#x27;s cleantech sector? Step one: protect it.</description><pubDate>Wed, 16 Feb 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0a7f34a8-3774-4eec-b074-40b98eb380c9</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/white-papers/2022/annual-review-of-uk-patent-judgments-2021</link><title>Annual review of UK patent judgments &#x2013; 2021</title><description>Read our complete guide to the key patent case law emerging from the courts in the UK in 2021, in which partner Gordon Harris takes you through a blockbuster year of patent case law, noting trends and points to watch out for.</description><pubDate>Fri, 11 Feb 2022 11:08:00 Z</pubDate></item><item><guid isPermaLink="false">9686d33f-16e2-4b6d-adf3-98bc9f35eae2</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/protecting-innovation-in-fintech</link><title>How to protect innovation in FinTech - The role of trade secrets</title><description>We take a look at a recent example of an innovator&#x27;s rights in FinTech apparently being under threat by a departing employee, before discussing how to protect your trade secrets.</description><pubDate>Wed, 09 Feb 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c7f8db40-5ff5-4c74-ab81-d2395e8d7d86</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/patent-infringement-summary-trend-continues</link><title>Jugements sommaires en mati&#xE8;re de contrefa&#xE7;on de brevets : la tendance se poursuit</title><description>La d&#xE9;cision de la Cour f&#xE9;d&#xE9;rale dans l&#x27;affaire Kobold v. NCS, 2021&#xA0;FC&#xA0;1437 pr&#xE9;sente plusieurs &#xE9;l&#xE9;ments in&#xE9;dits. Plus important encore, la Cour a &#xE9;t&#xE9; appel&#xE9;e &#xE0; y interpr&#xE9;ter et &#xE0; y appliquer pour la premi&#xE8;re fois la nouvelle d&#xE9;fense de l&#x27;&#xAB;&#xA0;utilisation ant&#xE9;rieure&#xA0;&#xBB;, pr&#xE9;vue &#xE0; l&#x27;article&#xA0;56 de la Loi sur les brevets.</description><pubDate>Tue, 08 Feb 2022 14:48:00 Z</pubDate></item><item><guid isPermaLink="false">9c2b8ebd-d6d5-463d-b6b5-5427e28c36f0</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/what-to-expect-in-2022-pending-patent-decisions</link><title>D&#xE9;cisions en mati&#xE8;re de brevets et proc&#xE8;s/appels &#xE0; venir devant les tribunaux f&#xE9;d&#xE9;raux : un aper&#xE7;u de 2022</title><description>Un mois &#xE0; peine apr&#xE8;s le d&#xE9;but de l&#x2019;ann&#xE9;e 2022, les tribunaux f&#xE9;d&#xE9;raux ont pratiquement r&#xE9;ussi &#xE0; statuer sur toutes les d&#xE9;cisions pendantes en mati&#xE8;re de brevets. Celles relatives &#xE0; l&#x2019;affaire Rovi Guides sont toujours en instance devant la Cour f&#xE9;d&#xE9;rale, et la Cour d&#x2019;appel a encore une d&#xE9;cision &#xE0; rendre en la mati&#xE8;re.</description><pubDate>Tue, 08 Feb 2022 14:42:00 Z</pubDate></item><item><guid isPermaLink="false">ce265dfc-bce1-4adf-8fbd-338ab10beed8</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/new-uae-patent-law-what-do-you-need-to-know</link><title>New UAE Patent Law: What do you need to know?</title><description>The UAE has issued Federal Law no. 11 of 2021 concerning the regulation and protection of Industrial Property Rights. In this article, we review the key changes in the Law and their implications.</description><pubDate>Thu, 03 Feb 2022 08:53:00 Z</pubDate></item><item><guid isPermaLink="false">e869e1ff-c63c-4c1b-a25b-76f199b8145b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/gcc-patent-office-new-working-model-confirmed</link><title>Implementing Regulations confirm the GCC patent office&#x27;s new working model</title><description>The Implementing Regulations for the GCC Patent Office&#x27;s new working model were issued in November 2021. We take you through the key takeaways for the new Regulations.</description><pubDate>Tue, 01 Feb 2022 10:20:00 Z</pubDate></item><item><guid isPermaLink="false">baf9e12d-ae20-42e9-88b9-a5f724e326fa</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2022/licensing-for-global-companies-in-china</link><title>Licensing considerations for global companies in China</title><description>A common strategy to deal with patent infringement claims is to negotiate to obtain a patent licence. However, there are particular issues other than the common issues one may experience in other jurisdictions, this article raises some red flag issues for global companies signing licensing agreements in China.</description><pubDate>Fri, 28 Jan 2022 20:53:00 Z</pubDate></item><item><guid isPermaLink="false">0e920527-4e8b-45da-86bc-156183d2f3a6</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/case-of-xenobots-part-i-patenting-living-machines</link><title>The curious case of xenobots part 1 &#x2013; Patenting of living machines</title><description>Since the 1970s when genetically-engineered bacterium capable of breaking down crude oil was held to be patentable subject-matter, much attention has been paid to the patenting of living inventions.</description><pubDate>Wed, 26 Jan 2022 13:51:00 Z</pubDate></item><item><guid isPermaLink="false">12475dc8-12aa-4d4b-81cc-6788d0ac41a5</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/invega-sustenna-patent-is-infringed</link><title>Proc&#xE8;s sommaire aux termes du &#x3C;em&#x3E;R&#xE8;glement sur les m&#xE9;dicaments brevet&#xE9;s (Avis de conformit&#xE9;)&#x3C;/em&#x3E; : le brevet INVEGA SUSTENNA de Janssen jug&#xE9; contrefait</title><description>Cette nouvelle d&#xE9;cision se distingue par le fait qu&#x27;il s&#x27;agit de la premi&#xE8;re d&#xE9;cision de proc&#xE8;s sommaire sur la contrefa&#xE7;on dans une affaire pharmaceutique en vertu du R&#xE8;glement sur les m&#xE9;dicaments brevet&#xE9;s (avis de conformit&#xE9;).</description><pubDate>Mon, 24 Jan 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ebfbd72c-756a-456f-8077-570405fe0d06</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/upcoming-changes-to-the-european-patent-system</link><title>R&#xE9;forme &#xE0; venir du syst&#xE8;me europ&#xE9;en des brevets : le brevet unitaire et la juridiction unifi&#xE9;e du brevet</title><description>Le syst&#xE8;me europ&#xE9;en des brevets est engag&#xE9; dans de profonds changements qui toucheront tous les d&#xE9;posants de brevets d&#x27;Europe. En effet, apr&#xE8;s des ann&#xE9;es d&#x27;emb&#xFB;ches juridiques et politiques, les tant attendus brevet unitaire et juridiction unifi&#xE9;e du brevet devraient bient&#xF4;t voir le jour, possiblement d&#x27;ici la fin de&#xA0;2022.</description><pubDate>Tue, 18 Jan 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b8fa5ce4-1bf2-4bc2-8481-af39bbaca2a9</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2022/google-wins-patent-infringement-for-google-ads</link><title>Google wins patent infringement litigation aimed at Google ads</title><description>The Federal Court of Canada has dismissed a long-running patent infringement case against Google Canada Corporation, Google LLC and Alphabet Inc.</description><pubDate>Thu, 13 Jan 2022 20:56:00 Z</pubDate></item><item><guid isPermaLink="false">812b72a4-7d5b-4ca3-b78e-abd44cb8e601</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/enforcement-related-consideration-patent-valuation</link><title>Application visant l&#x27;&#xE9;valuation des brevets : le point de vue du Canada (Article en anglais)</title><description>Organisations acquire patent rights in a number of different ways and for a number of different reasons.</description><pubDate>Thu, 13 Jan 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1da81553-aece-46df-ab11-f2607fe0d354</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2022/talan-to-acquire-createch</link><title>Talan to acquire Createch in cross-border transaction</title><description>Le 13 janvier 2022, Talan a annonc&#xE9; qu&#x27;elle avait conclu une entente en vue de l&#x27;acquisition de Createch, qui sera vraisemblablement finalis&#xE9;e d&#x27;ici la fin du premier trimestre.</description><pubDate>Thu, 13 Jan 2022 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c3edcb1a-3b7a-4cb6-988b-244474b04853</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2022/epo-rejects-patent-application-in-dabus-case</link><title>EPO rejects patent application identifying AI system DABUS as inventor</title><description>In the latest on the DABUS case, the European Patent Office has confirmed the decision of the Receiving Section that a patent application cannot succeed where the designated inventor is not a person, but an AI machine.</description><pubDate>Fri, 07 Jan 2022 09:34:00 Z</pubDate></item><item><guid isPermaLink="false">91c931b5-5fb4-4a95-bf39-7c875eadb158</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2021/upcoming-changes-to-the-canadian-patent-rules</link><title>Changements &#xE0; venir pour les r&#xE8;gles canadiennes sur les brevets</title><description>Cela dit, le nouveau r&#xE9;gime d&#x2019;ajustement de la dur&#xE9;e des brevets que le pays s&#x2019;appr&#xEA;te &#xE0; instaurer, aux termes de l&#x2019;Accord Canada&#x2013;&#xC9;tats-Unis&#x2013;Mexique, viendra modifier les R&#xE8;gles sur les brevets en vue de simplifier le processus d&#x2019;examen et ainsi d&#x2019;&#xE9;viter les retards inutiles.</description><pubDate>Thu, 16 Dec 2021 15:09:00 Z</pubDate></item><item><guid isPermaLink="false">90547118-5dcb-4612-90a1-eeb3f9d9acda</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2021/cleantech-protection-of-intellectual-property</link><title>L&#x27;&#xE9;nergie propre et la protection de la propri&#xE9;t&#xE9; intellectuelle (Webinaire en anglais)</title><description>Roch Ripley, a Gowling WLG partner who leads the firm&#x27;s Intellectual Property Group in Vancouver, recently connected with Jeanette Jackson, CEO of the cleantech ecosystem accelerator Foresight, for an engaging and illuminating podcast on this very subject.</description><pubDate>Wed, 15 Dec 2021 21:01:00 Z</pubDate></item><item><guid isPermaLink="false">60dec7ed-93b7-4931-a2d8-2fd965ecc103</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/reports/2021/patent-litigation-trends-the-future-of-biologics</link><title>Patent litigation trends: the future of biologics?</title><description>As the biologics market continues to expand, patent litigation is also increasing. Our report examines what we&#x27;re likely to see in the next few years in this industry and how litigators can prepare for the increase of innovation in next generation therapies.</description><pubDate>Mon, 06 Dec 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8fa63d9b-6a12-4380-b222-540b53eb1945</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2021/exhaustion-of-intellectual-property-rights</link><title>Exhaustion of intellectual property rights in Singapore</title><description>In Singapore, the question of whether an intellectual property right (such as a registered trademark or a patent) can be enforced by way of an infringement action against the sale of genuine goods placed on the market in another country and then parallel imported into Singapore, is governed by an area of law called &#x27;exhaustion&#x27;.</description><pubDate>Thu, 18 Nov 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">645e05f8-3594-466b-a9f6-295cac02177a</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2021/exhaustion-in-the-uk-ip-law-under-review</link><title>Exhaustion in the UK: IP law under review</title><description>How might UK law on exhaustion of IP rights change soon? And what does this mean for parallel imports into post #Brexit Britain? Our IP team detail the key points to note.</description><pubDate>Fri, 12 Nov 2021 13:42:00 Z</pubDate></item><item><guid isPermaLink="false">c1057bef-4a85-478d-b936-537cfd214145</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2021/role-of-ip-strategy-in-drug-development</link><title>De la communication pr&#xE9;alable jusqu&#x27;&#xE0; la commercialisation : le r&#xF4;le de la strat&#xE9;gie de PI dans le d&#xE9;veloppement des m&#xE9;dicaments (Webinaire en anglais)</title><description>With vaccine brand names still very much top-of-mind for Canadians, Gowling WLG&#x27;s own Brian Kingwell and Dr. Sonia Ziesche took part in a recent online panel discussion surrounding drug development and intellectual property.</description><pubDate>Mon, 08 Nov 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b36fb33a-88df-49f4-b274-6ad9ebbb1364</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/exclusions-in-russian-patent-law</link><title>Exclusions dans les lois sur les brevets de Russie : comment s&#x27;y retrouver plus facilement (Article en anglais)</title><description>The question of what constitutes an invention does not have a universally accepted definition, but according to the Russian Patent Office, there are a number of objects that are excluded from patentability. To succeed in their application, candidates are advised to avoid terms that unambiguously exclude inventions from consideration as patents.</description><pubDate>Fri, 05 Nov 2021 16:45:00 Z</pubDate></item><item><guid isPermaLink="false">f27e0dc0-e690-49ac-8866-89225b72f85c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2021/strategies-to-protect-your-intellectual-property</link><title>Strat&#xE9;gies pour prot&#xE9;ger vos droits de propri&#xE9;t&#xE9; intellectuelle (Webinaire en anglais)</title><description>Nelson Godfrey, partner and head of the IP litigation department of Gowling WLG&#x27;s Vancouver office, took part in a recent online panel discussion on how companies can survive and thrive when it comes to safeguarding IP.</description><pubDate>Tue, 02 Nov 2021 18:48:00 Z</pubDate></item><item><guid isPermaLink="false">d760094a-13e8-4679-9bc2-1838e776decc</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/eurasian-patent-organisation-register</link><title>Inscription au nouveau registre pharmaceutique de l&#x27;Organisation eurasienne des brevets : comment faire (Article en anglais)</title><description>The Eurasian Patent Organisation (EAPO) launched its Pharmaceutical Register in March 2021, and it can be accessed on the EAPO&#x27;s website in Russian and partially in English. However, those wishing to register need to be aware of the particular requirements before filing a request.</description><pubDate>Tue, 02 Nov 2021 16:23:00 Z</pubDate></item><item><guid isPermaLink="false">f245fa18-f682-434f-9136-1b2c4d5a8fa0</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2021/how-to-protect-ideas-in-the-life-sciences-sector</link><title>Comment prot&#xE9;ger les id&#xE9;es dans le secteur en plein essor des sciences de la vie (Webinaire en anglais)</title><description>The life sciences sector is booming! Most sectors of the economy are now becoming knowledge-based industries, and in those industries &#x2013; the competition is for ideas. But how do firms protect ideas and innovations, and shield them from being stolen?</description><pubDate>Thu, 28 Oct 2021 14:13:00 Z</pubDate></item><item><guid isPermaLink="false">461bb5d1-e952-42f0-9008-d1ecbfdd7191</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2021/optis-v-apple-form-of-order-published</link><title>Apple falls short of committing to take court-determined FRAND licence in &#x3C;em&#x3E;Optis v Apple&#x3C;/em&#x3E;... for now</title><description>The Court reiterated that it had made it clear that Apple was expected to &#x27;give a simple and unconstrained undertaking to accept whatever licence was ruled to be FRAND&#x27; following a trial planned in June/July 2022.</description><pubDate>Mon, 25 Oct 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1d8520de-5ef4-4c92-be41-0811bfb0813b</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2021/optis-v-apple-decision-to-be-appealed</link><title>UK Court&#x27;s &#x27;willingness&#x27; decision in Optis v Apple to be appealed</title><description>Only a week after the judgment the UK Court sat again to hear Apple&#x27;s request for permission to appeal</description><pubDate>Fri, 08 Oct 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e65f023a-1693-40c1-93cd-5099ad6f53a0</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2021/sep-licensing-wars-put-up-or-shut-up</link><title>SEP Licensing Wars: Put up or shut up</title><description>UK Court says implementers must either commit to taking a court-determined FRAND licence once a patent trial has been won or face an injunction in Optis v. Apple.</description><pubDate>Fri, 01 Oct 2021 08:37:00 Z</pubDate></item><item><guid isPermaLink="false">5486fab3-c177-4146-9f13-251600cc3fa7</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2021/evidence-in-patent-cases</link><title>Cycle de vie d&#x27;une bonne id&#xE9;e | Ce brevet est-il bien prot&#xE9;g&#xE9;? La preuve dans les dossiers de brevets (Webinaire en anglais)</title><description>In this instalment of our &#x27;Lifecycle of a Smart Idea&#x27; series, members of Gowling WLG&#x27;s global IP team examine the main issues that can arise in a patent dispute.</description><pubDate>Wed, 29 Sep 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5aaba54e-c831-47a7-a1da-b5c9a6e19d76</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2021/updated-ai-invention-denied-patent-in-dabus-case</link><title>UPDATED: Court of Appeal - AI generated inventions denied UK Patent in DABUS case</title><description>The Court of Appeal held that a patent cannot be granted if the inventor is not a person and the law would need to be changed in order for purely machine-created inventions to be patentable.</description><pubDate>Thu, 23 Sep 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d36ebec2-a9a4-45e5-b149-1a712ff141ee</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2021/exhaustion-of-ip-rights-in-the-uk-past-future</link><title>Exhaustion of IP rights in the UK &#x2013; the past and the future</title><description>The UK Government is considering the shape of the UK&#x27;s future regime for the &#x27;exhaustion&#x27; of intellectual property rights. The regime settled upon will govern future rules on parallel imports of genuine goods into the UK.</description><pubDate>Mon, 20 Sep 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c781f37b-0095-4550-9ede-47023d9cded0</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/patent-faqs-for-canadian-smes</link><title>FAQ sur les brevets &#xE0; l&#x27;intention des PME du Canada (article en anglais)</title><description>What are the frequently asked questions (FAQ) among Canadian Small Medium Enterprises (SMEs) looking to protect their inventions? Download the PDF to find out.</description><pubDate>Tue, 14 Sep 2021 15:33:00 Z</pubDate></item><item><guid isPermaLink="false">a9b6b238-b224-4305-af72-70b2774b887e</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2021/china-joint-patent-infringement-hearings</link><title>Joint patent infringement and validity hearings in China</title><description>In July 2021, in Guangdong Province (Foshan City), a joint hearing took place to determine patent validity and patent infringement. This was the first time such a joint hearing had been held in Guangdong Province: Does it signal a fundamental change in China&#x27;s bifurcated patent system? And is it bad news for plaintiffs, good news for defendants? Or too early to tell?</description><pubDate>Thu, 09 Sep 2021 10:55:00 Z</pubDate></item><item><guid isPermaLink="false">f90d08dc-8be7-4ef6-a468-393adcbd1b06</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2021/influencers-in-toronto-spotlight-on-natalie-rk</link><title>Personnes influentes de Toronto : pleins feux sur Natalie Rizkalla-Kamel (en anglais)</title><description>Natalie Rizkalla-Kamel shares her story about how she became an IP lawyer and the importance of building a relationship with her clients to become a &#x22;trusted adviser.&#x22;</description><pubDate>Wed, 01 Sep 2021 18:06:00 Z</pubDate></item><item><guid isPermaLink="false">7b258971-bb6f-4b7e-b28e-2b04ab8a9732</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/federal-court-appeal-bauer-patent-lawsuit</link><title>Action en contrefa&#xE7;on de brevet intent&#xE9;e par Bauer : la Cour d&#x27;appel f&#xE9;d&#xE9;rale confirme la d&#xE9;fense de CCM (Article en anglais)</title><description>On August 12, 2021, the Federal Court of Appeal dismissed Bauer&#x27;s appeal, which sought to overturn the May 2020 dismissal of Bauer&#x27;s patent infringement lawsuit against CCM on the basis that the asserted patent was invalid.</description><pubDate>Thu, 19 Aug 2021 18:06:00 Z</pubDate></item><item><guid isPermaLink="false">0b6428b0-2381-4733-ba9e-8acb1c8b38ff</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/the-new-gcc-patent-filing-system</link><title>The new GCC patent filing system and what to expect</title><description>In January 2021 the GCC Patent Office (GCCPO) announced the suspension of the GCC patent filing system.</description><pubDate>Mon, 16 Aug 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9461b2ce-9506-417d-be00-b2552bd2b745</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/the-great-divide-patent-law-and-antitrust</link><title>The great divide? The interaction of patent law and antitrust in the pharmaceutical markets</title><description>In his article &#x27;The Great Divide? The interaction of patent law and antitrust in the pharmaceutical markets&#x27;, first published in the BIO-Science Law Review, IP partner Gordon Harris looks at the position and concludes that the patent system is capable of policing itself.</description><pubDate>Thu, 12 Aug 2021 10:04:00 Z</pubDate></item><item><guid isPermaLink="false">e19a9cf1-a06c-43f6-9467-d4f79bef1ee9</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2021/fca-dismisses-bauer-patent-infringement-lawsuit</link><title>Federal Court of Appeal upholds CCM&#x27;s defence of Bauer&#x27;s patent infringement lawsuit</title><description>On August 12, 2021, the Federal Court of Appeal dismissed Bauer&#x27;s appeal, which sought to overturn the May 2020 dismissal of Bauer&#x27;s patent infringement lawsuit against CCM on the basis that the asserted patent was invalid.</description><pubDate>Thu, 12 Aug 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">94c8c817-571b-4163-9ed1-9f3a01ab8ba3</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/protecting-trade-secrets-in-china</link><title>Trade secret protection in China in the era of civil code</title><description>The Supreme People&#x27;s Court of China handed down the second-instance judgment for the dispute between the plaintiffs Jiaxing Zhonghua Chemical Co., Ltd. et al. and the defendants Wanglong Group Co., Ltd. et al. over the infringement of technical secrets involving the chemical Vanillin. We provide an overview of the case.</description><pubDate>Wed, 11 Aug 2021 09:14:00 Z</pubDate></item><item><guid isPermaLink="false">5dcc5b46-55ad-4b1c-9d48-5622490da842</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/fca-upholds-compound-interest-cefaclor-appeal</link><title>Int&#xE9;r&#xEA;ts compos&#xE9;s accord&#xE9;s dans un recours en dommages visant le &#x3C;em&#x3E;Cefaclor&#x3C;/em&#x3E;: la CAF confirme sa d&#xE9;cision (Article en anglais)</title><description>In the latest Cefaclor decision, the Federal Court of Appeal of Canada has upheld the award of compound interest as damages for the time value of money lost, where there is trial evidence to support the award.</description><pubDate>Tue, 27 Jul 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a55285ec-eeb8-4c0b-bafe-6d022b64eef7</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/helpful-tips-about-expert-witnesses-patent-cases</link><title>T&#xE9;moins experts dans les litiges en mati&#xE8;re de brevets (quel que soit le lieu o&#xF9; le litige en PI est instruit) : conseils utiles (article en anglais)</title><description>In patent cases, expert witnesses are almost always called upon to render expert opinions concerning claim construction and the issues of infringement and invalidity.</description><pubDate>Mon, 26 Jul 2021 15:21:00 Z</pubDate></item><item><guid isPermaLink="false">f338c801-e535-40cc-a6f5-291b3ada9f50</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/proposed-amendments-canadian-patent-rules</link><title>Modifications propos&#xE9;es aux R&#xE8;gles sur les brevets du Canada : introduction de taxes sur les revendications exc&#xE9;dentaires et limitation du nombre d&#x2019;actions officielles</title><description>Les modifications propos&#xE9;es aux R&#xE8;gles sur les brevets, que vous pouvez consulter ici, introduiraient, si elles sont mises en &#x153;uvre, des taxes sur les revendications exc&#xE9;dentaires au-del&#xE0; de 20 revendications et limiteraient le nombre d&#x2019;actions officielles &#xE0; trois.</description><pubDate>Fri, 09 Jul 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b86cec0d-85f3-4753-a419-29a00bbf2338</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/amendments-russian-regulations-generic-drugs</link><title>New amendments to Russian regulations pave way for generic drugs</title><description>Two new amendments to existing regulations have come into force, which could have a significant impact on the Russian pharmaceutical sector. The initiative behind these was the belief that original drug manufacturers pursue a patent renewal strategy by filing applications and obtaining patents for various forms and derivatives of known compounds, which in turn prevent the eventual production of corresponding generic drugs.</description><pubDate>Mon, 05 Jul 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5ea00a23-3d38-43de-b2b1-97df0bf09a2d</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/russia-fast-tracks-patent-applications-covid-19</link><title>Lutte contre la COVID-19 : la Russie acc&#xE9;l&#xE8;re le traitement des demandes de brevets (Article en anglais)</title><description>As part of its efforts to address the COVID-19 pandemic, since April 2020 the Russia Patent and Trademark Office (Rospatent) has introduced faster prosecution for patent applications for viruses and concomitant diseases, such as pneumonia.</description><pubDate>Mon, 28 Jun 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">14b42aea-5fc7-4500-b683-4dfc4b5c51c0</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/schrodinger-s-seed-drill</link><title>Schr&#xF6;dinger&#x27;s Seed Drill - A short review of Prior Use cases in the UK</title><description>If the alleged disclosure takes place in the open, but there is no allegation that it was actually observed, just what actually constitutes a level of disclosure sufficient to invalidate a patent?</description><pubDate>Thu, 10 Jun 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">282835b5-06b2-4fcb-9dcc-9956edb1448d</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2021/influencers-in-toronto-spotlight-on-omar-nassif</link><title>Personnes influentes de Toronto : pleins feux sur Omar Nassif (en anglais)</title><description>Omar discusses the collaborative approach he takes with his clients in order to understand how to protect and maximize their inventions.</description><pubDate>Mon, 07 Jun 2021 21:44:00 Z</pubDate></item><item><guid isPermaLink="false">505d513b-3798-4db4-9b61-e1237ff813d0</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/patent-protection-microorganism-russia</link><title>Russie : comment obtenir la protection de brevets pour des souches de micro-organismes (article en anglais)</title><description>The term &#x27;microorganism&#x27; includes yeast, bacteria, higher fungi, bacteriophages, unicellular algae, viruses and protozoa, among others. The cell lines of plants and animals are also defined as microorganisms.</description><pubDate>Wed, 02 Jun 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7488cd7b-fcc3-4bef-8fa1-585d2a844a98</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/russia-first-to-file-state-secret-check-explained</link><title>Russia&#x27;s first-to-file and state-secret check requirement explained</title><description>It is essential to understand the unique traits of the IP laws of the country in which an invention was created before seeking the legal protection of an invention in another country.</description><pubDate>Thu, 27 May 2021 22:04:00 Z</pubDate></item><item><guid isPermaLink="false">e90adc0e-48ec-4964-a04d-29a22f0cab6a</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/canadian-industrial-design-marking-three-things</link><title>Marquage des dessins industriels canadiens : 3 erreurs fr&#xE9;quentes</title><description>Malgr&#xE9; les conseils de l&#x2019;Office de la propri&#xE9;t&#xE9; intellectuelle du Canada (OPIC), force est de constater que tr&#xE8;s peu de propri&#xE9;taires de dessins industriels canadiens enregistr&#xE9;s proc&#xE8;dent au marquage de leurs produits en y apposant un symbole pour d&#xE9;montrer qu&#x2019;ils sont bel et bien enregistr&#xE9;s. Si vous &#xEA;tes &#xE9;tonn&#xE9;s d&#x2019;apprendre l&#x2019;existence de tels symboles, sachez que vous &#xEA;tes loin d&#x2019;&#xEA;tre les seuls &#xE0; ne pas vous pr&#xE9;valoir des avantages qu&#x2019;ils procurent.</description><pubDate>Wed, 19 May 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">52649393-c6b1-4069-9b58-5055ec4053c5</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2021/introduction-of-utility-models-in-china</link><title>Introduction of Utility Models in China</title><description>Beijing-based Patent Agent, Jason Yang introduces a special type of patent protection in China known as a Utility Model.</description><pubDate>Fri, 07 May 2021 18:20:00 Z</pubDate></item><item><guid isPermaLink="false">325f0a9b-7d72-4bf1-bcc0-d6a95f3abca2</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/belarus-joins-hague-system-protecting-rights-cis</link><title>Adh&#xE9;sion du B&#xE9;larus au syst&#xE8;me de La Haye et nouvelles possibilit&#xE9;s de protection des droits aff&#xE9;rents au dessin industriel dans la CEI (disponible en anglais)</title><description>On April 19, 2021 Belarus joined the Hague System for the International Registration of Industrial Designs, expanding the system&#x27;s coverage further into the Commonwealth of Independent States (CIS). As of July 19, 2021, it will be possible to designate Belarus on an international design application and to benefit from the advantages of Hague System mechanisms for protecting industrial designs.</description><pubDate>Wed, 28 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1b168e2c-be22-468d-9787-3a6ca655b8da</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/ip-best-practices-for-canadian-scale-ups</link><title>Pratiques exemplaires en PI pour les entreprises canadiennes en expansion &#xE0; la recherche de capitaux (disponible en anglais)</title><description>No matter what the next phases of growth looks like for you company, you need to raise capital &#x2014; fast. IP strategy gives you the edge you need to do just that, opening the door to a universe of government funding programs tailored specifically for SMEs.</description><pubDate>Mon, 26 Apr 2021 17:45:00 Z</pubDate></item><item><guid isPermaLink="false">9072842b-0292-4d95-a8c7-a32b2c8c7664</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/understanding-ip-value-history-of-insulin</link><title>Comprendre la valeur r&#xE9;elle de vos actifs de PI : une br&#xE8;ve histoire de l&#x27;insuline (disponible en anglais)</title><description>On the occasion of a World IP Day that is taking place in the midst of a global pandemic, and during the life saving rollout of entirely new vaccine technologies, it is worth commemorating the role that innovation has long played in improving human health.</description><pubDate>Mon, 26 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d968d47c-da1c-4f07-8ecb-f0ed7754f1eb</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/investment-in-innovation-look-at-bc-budget-2021</link><title>Investissement dans l&#x27;innovation : examen du budget 2021 de la Colombie-Britannique (disponible en anglais)</title><description>On April 20, 2020, the Government of British Columbia tabled the 2021-2022 provincial budget (&#x22;Budget 2021&#x22;). Budget 2021 focuses on recovery from the economic harm inflicted on BC by the COVID-19 pandemic, and includes $3.25 billion in COVID-19 recovery spending.</description><pubDate>Thu, 22 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8ff5bd12-d170-4979-af71-86887576a512</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/the-essential-a-z-of-ip</link><title>The essential A-Z of IP</title><description>We&#x27;re here to help SMEs cut through the legal jargon, with a summary of some of the key terms you need to know to ensure the success of your brand when it comes to intellectual property law.</description><pubDate>Thu, 22 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">781d28b9-7135-4b5c-a7ae-1ab6b5b6f220</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/patenting-during-a-pandemic</link><title>Breveter en temps de pand&#xE9;mie</title><description>Peu d&#x27;entre nous s&#x27;&#xE9;taient imagin&#xE9; qu&#x27;un vaccin contre un nouveau virus pouvait &#xEA;tre mis au point en un an. Pourtant, 12 mois apr&#xE8;s l&#x27;apparition des premiers cas confirm&#xE9;s de COVID-19, deux vaccins ont d&#xE9;j&#xE0; commenc&#xE9; &#xE0; &#xEA;tre administr&#xE9;s dans nos collectivit&#xE9;s.</description><pubDate>Tue, 20 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a482af6f-4017-4c4d-be32-00b3ef1db0d1</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/government-panel-of-experts-russia-ip-cases</link><title>Proposition d&#x27;un groupe d&#x27;experts approuv&#xE9;s par le gouvernement pour les dossiers de propri&#xE9;t&#xE9; intellectuelle en Russie (disponible en anglais)</title><description>At the end of March 2021, the Ministry of Justice of the Russian Federation put forward a proposal to introduce an approved panel of experts to be responsible for forensic examinations in intellectual property matters. &#xA0;According to the draft Order of the Ministry of Justice of Russia N 237 a new panel of experts for the &#x22;Investigation of intellectual property&#x22; matters would be officially recognized.</description><pubDate>Tue, 20 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">052ff47d-2841-4428-a41a-0b4af52c1e1e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2021/top-tips-canadian-smes-patents</link><title>Patent 101: Top 3 things Canadian SMEs need to know about patents</title><description>In this video, Anthony Dearden discusses the top things Canadian small and medium enterprises need to know about patents, as part of the Patent 101 video series.</description><pubDate>Mon, 19 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6915773e-9fcd-4461-810a-d66fddb800bc</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2021/patent-protection-process-for-canadian-smes</link><title>Patent 101: A guide to the patent protection process for Canadian SMEs</title><description>In this video, Jeff Coles discusses the patent protection process for Canadian SMEs, as part of the Patent 101 video series.</description><pubDate>Mon, 19 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">371c904f-ae45-4bc6-ac4a-cc973b4516bb</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2021/patent-faqs-for-canadian-smes</link><title>Patent 101: Patent FAQs for Canadian SMEs</title><description>In this video, Jennifer Jannuska discusses frequently asked questions about patents for Canadian small and medium enterprises, as part of the Patent 101 video series.</description><pubDate>Mon, 19 Apr 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">269dce79-48ba-4280-aa27-3bd5aacb0f6c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/setting-up-global-anti-counterfeiting-program</link><title>Comment mettre en place un programme mondial de lutte contre la contrefa&#xE7;on pour la premi&#xE8;re fois (disponible en anglais)</title><description>When setting up a global anti-counterfeiting program for the first time, there are several aspects to consider.</description><pubDate>Wed, 31 Mar 2021 12:42:00 Z</pubDate></item><item><guid isPermaLink="false">5d4dd7ae-f684-4fb4-8174-0ab4c2150549</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/patent-for-detecting-marijuana-grow-ops-invalid</link><title>Un brevet permettant de d&#xE9;tecter les cultures de marijuana jug&#xE9; non contrefait et non valide (disponible en anglais)</title><description>In Dtechs EPM Ltd. v British Columbia Hydro and Power Authority and Awesense Wireless Inc., 2021 FC 190, Justice Fothergill addressed allegations of patent infringement concerning Canadian Patent No. 2,549,087 (the &#x201C;087 Patent&#x201D;), which relates generally to monitoring usage of electrical utilities to detect potential instances of atypical consumption or theft, such as theft of electricity related to the indoor cultivation of marijuana. The Defendants BC Hydro and Awesense successfully defended the claims of patent infringement.</description><pubDate>Fri, 26 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">26a0c550-7bce-43dc-8966-a5b716921d9e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2021/renewals-under-new-canadian-trademarks-act</link><title>A guide to Canadian trademark renewals under the new Canadian Trademarks Act</title><description>In this video, Susannah Rolston offers quick and helpful tips you should consider before renewing your trademark under the revised Canadian Trademarks Act.</description><pubDate>Fri, 19 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b51f9519-2121-4c43-897d-14eb7eedb339</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/evolving-approach-to-costs-in-the-federal-court</link><title>Il faut payer: L&#x27;&#xE9;volution des d&#xE9;pens &#xE0; la Cour f&#xE9;d&#xE9;rale</title><description>Dans le cadre d&#x27;un litige, l&#x27;octroi de d&#xE9;pens suit le principe g&#xE9;n&#xE9;ral selon lequel le &#xAB;&#xA0;perdant doit payer&#xA0;&#xBB;. Ceci signifie que la partie gagnante peut r&#xE9;cup&#xE9;rer une partie des frais encourus pour avoir intent&#xE9; ou d&#xE9;fendu une action. Bien que le concept soit simple, sa mise en &#x153;uvre est complexe et en &#xE9;volution constante.</description><pubDate>Wed, 17 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f340ea27-2b96-460d-8860-3c009ce3ad3c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/pending-patent-decisions-federal-courts-2021</link><title>D&#xE9;cisions des cours f&#xE9;d&#xE9;rales en 2021 : &#xE0; quoi s&#x2019;attendre en mati&#xE8;re de brevets (article en anglais)</title><description>The end of 2020 and start of 2021 have been busy with Federal Court judges writing, and the patent bar reading, several interesting patent decisions. That trend may continue in 2021. There are several pending decisions from patent trials and patent appeals heard in 2020, or early 2021. This article provides a snapshot of those trials and appeals, and what issues we can expect to be addressed by the decisions.</description><pubDate>Wed, 17 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">89b28e6a-7fdd-4961-a2fb-6f1d1da790f0</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/takeda-wins-canadian-vyvanse-patent-appeal</link><title>D&#xE9;fense r&#xE9;ussie du brevet canadien VYVANSEMD de Takeda en appel (article en anglais)</title><description>The Federal Court of Appeal has dismissed two appeals brought by Apotex in respect of the validity of certain claims of Takeda&#x2019;s (as Shire) Canadian Patent No. 2,527,646 which cover, inter alia, lisdexamfetamine (LDX), the active ingredient in Takeda&#x2019;s ADHD medication VYVANSE&#xAE;.</description><pubDate>Fri, 12 Mar 2021 22:52:00 Z</pubDate></item><item><guid isPermaLink="false">4fe1e21d-3fe8-4596-bdfd-ba67a7d1004a</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/focus-genetic-construct-drug-patent</link><title>Focusing on the genetic construct when applying for a drug patent could be key to obtaining protection</title><description>Russia has a lively pharmaceutical market, in which it is possible to obtain comprehensive patent protection for products and methods that are aimed at treating and diagnosing specific diseases. However, development in the sector relies on manufacturers being confident that their patents will provide adequate and reliable protection, which requires comprehensive patent protection for both the drug and for items in related fields. When drafting an application, it is therefore crucial to focus on aspects, such as genetic constructs.</description><pubDate>Thu, 11 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1ebe9931-1b70-4dba-a015-24c939a99473</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2021/appeals-dismissed-for-vyvanse-patent</link><title>Federal Court of Appeal dismisses appeals brought by Apotex in respect of Takeda&#x27;s Canadian VYVANSE&#xAE; patent</title><description>On March 11, 2021, the Federal Court of Appeal dismissed two appeals brought by Apotex in respect of the validity of certain claims of Takeda&#x27;s (as Shire) Canadian Patent No. 2,527,646 (the &#x22;646 Patent&#x22;) which covers, inter alia, lisdexamfetamine (LDX), the active ingredient in Takeda&#x27;s ADHD medication VYVANSE&#xAE;.</description><pubDate>Thu, 11 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7d27e535-88fb-4eb5-9011-60068fa30a23</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/federal-court-of-appeal-analysis-advantages</link><title>La Cour d&#x27;appel f&#xE9;d&#xE9;rale r&#xE9;affirme que les avantages peuvent &#xEA;tre pris en compte dans l&#x27;analyse de l&#x27;&#xE9;vidence (article en anglais)</title><description>The Federal Court of Appeal recently dismissed an appeal from Janssen v Apotex, 2019 FC 1355 (Phelan J.) in Apotex v Janssen, 2021 FCA 45.</description><pubDate>Wed, 10 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2c45b8c4-a20a-4cfd-ad8b-d8e70146a6b2</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/statute-of-monopolies-action-dismissed</link><title>Rejet par jugement sommaire d&#x27;une action relatives aux lois sur les monopoles (article en anglais)</title><description>The Ontario Superior Court of Justice has dismissed a claim brought by Apotex for treble damages and an accounting of the innovative defendants&#x2019; profits brought under the Statute of Monopolies, the Trademarks Act, and at common law.</description><pubDate>Wed, 10 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ddea8414-5e62-4705-8b55-4af3bb1040ce</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/eurasian-patent-office-launches-pharma-register</link><title>L&#x2019;Organisation eurasienne des brevets lance son registre des produits pharmaceutiques (article en anglais)</title><description>On March 1, 2021, the Eurasian Patent Office launched the EAPO Pharmaceutical Register. The Register lists Eurasian patents that relate to the active pharmaceutical ingredients of the drugs according to their International Non-proprietary Names (INN).</description><pubDate>Mon, 08 Mar 2021 14:02:00 Z</pubDate></item><item><guid isPermaLink="false">0fa2eb6c-1dd6-4d3a-beae-54ab02ed6064</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2021/apotex-claim-dismissed</link><title>Ontario Superior Court of Justice dismisses Statute of Monopolies action via summary judgment</title><description>On March 8, 2021, the Ontario Superior Court of Justice dismissed a claim brought by Apotex for treble damages and an accounting of the innovative defendants&#x27; profits brought under the Statute of Monopolies, the Trademarks Act, and at common law. This is the first final decision issued in a series of similar cases currently before the Ontario and Quebec Superior Courts.</description><pubDate>Mon, 08 Mar 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">589a6f16-d622-48f7-aae0-b7fa164dffbc</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2021/chambers-patent-litigation-2021-guide-france</link><title>Chambers Patent Litigation 2021 Guide &#x2013; France</title><description>C&#xE9;line Bey and Cl&#xE9;mence Lap&#xF4;tre have written the French Chapter of the 2021 Chambers Patent Litigation guide.</description><pubDate>Thu, 25 Feb 2021 12:53:00 Z</pubDate></item><item><guid isPermaLink="false">54a13da1-b37f-41f2-93de-e022fcbc2150</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2021/estee-lauder-increases-ownership-in-deciem</link><title>The Est&#xE9;e Lauder Companies increases ownership in DECIEM in US$1 billion transaction</title><description>On February 23, 2021, The Est&#xE9;e Lauder Companies Inc. (NYSE: EL) (&#x22;ELC&#x22;) announced that it had entered into an agreement to increase its investment in DECIEM Beauty Group Inc. (&#x22;DECIEM&#x22;).</description><pubDate>Tue, 23 Feb 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">73fcb2bf-baf8-484d-a0cb-8438ba076aa9</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2021/prosecuting-industrial-designs-in-china</link><title>Prosecuting industrial designs in China: An overview</title><description>In this video, Jason Yang, a patent agent in Gowling WLG&#x27;s Beijing office, describes how to file industrial designs effectively in China and highlights the latest developments in Chinese patent law.</description><pubDate>Tue, 09 Feb 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">19590a0c-63ce-406f-86b5-590b4e7c1c19</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2021/a-review-of-uk-patent-cases-in-2020</link><title>A review of UK patent cases in 2020</title><description>Gordon Harris gives his annual review and summary of 2020&#x27;s important patent cases.</description><pubDate>Thu, 04 Feb 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">35979bbb-0bdf-4e50-89cb-9400ddac1cde</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2021/second-medical-use-patents-verifying-validity</link><title>Second medical use patents part 2 - Verifying validity</title><description>What does it take for a second medical use to be sufficiently disclosed? A list of indications in the application? Clinical data? Or something in-between?</description><pubDate>Mon, 01 Feb 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">39245029-4526-422f-9ec1-24fe4fc5c5ac</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/brexit-and-trade-secrets-6-key-things-to-know</link><title>Brexit and trade secrets: 6 key things to know</title><description>On 31 December 2020, the Brexit transition period comes to an end, and significant changes to the law in the UK will take effect.</description><pubDate>Thu, 28 Jan 2021 10:38:00 Z</pubDate></item><item><guid isPermaLink="false">aa9c2555-b79c-45d9-a184-2f215e7e5d39</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/brexit-and-copyright-6-key-things-to-know</link><title>Brexit and copyright: Six key things to know</title><description>On 31 December 2020, the Brexit transition period comes to an end, and significant changes to the law in the UK will take effect. For copyright and neighbouring areas of the law, there are some important soundbites for businesses to be aware of &#x2013; some of which you may already have heard about, while others may be news outside the UK (even for experienced copyright lawyers).</description><pubDate>Thu, 28 Jan 2021 10:38:00 Z</pubDate></item><item><guid isPermaLink="false">9d8bb56f-169a-4813-af7a-58b363990eea</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/brexit-and-patents-key-things-to-know</link><title>Brexit and patents: 10 key things to know</title><description>On 31 December 2020, the Brexit transition period comes to an end and significant changes to the law in the UK will take effect.</description><pubDate>Thu, 28 Jan 2021 10:35:00 Z</pubDate></item><item><guid isPermaLink="false">211dd0ba-ec11-4fae-bb5c-186babc7f9ef</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2021/2020-annual-review-of-uk-patent-judgments</link><title>Annual review of UK patent judgments - 2020</title><description>&#x27;Swings and Roundabouts&#x27;, Gordon Harris&#x27; comprehensive annual review of patent case law, is your complete guide to the most important, industry-influencing UK patent judgments in 2020.</description><pubDate>Wed, 27 Jan 2021 12:46:00 Z</pubDate></item><item><guid isPermaLink="false">385bbc47-3b8d-4ab1-874d-a1c31b37c7b2</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/patent-infringement-against-oil-sands-dismissed</link><title>Non-practising entity&#x27;s allegations of patent infringement against oil sands producer /operator dismissed</title><description>On January 26, 2021, Justice Manson of the Federal Court of Canada dismissed a patent infringement action brought by an individual, non-practising entity, Maoz Betser-Zilevitch against PetroChina Canada Ltd.</description><pubDate>Wed, 27 Jan 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">135a3285-12d3-42ec-b317-d64fe4b49251</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/russia-blocking-websites-and-social-networks</link><title>Russia introduces new grounds for blocking websites and social networks</title><description>On&#xA0; January 10, 2021, the Federal law N 482-FZ came in force granting Roskomnadzor, the federal oversight service for communications, IT, and mass media, the right to block Internet resources premised upon improper censorship and/or on grounds of discrimination against Russian users or mass media.</description><pubDate>Tue, 26 Jan 2021 18:46:00 Z</pubDate></item><item><guid isPermaLink="false">7ae26f73-6a01-47a0-92e6-d86ce7e4f1e7</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2021/understanding-infringement-and-enforcement</link><title>Second medical use patent series: Understanding infringement and enforcement</title><description>As the scientific community continues to tackle some of the world&#x27;s most challenging diseases, research and innovation has led to the discovery of new uses for previously known medicines. Patents that cover these new uses are often called &#x22;second medical use&#x22; patents.</description><pubDate>Fri, 22 Jan 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2bb399dc-b3d6-4935-b89b-012ec74a5617</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/top-5-trademark-considerations-for-cleantech</link><title>Marques de commerce : 5 enjeux que tout entrepreneur en &#xE9;cotechnologie doit conna&#xEE;tre(article en anglais)</title><description>The growth in global demand for clean technology is creating a more competitive market where the competition for brand recognition has never been fiercer.</description><pubDate>Thu, 21 Jan 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">60750e67-fba3-44d9-b4da-96fc3178830a</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/podcasts/2021/the-patent-bar-and-beyond</link><title>The patent bar and beyond: In conversation with Sir Robin Jacob</title><description>In the latest podcast in our &#x27;In Conversation with Gowling WLG&#x27; series, global intellectual property partner Gordon Harris speaks to the Right Honourable Professor Sir Robin Jacob &#x2013; a veritable legend of the IP world.</description><pubDate>Wed, 20 Jan 2021 13:20:00 Z</pubDate></item><item><guid isPermaLink="false">444eeb85-e8b6-4a32-b711-53d8b08393d8</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/the-new-rules-of-canadian-patent-litigation</link><title>Nouvelles r&#xE8;gles canadiennes, litiges et brevets : la Cour d&#x2019;appel f&#xE9;d&#xE9;rale affirme la viabilit&#xE9; des jugements sommaires dans les cas d&#x2019;actions relatives aux brevets et confirme l&#x27;interpr&#xE9;tation de l&#x27;opposabilit&#xE9; du dossier de la demande de brevet (article en anglais)</title><description>On Jan. 20, 2021, the Federal Court of Appeal dismissed the appeal in CanMar Foods Ltd. v. TA Foods Ltd 2021 FCA 7. This precedent setting appeal stems from the underlying decision of Justice Manson which itself was recognized as the Canadian Patent Impact Case of the Year by Managing Intellectual Property (MIP) Americas Awards 2020.</description><pubDate>Wed, 20 Jan 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8f1113ae-5f18-41af-9f3d-b0ce8b33d661</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2021/canadian-patent-law-2020-year-in-review</link><title>Le droit canadien des brevets: &#x3C;br&#x3E;faits saillants de 2020</title><description>2020 a &#xE9;t&#xE9; une ann&#xE9;e bien remplie pour le droit canadien des brevets. Cet article fait la synth&#xE8;se des d&#xE9;cisions importantes rendues par les tribunaux dans le droit et la pratique des brevets au Canada.</description><pubDate>Thu, 14 Jan 2021 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">128b9bf5-519b-4b5e-9d63-cebefe0f9b6e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2021/influencers-in-toronto-spotlight-on-selena-kim</link><title>Influencers in Toronto: Spotlight on Selena Kim</title><description>Selena shares her inspiring story about how perseverance has played a key role in her success as a lawyer.</description><pubDate>Mon, 11 Jan 2021 20:52:00 Z</pubDate></item><item><guid isPermaLink="false">2ab7faed-6202-4104-b48e-a3ccd5c6f4b6</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/podcasts/2020/in-conversation-with-lord-neuberger</link><title>The UK Supreme Court, patent infringement, and the challenges of judging IP cases: In conversation with Lord Neuberger</title><description>What is it really like to be the UK Supreme Court&#x27;s leading decision maker, acting on some of the most important intellectual property decisions of recent times? In the latest podcast in our &#x27;In Conversation with Gowling WLG&#x27; series, global IP partner Ron Dimock speaks to the Right Honourable Lord Neuberger of Abbotsbury, former President of the United Kingdom Supreme Court.</description><pubDate>Tue, 15 Dec 2020 14:14:00 Z</pubDate></item><item><guid isPermaLink="false">1b1f1f53-9bfe-4dea-9287-d204c9f00225</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/what-rospatent-has-in-store-for-2021</link><title>What Rospatent has in store for 2021 &#x2013; head of Rospatent speaks out</title><description>The Association of European Businesses held a briefing in Russia, in which the head of the Russia Patent and Trademark Office (Rospatent) &#x2013; Grigory Ivliev &#x2013; outlined what Rospatent is doing in the IP field to improve the investment climate in Russia.</description><pubDate>Fri, 11 Dec 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9356b66a-d1c0-4ba5-9ce5-a8d7a3d5dd58</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/patenting-antibody-based-biologics-in-canada</link><title>Patenting antibody-based biologics in Canada</title><description>A summary of a number of important considerations when drafting claims for patent applications intended to be filed in Canada.</description><pubDate>Mon, 30 Nov 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">61dd744a-56cd-4e1e-a0d5-0169412f4ab6</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/patent-term-extension-in-canada</link><title>Patent term extension in Canada: An overview of certificates of supplemental protection</title><description>An overview of certificates of supplemental protection regarding patent term extension in Canada.</description><pubDate>Fri, 27 Nov 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">160c429d-b27c-4108-bad6-4ebac9b3b118</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2020/patents-to-protect-antibody-based-drugs-russia</link><title>Using patents to best protect antibody-based drugs in Russia</title><description>Antibody-based drugs are among the widest selling in the world. They are being used to treat a expanding range of conditions and their significance and value in treating cancer continues to grow. Accordingly, this makes them an indispensable component of the pharmaceutical industry and it also means that their protection through invention patents is absolutely essential.</description><pubDate>Thu, 26 Nov 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">98da9499-3cc9-4c3f-97bf-e645b79d55f9</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2020/cipo-clarifies-eligibility-analysis</link><title>Tous les &#xE9;l&#xE9;ments d&#x27;une invention revendiqu&#xE9;e sont pr&#xE9;sum&#xE9;s essentiels : l&#x27;OPIC doit clarifier son analyse de brevetabilit&#xE9;</title><description>Dans cette affaire, qui ne fera pas l&#x27;objet d&#x2019;un appel, la Cour avait conclu que l&#x27;approche probl&#xE8;me-solution pour l&#x27;interpr&#xE9;tation des revendications appliqu&#xE9;e par l&#x27;Office de la propri&#xE9;t&#xE9; intellectuelle du Canada (&#xAB; OPIC &#xBB;) posait probl&#xE8;me . L&#x27;OPIC a depuis publi&#xE9; un &#xE9;nonc&#xE9; de pratique d&#xE9;coulant de cette d&#xE9;cision, lequel fournit des orientations administratives sur la fa&#xE7;on d&#x27;interpr&#xE9;ter des revendications et l&#x27;admissibilit&#xE9; d&#x27;un objet &#xE0; la protection par brevet.</description><pubDate>Wed, 11 Nov 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8900e16d-025a-4b20-baf1-08e3b6ce59e7</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2020/patenting-cleantech-in-europe-global-market-canada</link><title>Les brevets en Europe : un march&#xE9; international pour le secteur des technologies propres du Canada</title><description>Il est parfois plus facile de justifier le besoin de prot&#xE9;ger une technologie propre avec un brevet que tout autre type de technologie. En effet, les bureaux de brevets font parfois preuve d&#x27;une plus forte r&#xE9;sistance envers la propri&#xE9;t&#xE9; intellectuelle (PI) renferm&#xE9;e dans un logiciel purement intangible en raison de sa nature trop abstraite. R&#xE9;sultat? Des poursuites de demande longues et co&#xFB;teuses. Alors que les politiques nationales favorisent d&#xE9;sormais les investissements de taille dans les technologies propres sur le plan environnemental, les innovations de ce type &#xE0; forte intensit&#xE9; de capital requi&#xE8;rent souvent une protection de PI solide, particuli&#xE8;rement sous forme de brevets, pour permettre aux entreprises de maintenir leur capacit&#xE9; &#xE0; les exploiter &#xE0; long terme et ainsi g&#xE9;n&#xE9;rer davantage de revenus.</description><pubDate>Wed, 11 Nov 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cdbc874d-c9ba-4c8c-98d7-44147e2587cb</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/working-with-known-materials-in-the-life-science</link><title>Sciences de la vie et utilisation de mat&#xE9;riel connu : des consid&#xE9;rations cl&#xE9;s en mati&#xE8;re de brevets (article en anglais)</title><description>Life science companies who are in the early stages of research often ask &#x27;how will I know if I have something patentable&#x27;.</description><pubDate>Wed, 11 Nov 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1d213144-dad9-4b3b-a4fd-8d8baa40897a</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/what-does-brexit-mean-for-intellectual-property</link><title>What does Brexit mean for intellectual property?</title><description>On 31 December 2020, the intellectual property regime in the UK (and Europe) will undergo transition as a consequence of the UK&#x27;s exit from the EU (Brexit).</description><pubDate>Mon, 09 Nov 2020 14:36:00 Z</pubDate></item><item><guid isPermaLink="false">64abc244-87d3-43ea-afdd-80ce9a7c4257</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/simplify-patent-security-clearance-for-inventions</link><title>Comment simplifier la v&#xE9;rification de s&#xE9;curit&#xE9; li&#xE9;e &#xE0; une invention (article en anglais)</title><description>When an invention is made in Russia, the filing of counterpart patent applications in other countries is temporarily restricted for national security reasons.</description><pubDate>Wed, 28 Oct 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">dd1a1340-ca91-4480-8d8a-eeb9a073cfe2</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/new-possibilities-to-protect-designs-in-eurasia</link><title>New possibilities to protect designs in Eurasia</title><description>In September 2019 a conference on adopting the Protocol on the Protection of Industrial Designs in Eurasia was held in Nur-Sultan (formerly Astana), the capital of Kazakhstan. The member states of the Eurasian Patent Convention (EAPC) &#x2013; Armenia, Azerbaijan, Belarus, Kazakhstan, Kyrgyzstan, Russia, Tajikistan and Turkmenistan &#x2013; discussed the possibility of introducing a unitary Eurasian industrial design regime. As a result of the meeting, Armenia, Azerbaijan, Kazakhstan, Kyrgyzstan and Russia signed the protocol.</description><pubDate>Thu, 22 Oct 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">53566e38-721b-4ad8-a88f-1a50a9c1ec50</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2020/five-tips-for-choosing-an-ip-professional</link><title>Five tips for choosing an IP professional</title><description>In this video, Neil Henderson advises that choosing a patent agent or attorney is an important decision, that cost is not the only factor, and to not underestimate the importance of &#x27;personality&#x27; in the decision.</description><pubDate>Thu, 22 Oct 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">eb24cecd-70f8-4b02-a81c-96877d1c17a6</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2020/toilette-station-spatiale</link><title>Est-ce que la nouvelle toilette de la station spatiale internationale est brevetable?</title><description>Dans cet article, nous nous int&#xE9;ressons &#xE0; la brevetabilit&#xE9; du nouveau syst&#xE8;me de toilettes spatial. &#xC9;videmment, pour qu&#x27;une technologie soit brevetable au Canada, il faut qu&#x27;elle soit nouvelle, inventive et utile. Il ne fait aucun doute que le nouveau syst&#xE8;me sera particuli&#xE8;rement utile &#xE0; la SSI!</description><pubDate>Wed, 21 Oct 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ec5ab3aa-ffab-42c3-894c-9188b97451d7</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/patent-infringement-in-multiple-jurisdictions</link><title>Worried about being sued for patent infringement in multiple jurisdictions?</title><description>Three ways to gain control is you are worried about being sued for patent infringement in multiple jurisdictions.</description><pubDate>Thu, 15 Oct 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f71c9087-2c4f-4e09-8417-50639eebb2d6</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/ip-audits-what-s-in-your-ip-portfolio</link><title>IP audits: What&#x27;s in your IP portfolio?</title><description>Fundamental to the development of a robust IP strategy is a thorough understanding of the business&#x27; IP portfolio, which may include patents, trademarks, copyrights, trade secrets, domain names, and industrial designs. An IP audit provides just such an insight.</description><pubDate>Wed, 14 Oct 2020 20:42:00 Z</pubDate></item><item><guid isPermaLink="false">bdd45489-8e19-4522-941c-6b69de9df832</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/644-million-award-for-patent-infringement-upheld</link><title>$644-million award for patent infringement upheld on appeal; Accounting of profits remedy removes &#x22;economic incentive to infringe&#x22;</title><description>In 2020 FCA 141, the Federal Court of Appeal has upheld the Federal Court&#x27;s earlier judgment awarding Dow Chemical $644 million, the largest monetary award by a Canadian Court in history for patent infringement.</description><pubDate>Wed, 07 Oct 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cee750f3-452e-46a2-bf0e-dcb5f382ff19</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/rospatent-s-ban-on-misleading-trademark-transfers</link><title>Keeping the right side of Rospatent&#x27;s ban on misleading trademark transfers</title><description>Trademarks are a valuable corporate asset and, as with any asset, one way to make money from it is to sell it. It therefore follows that the transfer of trademark rights is fairly common.</description><pubDate>Wed, 30 Sep 2020 21:22:00 Z</pubDate></item><item><guid isPermaLink="false">86d27cce-a1bc-4ed2-b565-1e79c0425b50</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/electronic-signature-considerations-for-patent-pra</link><title>Electronic signature considerations for patent practice</title><description>In the wake of the COVID-19 pandemic, many people are working from home, making it more difficult than usual to get handwritten signatures. In this article, we provide answers to some frequently asked questions regarding the use of electronic signatures on assignment documents for patents and patent applications.</description><pubDate>Mon, 21 Sep 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">98d319dc-9200-4297-bcc5-368d99ae45f9</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/overview-doctrine-equivalence-china</link><title>A practical overview of the doctrine of equivalence in China</title><description>Equivalence infringement, or the doctrine of equivalence, was officially introduced into Chinese patent law legislation in 2009, through the implementation of the Chinese Supreme Court&#x27;s judicial interpretation, which stated the following: Equivalent features shall mean features which use identical means to achieve identical functions and realise identical effects, and which can be contemplated by people skilled in the art without creative effort.</description><pubDate>Thu, 17 Sep 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">62eac6d6-7971-4c63-a71b-a21602ddd244</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2020/design-patent-practice-in-russia</link><title>Design patent practice in Russia</title><description>In this video you will learn more on design patents in Russia. There are three possible filing systems: Direct national filings for Russia; International filings via Hague System Eurasian Design Patents (soon to be launched); and regional protection in Russia and many countries of the former Soviet Union.</description><pubDate>Wed, 16 Sep 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1ef753e7-5a17-42d2-9ef9-1f019bd6a327</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/getting-the-most-out-of-pharmaceutical-extensions</link><title>Getting the most out of pharmaceutical patent-term extensions in Russia</title><description>The Russia Patent and Trademark Office (Rospatent) has tightened up its approach to allowing patent-term extensions to pharmaceutical and agrochemical patents. However, a strategic and far-sighted approach can still result in excellent protection.</description><pubDate>Thu, 10 Sep 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">175f36ae-3850-4af1-8764-aad3fdfbc1fc</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/federal-court-finds-problem-with-problem-solution</link><title>L&#x27;approche &#xAB; probl&#xE8;me-solution &#xBB; pose probl&#xE8;me &#xE0; la Cour f&#xE9;d&#xE9;rale</title><description>L&#x27;affaire Yves Choueifaty v. Attorney General of Canada est une importante d&#xE9;cision pour les demandeurs de brevets pr&#xE9;occup&#xE9;s par l&#x27;admissibilit&#xE9; d&#x27;une invention &#xE0; la protection par brevet ou, plus simplement, la notion de sujet brevetable. La Cour f&#xE9;d&#xE9;rale du Canada a tranch&#xE9; : l&#x27;approche probl&#xE8;me-solution qu&#x27;applique l&#x27;Office canadien de la propri&#xE9;t&#xE9; intellectuelle (&#xAB;&#x2009;OPIC&#x2009;&#xBB;) depuis 2013 pour interpr&#xE9;ter les demandes de brevets est incompatible avec le droit canadien.</description><pubDate>Wed, 09 Sep 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">62686f09-06f8-4d4d-a5d7-a707d1a71a64</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/simple-steps-to-expedite-patent-prosecution-russia</link><title>Simple steps to expedite patent prosecution in Russia</title><description>In order to expedite patent prosecution, both offices recognise the Patent Prosecution Highway (PPH) programme, as well as requests for expedited prosecution.</description><pubDate>Wed, 12 Aug 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">65d5e540-c054-4233-a2ea-d1b7ca40330e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/covid-19-impacts-on-ip-activity-in-the-courts</link><title>COVID-19: impacts on IP activity in the courts and UK IPO</title><description>In the UK, COVID-19 is leading to unprecedented adaption by the courts and the UK IPO to audio and video platforms, to enable normal business to continue as far as possible. New rules, guidance and practice seek to maintain access to justice for litigants and the public nature of hearings, including in intellectual property disputes, as Lydia Birch and Kate Hawkins explain.</description><pubDate>Mon, 10 Aug 2020 10:21:00 Z</pubDate></item><item><guid isPermaLink="false">6ace353f-5767-409f-bc0d-f6e9af7246bf</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2020/strategies-patent-litigation-defendant-view</link><title>Lifecycle of a Smart Idea | The game begins: Strategies for the early stages of patent litigation: The defendant&#x27;s view</title><description>In this seventh episode in our series, &#x27;Lifeycle of a Smart Idea,&#x27; Gowling WLG&#x27;s IP professionals from around the world are going to take a look at patent litigation strategy in the early stages.</description><pubDate>Fri, 07 Aug 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">43249bf6-7722-418e-904a-f36f81eeb356</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2020/strategies-for-patent-litigation-claimants-view</link><title>Lifecycle of a smart idea | The game begins: Strategies for the early stages of Patent Litigation: The Claimant&#x27;s View</title><description>In the sixth and seventh episodes in our series, &#x27;Lifecycle of a Smart Idea&#x27;, Gowling WLG&#x27;s IP professionals from around the world examine patent litigation strategy in the early stages.</description><pubDate>Mon, 27 Jul 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">16222b24-5014-4641-b466-da1cbd105e85</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/doctrine-of-equivalents-in-russian-pharma</link><title>Applying the doctrine of equivalents in Russian pharma</title><description>A patent&#x27;s scope of protection is determined by the specific wording of its claims, which are understood in the context of the patent disclosure. Patent offices and courts therefore construe the words of these claims to determine the breadth or scope of protection.</description><pubDate>Thu, 16 Jul 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">83936769-9c40-43e0-b4e4-3d4b3eb46ecf</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2020/catching-trade-secret-thieves</link><title>Lifecycle of a Smart Idea | Ready or not, here we come: Tips for catching trade secret thieves</title><description>Your patent strategy is optimized and your business is running smoothly - until an employee goes rogue and steals one of your trade secrets. What should you do to mitigate the damage and salvage your secret?</description><pubDate>Wed, 15 Jul 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fae2bd96-7534-41b5-9f8b-932d04bc5b02</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2020/patent-strategies-tech-engineering</link><title>Lifecycle of a Smart Idea | Global patent strategies in the world of tech &#x26; engineering</title><description>Patenting an invention is a complex undertaking across all sectors &#x2013; but there are particular issues that organizations operating in the tech and engineering fields need to contemplate as part of their global patent strategy.</description><pubDate>Thu, 02 Jul 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1fa4472a-45a9-407e-b39f-daedcfe62236</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/upheaval-for-patent-law-of-sufficiency-from-the-uk</link><title>Upheaval for patent law of sufficiency from the UK Supreme Court</title><description>The UK Supreme Court (UKSC) has handed down its judgment in patent dispute Regeneron Pharmaceuticals Inc v Kymab Ltd ([2020] UKSC 27 (24 June 2020), making key rulings for the law of &#x27;sufficiency&#x27;.</description><pubDate>Thu, 25 Jun 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5b54c3db-93a6-406b-9063-549ed647a950</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2020/patent-strategy-optimizing-life-sciences-patents</link><title>Lifecycle of a smart idea | Patent strategy: Optimizing life sciences patents</title><description>Third on-demand webinar in our &#x27;Lifecycle of a Smart Idea&#x27; series exploring the scope of patent protection across jurisdictions.</description><pubDate>Tue, 23 Jun 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">aa0ea6a6-f291-4cc2-8e75-b060cf404a82</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2020/trade-secrets-international-protection</link><title>Secrets commerciaux : l&#x27;ABC de la protection internationale (webinaire en anglais)</title><description>2nd Webinar in our &#x22;Lifecycle of a Smart Idea&#x22; series with a closer look at protecting trade secrets.</description><pubDate>Mon, 08 Jun 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2e28018d-b0eb-4e84-825d-4a17a04cdf6e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/infringement-action-under-pm-noc-regulations</link><title>Infringement Action Under PM(NOC) Regulations Cannot Become Moot</title><description>In a recently released decision (2020 FC 635), Justice O&#x2019;Reilly held that patent infringement actions taken under section 6(1) of the Patent Medicines (Notice of Compliance) Regulations do not become moot if the action is not heard or decided before the patent(s) at issue expires.</description><pubDate>Fri, 05 Jun 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">97c2aafc-0c8b-4427-9020-e7c3a4e434d6</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/protection-of-secrets-in-patent-infringement</link><title>Protection of Secrets in Patent Infringement Proceedings</title><description>The need to strengthen procedural protection of trade secrets in patent infringement proceedings has recently taken shape. Speech is silver, but silence is golden.</description><pubDate>Tue, 02 Jun 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4b451020-5ef4-4f9c-84e8-2f9d9b2d5146</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/trademarks-in-russia</link><title>What you need to know about trademarks in Russia</title><description>Whether you already do business in Russia or are just considering entering the market, managing and defending your trademarks rights can be a daunting prospect. To help you navigate this area with confidence, we outline some key aspects of Russia&#x2019;s trademark regime.</description><pubDate>Wed, 20 May 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d0ae7e52-518c-4a8f-abb6-6236652da265</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/client-work/2020/fca-dismisses-bauer-hockey-s-patent-infringement</link><title>Federal Court dismisses Bauer Hockey&#x27;s patent infringement action against CCM</title><description>On May 15, 2020, the Federal Court dismissed a patent infringement action brought by Bauer against Sport Maska Inc. dba CCM Hockey and allowed CCM&#x27;s counterclaim of patent invalidity.</description><pubDate>Fri, 15 May 2020 12:00:00 Z</pubDate></item><item><guid isPermaLink="false">b0a6d5c0-e660-43e2-bd54-64facb86ade6</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/cipo-extension-of-designated-days</link><title>Mise &#xE0; jour de l&#x27;OPIC : Prolongation finale des d&#xE9;lais jusqu&#x27;au 24 ao&#xFB;t 2020</title><description>Le 5 ao&#xFB;t, l&#x27;Office de la propri&#xE9;t&#xE9; intellectuelle du Canada (OPIC) a annonc&#xE9; sa prolongation finale des d&#xE9;lais, de sorte que toutes les &#xE9;ch&#xE9;ances tombant entre le 16 mars et le 21 ao&#xFB;t de cette ann&#xE9;e sont automatiquement prolong&#xE9;es jusqu&#x27;au 24 ao&#xFB;t 2020.</description><pubDate>Thu, 14 May 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e8c0c318-4b26-4ab2-9682-5f10c67a3e54</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/on-demand-webinars/2020/to-patent-or-keep-secret</link><title>Lifecycle of a smart idea | To patent or keep secret?</title><description>Given the frenetic pace of today&#x27;s innovation lifecycle, do patents always afford the best protection of proprietary inventions?</description><pubDate>Thu, 14 May 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">97fc9e8b-8424-44b4-9cb1-9851fbd5c3c1</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/ip-protection-notes-in-china-during-covid-19</link><title>Overview on Intellectual Property protection notes in China during the COVID-19 outbreak</title><description>COVID-19 has swept across the globe causing massive disruption to businesses everywhere. While the impact of COVID-19 on other parts of the world continues to increase, China&#x27;s economic activity is now gradually returning to &#x22;business as usual&#x22;. This note will give an overview on the measures taken by the Chinese authorities in relation to IP during the period of COVID-19 outbreak in China and will shed light on what businesses should be aware of in terms of IP protection during this unprecedented time.</description><pubDate>Wed, 13 May 2020 08:40:00 Z</pubDate></item><item><guid isPermaLink="false">64e732b6-3545-4936-9047-0f4b56d3093f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/new-trademark-developments-in-french-law</link><title>Protecting and maximizing trademark rights in France: Five new developments in French law</title><description>An outline of new trademark developments in french law regarding protecting and maximising trademark rights.</description><pubDate>Mon, 04 May 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">92d61e9d-d654-4039-a8e0-bb4543b1de64</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/managing-your-patent-portfolio-during-a-crisis</link><title>La gestion de votre portefeuille de brevets pendant une crise</title><description>Pour prot&#xE9;ger un produit ou un service au moyen de brevets, la pratique exemplaire consiste &#xE0; demander la protection de toute invention int&#xE9;gr&#xE9;e dans ce produit ou service avant de proc&#xE9;der &#xE0; la divulgation publique, vente, offre de vente ou utilisation commerciale du produit ou service en question.</description><pubDate>Thu, 30 Apr 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">85d67186-c26f-4da5-8053-9960d2468c5b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/covid-19-manage-vr-ar-ip-portfolio</link><title>Managing your VR/AR IP portfolio during the COVID-19 crisis: Strategies and best practices</title><description>For VR/AR companies, spending money on intellectual property is often an investment for the future. In contrast, during the current COVID-19 public health crisis, our attention naturally turns to the present.</description><pubDate>Wed, 29 Apr 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">908600f7-277b-4923-91f5-f5bf6d4be87e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/covid-19-the-impact-on-ip-law-practice-in-russia</link><title>COVID-19: The impact on IP law and practice in Russia</title><description>David Aylen and the IP team at Gowling WLG Russia wrote an article about the COVID-19 measures in Russia and their impact on IP enforcement and protection.</description><pubDate>Tue, 28 Apr 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c70c6ece-d885-4397-8995-2f8e2b47b7e6</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2020/protecting-your-ai-investment-using-patent-applica</link><title>Protecting your AI investment using patent applications</title><description>Wondering how you can leverage intellectual property laws to best protect and commercialise your AI-based inventions? Watch this short IP Explainer from Roch Ripley.</description><pubDate>Sun, 26 Apr 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b89ce5e2-a495-4b45-a8f3-1966705ce071</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2020/federal-court-supports-broad-interpretation-csp</link><title>Better Together &#x2013; Federal Court Supports Broader Interpretation of CSP Regulations Based Upon A Purposive Review of CETA</title><description>The Federal Court has released the first Judicial Review decision addressing the Certificate of Supplementary Protection Regulations, in a case pertaining to a refusal by the Minister of Health to award a CSP to Glaxosmithkline Biologicals for a patent covering its SHINGRIX&#xAE; product.</description><pubDate>Thu, 09 Apr 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">186d1479-0ac5-4097-845c-f5a3ef271c15</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/developments-in-arrow-declarations</link><title>English Court of Appeal &#x27;widens the target&#x27; for Arrow declarations (and hands control to defendants)</title><description>Arrow relief continues to develop in the law of the UK, with the Court of Appeal recently refusing to strike out claims for a much broader declaration than has previously been granted.</description><pubDate>Thu, 09 Apr 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c3733d9b-dfab-4ed7-a6a1-6b76850c20cf</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/expedited-court-of-appeal-confirms-lucentis-expiry</link><title>Expedited Court of Appeal confirms expiry of Lucentis SPC ahead of time</title><description>Following a highly expedited, video-conferenced hearing, the Court of Appeal has confirmed that Master Data Center and Genentech could not correct the error in payment of the prescribed fee for the SPC for Lucentis, which has therefore expired early.</description><pubDate>Wed, 08 Apr 2020 08:56:00 Z</pubDate></item><item><guid isPermaLink="false">306385dc-9736-4f48-b3ad-9f1ca56d6fb3</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2020/trade-secrets-directive-has-not-changed</link><title>Trade Secrets Directive has not changed substantive English law principles protecting confidential information</title><description>Since the implementation of the Trade Secrets Directive in 2018, there has been a question in the UK about the extent to which the protection for confidential information provided by the common law has been impacted.</description><pubDate>Fri, 03 Apr 2020 13:42:00 Z</pubDate></item><item><guid isPermaLink="false">1bef19fb-3645-48c6-8c7c-583acee75385</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/videos/2020/a-message-from-our-global-ip-group</link><title>A message from our Global IP Group</title><description>Our professionals around the world are continuing to work to support you. We are also redefining business casual.</description><pubDate>Mon, 30 Mar 2020 17:57:00 Z</pubDate></item><item><guid isPermaLink="false">4ac8a4a9-2572-4c1c-9b2e-f9d424af8913</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2020/cipo-further-extends-deadlines-due-to-covid-19</link><title>L&#x2019;OPIC prolonge de nouveau les d&#xE9;lais en raison de la COVID-19</title><description>Le 27&#xA0;mars, l&#x2019;Office de la Propri&#xE9;t&#xE9; Intellectuelle du Canada (OPIC) a annonc&#xE9; avoir encore prolong&#xE9; ses d&#xE9;lais&#xA0;: toutes les &#xE9;ch&#xE9;ances tombant entre le 16&#xA0;mars et le 30&#xA0;avril ont automatiquement &#xE9;t&#xE9; prolong&#xE9;es jusqu&#x2019;au 1er&#xA0;mai&#xA0;2020.</description><pubDate>Sat, 28 Mar 2020 22:32:00 Z</pubDate></item><item><guid isPermaLink="false">6eba90ce-f819-407d-a0f2-48c28ff90de1</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/pay-the-correct-spc-fee-or-risk-expiry</link><title>Pay the correct SPC fee or risk expiry ahead of time!</title><description>Inga Pietsch and Huw Evans explain the need for fully informed and careful compliance with administrative requirements for SPCs, which are national in nature.</description><pubDate>Fri, 27 Mar 2020 10:22:00 Z</pubDate></item><item><guid isPermaLink="false">f0901477-6eda-4f1e-af42-5580b9ba8716</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2020/covid-19-amendments-to-the-patent-act</link><title>Loi concernant certaines mesures en r&#xE9;ponse &#xE0; la COVID-19 : modifications &#xE0; la Loi sur les brevets</title><description>Apr&#xE8;s de longues d&#xE9;lib&#xE9;rations, le gouvernement f&#xE9;d&#xE9;ral a adopt&#xE9; une loi d&#x27;aide en r&#xE9;ponse &#xE0; la pand&#xE9;mie de la COVID-19 (Loi concernant certaines mesures en r&#xE9;ponse &#xE0; la COVID-19). Cette loi a obtenu la sanction royale &#xE0; 13 h 30 environ, le 25 mars dernier.</description><pubDate>Thu, 26 Mar 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7fbf999a-dc99-4493-bd97-c054294044df</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/patent-and-infringement-together-patent-owners</link><title>Pour la premi&#xE8;re fois en Chine, la question de la validit&#xE9; d&#x27;un brevet et celle de sa contrefa&#xE7;on sont entendues ensemble : ce que les titulaires de brevet doivent prendre en consid&#xE9;ration avant de choisir cette voie</title><description>En d&#xE9;cembre 2019, le Tribunal de la propri&#xE9;t&#xE9; intellectuelle de la Cour populaire supr&#xEA;me (le &#xAB;&#xA0;Tribunal de la propri&#xE9;t&#xE9; intellectuelle de la CPS&#xA0;&#xBB;) a entendu un litige opposant Xiamen Shizheng Electronic Technology Co.,&#xA0;Ltd (&#xAB;&#xA0;Shizheng Technology&#xA0;&#xBB;) et Tianjin Lejin Electronic Appliance Co.,&#xA0;Ltd (&#xAB;&#xA0;Lejin Appliance&#xA0;&#xBB;) &#xE0; propos d&#x27;un mod&#xE8;le d&#x27;utilit&#xE9;.</description><pubDate>Tue, 24 Mar 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">67781ece-1488-4fca-b480-d9a85b10cf02</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/german-constitutional-court-delays-upc</link><title>German Constitutional Court delays UPC</title><description>In Germany, the Federal Constitutional Court (Bundesverfassungsgericht) has held that the statute by which the German Parliament (Bundestag) sought to ratify the UPC Agreement (the &#x27;Act of Approval&#x27;) is void.</description><pubDate>Fri, 20 Mar 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9f014d7d-e6e4-4858-96ad-76253545b312</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/update-from-the-canadian-ip-office</link><title>Mise &#xE0; jour de l&#x27;Office de la propri&#xE9;t&#xE9; intellectuelle du Canada</title><description>Face &#xE0; la distanciation sociale et &#xE0; la propagation de la COVID-19, l&#x27;Office de la propri&#xE9;t&#xE9; intellectuelle du Canada (OPIC) a fait part de r&#xE9;centes mesures pr&#xE9;ventives</description><pubDate>Tue, 17 Mar 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d4271043-a66b-4ef9-be82-2d7d2a751500</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/canadian-patent-law-2019-year-in-review</link><title>Droit canadien en mati&#xE8;re de brevets : faits saillants de 2019 (article en anglais)</title><description>There were various developments in Canadian patent law in 2019. Numerous decisions of the Federal Court of Appeal and Federal Court will have a notable impact on patent law in Canada going forward. In addition, the Patent Rules were the subject of significant amendments that will impact both prosecution and enforcement of patent rights in Canada for years to come.</description><pubDate>Wed, 26 Feb 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">af056957-0892-4981-a7f8-ca040c13b32b</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2020/patent-federal-court-of-appeal-dosage-questions</link><title>Brevetabilit&#xE9; au Canada : la Cour d&#x27;appel f&#xE9;d&#xE9;rale se penche sur la question de la distinction entre le dosage fixe et la gamme posologique (article en anglais)</title><description>In Canada, claims to new uses based on the discovery of &#x27;hitherto unrecognized properties&#x27; constitute patentable subject matter.</description><pubDate>Thu, 13 Feb 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2927fab0-8ef0-45f5-9778-27e2b005f0c7</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2020/unity-of-invention-requirements-russia-versus-eur</link><title>Exigences d&#x27;unit&#xE9; d&#x27;invention : la Russie vs. l&#x27;Eurasie (article en anglais)</title><description>According to Russian and Eurasian patent regulations, an application must relate to one invention or a group of inventions.</description><pubDate>Wed, 12 Feb 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1d254376-2414-4e29-8ebe-e9d39307d6bd</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/annual-review-of-uk-patent-cases-2019</link><title>Annual Review of UK Patent Cases - 2019</title><description>Take a look at Gowling WLG&#x27;s annual review of 2019&#x27;s patent cases.</description><pubDate>Tue, 04 Feb 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ad58982e-7570-40d7-8265-3f2f5beef58c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/voluntarily-restrictions-on-russian-and-eurasian-p</link><title>Voluntarily restrictions on Russian and Eurasian patents: a useful option for patent holders</title><description>There is no formal procedure for post-grant amendments to Russian patents under the country&#x2019;s Patent Act. However, it is possible to request full or partial renunciation of the granted patent.</description><pubDate>Thu, 30 Jan 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3b8d7cdd-8a9d-49b2-a70e-6e0f6ba63f0b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/amendments-to-the-german-patent-act</link><title>Amendments to the German Patent Act: Introduction and discussion of the draft of a Second Act for simplifying and modernising patent law</title><description>On 14 January 2020, the German Ministry of Justice and Consumer Protection (BMJV) published the draft of a Second Act for simplifying and modernising patent law (hereinafter referred to as: &#x22;Modernisation Draft&#x22;). In this latest Insight, we discuss the most significant amendments.</description><pubDate>Wed, 29 Jan 2020 10:46:00 Z</pubDate></item><item><guid isPermaLink="false">03ccc83c-4db4-4491-beb3-73c05669b226</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2020/gowling-wlg-lawyers-contribute-russian-expertise</link><title>Gowling WLG lawyers David Aylen and Vladislav Ugryumov contribute Russian IP expertise to The Patent Litigation Law Review (3rd ed.)</title><description>Partners David Aylen and Vladislav Ugryumov of Gowling WLG&#x27;s Moscow office recently contributed their expertise to the third edition of The Patent Litigation Law Review, published late last year.</description><pubDate>Mon, 20 Jan 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f8b39332-b9a0-461e-9b7f-41d0b0f8e36f</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2020/vavilov-changes-to-administrative-law-in-canada</link><title>L&#x27;affaire &#x3C;em&#x3E;Vavilov&#x3C;/em&#x3E; : changements au droit administratif Canadien &#x3C;br&#x3E;(article en anglais)</title><description>In late December 2019, the Supreme Court released its decision in Canada (Minister of Citizenship and Immigration) v Vavilov, 2019 SCC 65.</description><pubDate>Wed, 08 Jan 2020 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7896be06-a82e-4f0f-861c-ed0cbbfce2ba</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/fto-assessments-rights-to-consider</link><title>FTO assessments: what rights holders need to consider</title><description>Patent rights are vigorously protected in Russia - it is therefore advisable that those interested in commercialising a product or process perform vital risk-management analysis in order to gauge their freedom to operate.</description><pubDate>Thu, 19 Dec 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">864d5719-093d-4079-bc93-7f0e556b07ae</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/third-party-rights-to-infringe</link><title>Third Party Rights to Infringe</title><description>Over the last year the Canadian Government has added two new sections to the Patent Act that have created new exceptions to infringement.</description><pubDate>Tue, 26 Nov 2019 18:27:00 Z</pubDate></item><item><guid isPermaLink="false">eae31db5-1e52-413f-b82c-ba52376803ba</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/canadian-v-us-monetary-for-patent-infringement</link><title>Show Me the Money! Canadian v. US Monetary Remedies for Patent Infringement</title><description>In recent years, Canada has become an increasingly attractive jurisdiction for patentees to obtain and enforce their patent rights. In terms of monetary remedies, as compared to the United States, there is often greater flexibility in Canada in crafting compensation for infringement. Despite our smaller market, the size of damages and profits awards can, at times, end up being larger in Canada.</description><pubDate>Mon, 11 Nov 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">61bdb2c4-c49a-4357-bc18-a063a3deb158</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/digital-economy-means-for-rospatent</link><title>The future is here: what the Digital Economy Programme means for Rospatent</title><description>Improving electronic interactivity has been a high priority for the Russian Patent and Trademark Office (Rospatent) in recent years, especially since the launch of the Digital Economy Programme in 2018. This long-term initiative aims to revolutionise the country&#x2019;s IT infrastructure, enabling the widespread, efficient and secure receipt, transmission, processing and storage of electronic data by all levels of government bodies by 2024.</description><pubDate>Wed, 06 Nov 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fe489f47-fca8-4bb2-bcfe-cd48fcec9e19</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/gowling-wlg-moscow-co-author-global-patent-book</link><title>Deux avocats de Gowling WLG &#xE0; moscou, Vladislav Ugryumov et Ruben Dzhermakyan, collaborent &#xE0; la r&#xE9;daction d&#x27;un ouvrage mondial sur les brevets (article en anglais)</title><description>Gowling WLG Russia is pleased to share that its own Vladislav M. Ugryumov and Ruben V. Dzhermakyan have authored a chapter of the 2019 edition of Global Patent Protection and Enforcement of In Vitro Diagnostic Inventions (Kluwer Law International). In this text, the authors describe special aspects of the patenting and enforcement of in vitro diagnostic inventions in Russia.</description><pubDate>Wed, 30 Oct 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a96eb6f0-671d-4fd4-8916-a18d48a82dd8</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/amendments-to-guidelines-for-patent-examination</link><title>A summary of the latest amendments to the Guidelines for Patent Examination in China</title><description>The China National Intellectual Property Administration (CNIPA) Guidelines for Patent Examination set detailed rules and explanations for Chinese patent examiners to determine the patentability of an invention, a utility model or a design.</description><pubDate>Tue, 29 Oct 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c4ea666b-0fe1-4935-a006-bc864a1adf0e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/shanks-v-unilever</link><title>Inventing employee wins &#xA3;2 million compensation for outstanding benefit of patents in UK Supreme Court</title><description>The UK Supreme Court has awarded an employee (Mr Shanks), whose inventions led to patents that were of &#x27;outstanding benefit&#x27; to his employer (Unilever), compensation of &#xA3;2&#xA0;million as a &#x27;fair share&#x27; of that benefit.</description><pubDate>Fri, 25 Oct 2019 14:24:00 Z</pubDate></item><item><guid isPermaLink="false">970510ae-5087-4983-b21c-e767bba23ba6</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/patenting-artificial-intelligence-inventions</link><title>Breveter des inventions dot&#xE9;es d&#x27;intelligence artificielle au Canada (article en anglais)</title><description>Artificial intelligence (AI)&#x2014;the use of various methods and algorithms to simulate cognitive functions in machines&#x2014;has its origins dating back to the 1950s. In recent years, the confluence of advancements in computational power and the abundance of rich data sets has led to a surge in the number of practical applications for AI. The time and money required to properly train, test, and deploy AI in these applications makes protecting them using patents a crucial consideration in any business plan.</description><pubDate>Thu, 24 Oct 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0f8dee9a-48c2-4412-9384-8dd59de33cc4</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/how-much-does-a-canadian-patent-cost</link><title>Combien co&#xFB;te un brevet canadien? (article en anglais)</title><description>Asking how much it costs to get a patent in Canada is a bit like asking how long a piece of string is. The answer, of course, depends on many different factors, but there are a number of general guidelines that can be used to anticipate likely costs that will be incurred over the lifetime of a patent.</description><pubDate>Thu, 24 Oct 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">edecda40-246c-4b0c-aad6-69799217ad9a</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/patentees-beware-of-foreign-patent-file-histories</link><title>Avis aux brevet&#xE9;s : l&#x27;historique d&#x27;une demande d&#xE9;pos&#xE9;e &#xE0; l&#x27;&#xE9;tranger peut &#xEA;tre nuisible</title><description>Le 25&#xA0;septembre 2019, la Cour f&#xE9;d&#xE9;rale du Canada a publi&#xE9; la premi&#xE8;re d&#xE9;cision interpr&#xE9;tant la port&#xE9;e du nouvel article 53.1 de la Loi sur les brevets. Aux termes de cette disposition l&#xE9;gislative, il est possible de se r&#xE9;f&#xE9;rer &#xE0; l&#x27;historique du dossier d&#x27;un brevet (principalement constitu&#xE9; de la correspondance &#xE9;chang&#xE9;e entre un brevet&#xE9; et un bureau des brevets durant la poursuite d&#x27;une demande de brevet) pour r&#xE9;futer les d&#xE9;clarations d&#x27;un brevet&#xE9; quant &#xE0; l&#x27;interpr&#xE9;tation des revendications d&#x27;un brevet.</description><pubDate>Thu, 26 Sep 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c19723cb-0783-4574-87d8-d1dd5d884033</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/client-work/2019/precedent-setting-decision-in-patent-infringement</link><title>Federal Court issues precedent-setting decision in patent infringement action</title><description>On Sept. 25, 2019, Justice Manson of the Federal Court of Canada summarily dismissed a patent infringement action brought by CanMar Foods Ltd. against TA Foods Ltd.</description><pubDate>Wed, 25 Sep 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cdc9ef79-7455-4243-a58d-2314d0dd3b65</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/reasons-to-seek-patent-protection-in-canada</link><title>&#xD4;, Canada! Quelques raisons &#x3C;br&#x3E;d&#x27;y prot&#xE9;ger ses brevets en 2019 (article en anglais)</title><description>Canada&#x27;s innovation and tech sectors have flourished in recent years, attracting leading entrepreneurs and major investments from around the world to Canada. Along with this rapid sector growth has come a corresponding flurry of interest in innovation and, by extension, intellectual property &#x2013; particularly in Canada&#x27;s finance and tech sectors.</description><pubDate>Thu, 12 Sep 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cb494e42-9059-4afb-b14e-5199112b3cf8</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/why-registering-ip-in-china-is-essential</link><title>L&#x27;enregistrement d&#x27;actifs de pi en &#x3C;br&#x3E;Chine : une mesure essentielle</title><description>Malgr&#xE9; l&#x27;optimisme dont font preuve les administrateurs de multinationales &#xE0; l&#x27;&#xE9;gard du march&#xE9; chinois, il est rare que ces derniers songent &#xE0; y d&#xE9;ployer une strat&#xE9;gie de propri&#xE9;t&#xE9; intellectuelle (PI). Or, enregistrer leurs actifs de PI dans ce pays devraient &#xEA;tre un r&#xE9;flexe.</description><pubDate>Tue, 03 Sep 2019 08:35:00 Z</pubDate></item><item><guid isPermaLink="false">8d48ecfd-194c-40eb-8c46-af5c9ddfbbb3</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/dazed-and-confused-a-closer-look-at-the-amended-p</link><title>Besoin d&#x27;&#xE9;claircissement? Un examen plus attentif de la version modifi&#xE9;e du &#x3C;em&#x3E;R&#xE8;glement sur les m&#xE9;dicaments brevet&#xE9;s&#x3C;/em&#x3E;</title><description>Si l&#x27;annonce, vendredi dernier, des modifications apport&#xE9;es au R&#xE8;glement sur les m&#xE9;dicaments brevet&#xE9;s (le &#xAB;&#xA0;RMB&#xA0;&#xBB;) n&#x27;a pas caus&#xE9; de v&#xE9;ritable surprise, elle a cependant mis en &#xE9;vidence la profonde incertitude avec laquelle doivent composer les brevet&#xE9;s qui commercialisent des m&#xE9;dicaments au Canada.</description><pubDate>Thu, 15 Aug 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1f073425-95d9-4e4f-873f-cc6df7310bb8</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/pmprb-shakeup-united-states-and-switzerland-no-l</link><title>Du nouveau au CEPMB &#x2013; Les &#xC9;tats-Unis et la Suisse exclus des pays de comparaison (article en anglais)</title><description>The federal government has announced the long-awaited changes to the Patented Medicines Regulations, which are set to come into force on July 1, 2020.</description><pubDate>Fri, 09 Aug 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a04d84e1-a543-4752-b182-3ca48ec4d9aa</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/patent-extension-in-russia</link><title>Patent extension in Russia</title><description>Since 2003 it has been possible to extend the duration or term of a Russian patent for a drug, pesticide or agricultural chemical by up to five years. Upon the patent holder&#x27;s request, an extension to a patent term may be obtained based on the product&#x27;s first marketing authorisation.</description><pubDate>Thu, 08 Aug 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6ee590c1-2e8e-4603-91b8-8a487a91698c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/update-implementation-of-the-patent-law-treaty</link><title>Mise &#xE0; jour : Mise en &#x153;uvre du Trait&#xE9; sur le droit des brevets</title><description>Le gouvernement canadien a publi&#xE9; la version d&#xE9;finitive des nouvelles R&#xE8;gles sur les brevets, qui entreront en vigueur le 30&#xA0;octobre&#xA0;2019. Ces R&#xE8;gles, ainsi que les modifications compl&#xE9;mentaires apport&#xE9;es &#xE0; la Loi sur les brevets, mettent en &#x153;uvre le Trait&#xE9; sur le droit des brevets et devraient &#xE9;galement acc&#xE9;l&#xE9;rer certains aspects de la poursuite des demandes de brevet en r&#xE9;duisant certains d&#xE9;lais aff&#xE9;rents. Les principaux changements qu&#x27;introduisent les nouvelles R&#xE8;gles et la nouvelle Loi sont d&#xE9;crits ci-dessous.</description><pubDate>Wed, 07 Aug 2019 14:25:00 Z</pubDate></item><item><guid isPermaLink="false">d16544c0-bab7-4598-b0fd-23aff3455e0f</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2019/the-importance-of-ip-rights-in-technology</link><title>The importance of intellectual property rights in technology</title><description>Our intellectual property experts consider the importance of IP rights in technology during disruptive times.</description><pubDate>Thu, 25 Jul 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b6b4c626-e0a6-4309-965d-0af6ef69e6c5</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/ip-strategy-learning-from-the-disruptors</link><title>IP Strategy: What management can learn from the disruptors</title><description>Four tips to creating the best IP strategy in the face of disrupted markets.</description><pubDate>Tue, 23 Jul 2019 08:02:00 Z</pubDate></item><item><guid isPermaLink="false">a81a120c-f50c-4946-a3b5-e669ea974a07</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/actavis-v-eli-lilly-impact-on-patent-infringement</link><title>Actavis v Eli Lilly: the impact on patent infringement law in the UK two years on</title><description>Our intellectual property experts discuss the impact that Actavis v Eli Lilly had on patent infringement law in the UK.</description><pubDate>Thu, 18 Jul 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5cc71f77-399a-4639-86ea-1d460a9a0a96</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/publication-of-the-finalized-patent-rules</link><title>Publication de la version finale des &#x3C;em&#x3E;R&#xE8;gles sur les brevets&#x3C;/em&#x3E; et annonce de la date d&#x27;entr&#xE9;e en vigueur</title><description>Le 10 juillet de cette ann&#xE9;e, le gouvernement du Canada a publi&#xE9; les nouvelles R&#xE8;gles sur les brevets dans la Partie II de la Gazette du Canada. Cette publication des R&#xE8;gles d&#xE9;finitives fait suite &#xE0; la publication d&#x27;une version pr&#xE9;liminaire le 1er d&#xE9;cembre 2018 et &#xE0; la p&#xE9;riode de consultation qui s&#x27;en est ensuivie.</description><pubDate>Wed, 10 Jul 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4453b11b-6e8e-41bf-8ee4-025898e1c3b6</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2019/going-overboard-on-overbreadth</link><title>Quand les all&#xE9;gations de port&#xE9;e excessive vont trop loin (article en anglais)</title><description>Under the doctrine of overbreadth a patent is invalid if its claims extend beyond the invention.</description><pubDate>Tue, 28 May 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e2458540-bb3b-424b-a0ae-e497a8b517e6</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/jaguar-land-rover-v-landwind-unfair-competition</link><title>Jaguar Land Rover v LandWind: acts of unfair competition and copyright infringement</title><description>The three-year court battle between JLR and Chinese automotive manufacturer Jiangling resulted in a long-awaited victory for JLR and the wider automotive industry.</description><pubDate>Thu, 23 May 2019 13:03:00 Z</pubDate></item><item><guid isPermaLink="false">c2028169-539b-43ff-8566-362c2533b5b0</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/brexit-the-clock-ticks</link><title>Brexit : l&#x27;heure de v&#xE9;rit&#xE9; approche (article en anglais)</title><description>&#x27;Brexit&#x27; poses considerable challenges for intellectual property law and presents uncertainty as to the involvement of the UK, following its exit from the EU, in existing and proposed international regimes involving European Union (EU) law.</description><pubDate>Tue, 21 May 2019 10:20:00 Z</pubDate></item><item><guid isPermaLink="false">ed03cb37-b44d-441b-9152-be8a7988bc85</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/intellectual-property-enforcement-guidelines</link><title>Intellectual Property Enforcement Guidelines: Settlements of Proceedings under the PM(NOC) Regulations</title><description>On March 13, 2019 the Competition Bureau introduced its new Intellectual Property Enforcement Guidelines, which seek to increase transparency regarding the Bureau&#x27;s application of the Competition Act as it relates to the assertion of IP rights.</description><pubDate>Wed, 03 Apr 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f3c851f6-6535-45dd-b804-a8cb0974c13e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2019/winning-judgment-for-tq-delta-reaffirms-expertise</link><title>Gowling WLG reaffirms its patent expertise with a winning judgment for TQ Delta</title><description>Gowling WLG&#x27;s award-winning Patent team has gained recognition in the market for a significant patent win for client TQ Delta LLC.</description><pubDate>Wed, 03 Apr 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">53a2a91b-e82f-4de9-ade4-c239e72c2fba</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/uk-supreme-court-explains-the-law-of-obviousness</link><title>UK Supreme Court explains the law of obviousness</title><description>The UK Supreme Court has delivered an important judgment on the test of &#x27;obviousness&#x27; in patent law, and in particular for dosing regimen patents.</description><pubDate>Tue, 02 Apr 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a31e4563-a11d-45d6-9bb9-a4c0b0c05045</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/first-reading-bill-c-86</link><title>Premi&#xE8;re lecture du projet de loi C-86 : mise en &#x153;uvre de modifications &#xE0; la &#x3C;em&#x3E;Loi sur les brevets&#x3C;/em&#x3E;, la &#x3C;em&#x3E;Loi sur le droit d&#x27;auteur&#x3C;/em&#x3E; et la &#x3C;em&#x3E;Loi sur les marques de commerce&#x3C;/em&#x3E;</title><description>La premi&#xE8;re lecture du projet de loi C-86, la Loi no 2 d&#x2019;ex&#xE9;cution du budget de 2018 (la &#xAB; loi &#xBB;) a eu lieu &#xE0; la Chambre des communes le 29 octobre 2018. La loi met en &#x153;uvre, entre autres choses, la Strat&#xE9;gie en mati&#xE8;re de propri&#xE9;t&#xE9; intellectuelle du Canada, qui propose des modifications &#xE0; diverses lois sur la propri&#xE9;t&#xE9; intellectuelle et &#xE9;dicte la Loi sur le Coll&#xE8;ge des agents de brevets et des agents de marques de commerce.</description><pubDate>Wed, 27 Feb 2019 17:34:00 Z</pubDate></item><item><guid isPermaLink="false">a3d7f9ec-0d09-4340-95e6-8e2fdbb0e35b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/benefits-of-industry-group-intervention</link><title>Les avantages des interventions de groupes sectoriels &#xE0; la Cour f&#xE9;d&#xE9;rale du Canada (article en anglais)</title><description>Few industry groups have sought to intervene at the Federal Court in such judicial reviews. However, a recent decision of the Federal Court provides useful guidance on the benefits that industry groups can bring to the proceeding in light of their unique perspectives.</description><pubDate>Mon, 25 Feb 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">acc42307-57c4-4cea-a8ed-e44c960b7ac2</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/bad-faith-trademark-applications</link><title>Bad Faith Trademark Applications</title><description>Gowling WLG&#x27;s experts address the topic of &#x27;bad faith&#x27; applications in the field of trademarks; considering the significance of the problem; how such applications may be dealt with; and strategies for risk prevention, across multiple jurisdictions.</description><pubDate>Thu, 31 Jan 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">80015a71-8940-4ffd-b101-39d32b44a5b6</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/annual-review-of-the-2018-patent-cases</link><title>Annual Review of the 2018 Patent Cases</title><description>In January 2019, Gowling WLG&#x27;s co-head of global Intellectual Property (IP), Gordon Harris, delivered his much anticipated annual review of the year&#x27;s UK patent.</description><pubDate>Wed, 30 Jan 2019 12:24:00 Z</pubDate></item><item><guid isPermaLink="false">c99ea383-59fe-4120-8376-edcc99851823</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/changes-to-the-uk-s-trademarks-law</link><title>Changes to the UK&#x27;s Trademarks Law</title><description>The EU Trademarks Directive 2015 comes into force in the UK; bringing with it some key changes to the UK&#x27;s legal system governing the application, registration, enforcement and licensing of trademarks.</description><pubDate>Mon, 14 Jan 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">795b2598-6c6d-4d7c-b7ad-08bd2132f95e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/foreign-patent-holders-beware-when-writing</link><title>Avis aux titulaires de brevets &#xE9;trangers (et aux avocats/agents de brevets) : prenez garde lorsque vous &#xE9;crivez &#xE0; des Canadiens (article en anglais)</title><description>A number of changes to Canada&#x27;s intellectual property legislation came into force on Dec. 13, 2018. One of the changes to Canada&#x27;s Patent Act is a new subsection relating to written demands (a.k.a. cease and desist letters) in relation to patents - seemingly any patents, including foreign patents.</description><pubDate>Thu, 10 Jan 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1a7536cf-fc40-44df-8946-deec737aec3f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2019/canadian-patent-law-2018-year-in-review</link><title>Droit canadien en mati&#xE8;re de brevets - R&#xE9;trospective de l&#x27;ann&#xE9;e 2018</title><description>De nombreuses d&#xE9;cisions de la Cour f&#xE9;d&#xE9;rale et de la Cour d&#x2019;appel f&#xE9;d&#xE9;rale auront une incidence notable sur l&#x2019;avenir du droit des brevets au Canada.</description><pubDate>Mon, 07 Jan 2019 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1460da15-d74d-4225-a921-13749147208f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/gsk-awarded-arrow-declaration-in-patent-dispute</link><title>GSK awarded &#x3C;em&#x3E;Arrow&#x3C;/em&#x3E; declaration in patent dispute with Vectura</title><description>Gowling WLG&#x27;s IP experts discuss GSK&#x27;s High Court patent dispute with Vectura.</description><pubDate>Thu, 13 Dec 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">61dd4b4f-40d8-4a44-873e-5dcea8df678a</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/another-step-towards-ratification-of-patent-law</link><title>Un pas de plus vers la mise en &#x153;uvre du trait&#xE9; sur le droit des brevets</title><description>Le 1er d&#xE9;cembre 2018, le gouvernement canadien a publi&#xE9; aux fins de consultation publique une version actualis&#xE9;e des modifications propos&#xE9;es aux R&#xE8;gles sur les brevets du Canada.</description><pubDate>Mon, 03 Dec 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e94ea64a-fab4-471d-b50e-90952be171ef</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/uk-supreme-court-ruling-in-warner-lambert-case</link><title>UK Supreme Court confirms Warner-Lambert patent claims insufficient&#x2026;</title><description>The UK Supreme Court&#x27;s judgment in Warner-Lambert v Generics has, sadly, unsettled areas of patent law in the UK, while confirming the invalidity of key claims of Warner-Lambert&#x27;s patent.</description><pubDate>Wed, 21 Nov 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cbcc8bee-08fb-47bd-b52d-7a8d1e468ef3</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/warner-lambert-pregabalin-patent-case</link><title>UK Supreme Court majority against Warner-Lambert in pregabalin patent case</title><description>Gowling WLG&#x27;s IP team provides a snap-shot commentary on the Supreme Court&#x27;s reasoning in the Warner-Lambert case.</description><pubDate>Wed, 14 Nov 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">78a1bf15-e891-4940-b2c3-6298d1865555</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/usmca-what-it-means-for-patents-and-pharmaceutical</link><title>Quelle est l&#x2019;incidence de l&#x2019;AEUMC dans le domaine des brevets et de l&#x2019;industrie pharmaceutique? (Article en anglais)</title><description>In a joint statement on Sept. 30, 2018, the United States and Canadian Governments announced that they reached an agreement, alongside Mexico, on a new, modernized trade agreement for the 21st century. The pending trilateral deal, called the United States-Mexico-Canada Agreement (USMCA), is intended to replace the North American Free Trade Agreement (NAFTA) currently in force.</description><pubDate>Fri, 05 Oct 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9192fc3e-9cf1-4816-af33-fb69a99c05bc</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/the-intellectual-property-review-seventh-edition</link><title>The Intellectual Property Review, seventh edition</title><description>The Intellectual Property Review, seventh edition, has been published. Gowling WLG (Gordon Harris, Andrew Maggs, George Sevier and Ailsa Carter) authored the UK Chapter.</description><pubDate>Wed, 26 Sep 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fdccc7d2-561a-4015-9fd8-a863a1b043c8</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/uk-government-no-deal-brexit-guidance-for-ip</link><title>Incidence du Brexit &#xAB; sans accord &#xBB; : le gouvernement britannique se prononce quant &#xE0; la PI (article en anglais)</title><description>The UK Government has released guidance on the Brexit process for intellectual property in a no deal scenario. UK legislation will extract UK rights from existing EU-wide trademark and design registrations. The UK will continue to recognise existing unregistered Community design right and will create a new unregistered design right of equivalent scope. For the &#x22;immediate&#x22; term, the UK will also continue to recognise regional exhaustion (but the European Economic Area (EEA) will not recognise the UK within that system). The existing patent systems will largely be unaffected by Brexit. Please read on for our fuller summary of the highlights of the 24 September 2018 guidance.</description><pubDate>Tue, 25 Sep 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">374509b0-b45e-45f4-abfb-bf3d4029e17b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/one-year-anniversary-of-the-csp-regulations</link><title>Premier anniversaire du &#x3C;em&#x3E;R&#xE8;glement sur les certificats de protection suppl&#xE9;mentaire&#x3C;/em&#x3E;</title><description>Le 21&#xA0;septembre&#xA0;2017, le R&#xE8;glement sur les certificats de protection suppl&#xE9;mentaire (R&#xE8;glement sur les CPS) est entr&#xE9; en vigueur, permettant pour la premi&#xE8;re fois de prolonger la p&#xE9;riode de protection d&#x27;un brevet pour les drogues &#xE0; usage humain ou v&#xE9;t&#xE9;rinaire au Canada.</description><pubDate>Mon, 17 Sep 2018 18:26:00 Z</pubDate></item><item><guid isPermaLink="false">bd5bf0ac-98aa-4b41-81d2-a216404d9683</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/new-automotive-technology-and-brexit</link><title>New automotive technology and Brexit</title><description>This short guide highlights key areas requiring action by companies in the UK&#x27;s automotive sector involved in the development of new technology: access to funding; access to skilled workers; potential divergence in legal and regulatory frameworks; intellectual property; and technical standards.</description><pubDate>Fri, 07 Sep 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fc1b794e-8742-4e21-b166-0dba3831b36e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/no-deal-brexit-implications-for-automotive-ip</link><title>No deal Brexit implications for automotive IP?</title><description>This article explores the implications of a no deal Brexit, for IP regimes supporting the UK automotive sector.</description><pubDate>Wed, 05 Sep 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">bf4ea228-b71b-4ec7-84ae-8f61d8d81000</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/rospatent-fee-based-extradited-examination</link><title>Rospatent re-launches fee-based expedited examination</title><description>On October 5, 2017 the Russian Patent and Trademark Office (Rospatent) officially announced that expedited examination will be available for all applications.</description><pubDate>Tue, 17 Jul 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">20c8dee9-b22d-45c2-9414-b58dffbe1727</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/challenges-facing-the-automotive-sector</link><title>Des d&#xE9;fis sans pr&#xE9;c&#xE9;dent au sein de l&#x2019;industrie automobile forcent la r&#xE9;&#xE9;valuation urgente des strat&#xE9;gies de PI actuelles (article en anglais)</title><description>Research from our new report found that 86% of industry experts expect to see more litigation in the automotive sector.</description><pubDate>Tue, 10 Jul 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e3cb35e4-70d3-4801-aeab-8ee4bb33b420</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/shire-successfully-defends-canadian-vyvanse-paten</link><title>Shire Defends Canadian VYVANSE&#xAE; Patent against Apotex&#x27;s Impeachment Attacks</title><description>Apotex&#x27;s invalidity allegations regarding Shire&#x27;s Canadian Patent 2,527,646 covering the active ingredient in Shire&#x27;s ADHD medication VYVANSE&#xAE; have been rejected following a 17-day trial before Justice Fothergill of the Federal Court.</description><pubDate>Tue, 03 Jul 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2be3aff2-ee9e-4546-9827-5b6bcd9be15c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2018/shire-successfully-defends-against-apotex</link><title>Shire successfully defends Canadian VYVANSE&#xAE; patent against Apotex&#x27;s impeachment attacks</title><description>Le 29 juin 2018, apr&#xE8;s un proc&#xE8;s de 17 jours pr&#xE9;sid&#xE9; par le juge Fothergill, la Cour f&#xE9;d&#xE9;rale a publi&#xE9; son jugement et ses motifs relativement &#xE0; un diff&#xE9;rend mettant en cause des all&#xE9;gations d&#x2019;invalidit&#xE9; par Apotex quant au brevet canadien 2 527646 de Shire couvrant l&#x2019;ingr&#xE9;dient actif pr&#xE9;sent dans le m&#xE9;dicament contre le TDAH, VYVANSE&#xAE; de Shire.</description><pubDate>Fri, 29 Jun 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6367a1a0-2a56-4f86-9980-e2e7ed7bbc43</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/how-to-shoot-for-arrow-relief</link><title>How to shoot for Arrow relief</title><description>The Court of Appeal has ruled that the discretion as to whether or not to award Arrow relief lies with the trial judge, for exercise in light of the facts and circumstances at the date of the trial.</description><pubDate>Thu, 28 Jun 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">bc30037c-88b5-4db3-86c9-715fa4e3fe87</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/alcon-puts-the-brakes-on-ap-racing</link><title>The Court of Appeal confirms that retrial is not permitted</title><description>Alcon has successfully resisted AP Racing&#x27;s appeal against an Intellectual Property Enterprise Court (IPEC) decision. The case concerns Alcon&#x27;s high performance brake caliper designs and technology.</description><pubDate>Wed, 27 Jun 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9041352c-ca53-4946-866f-37ce8cce1fcf</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/eu-commission-proposes-softening-of-spc-law</link><title>EU Commission proposes softening of SPC law to assist EU-based manufacturers</title><description>The European Commission has proposed a &#x27;targeted adjustment&#x27; to intellectual property law with a view to reducing the restrictions on EU-based manufacturers of pharmaceuticals seeking to compete in global markets.</description><pubDate>Wed, 30 May 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d2b4c92e-c894-4262-9303-fe4b2eec19bb</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/post-grant-patent-validity-challenges-canada-uk</link><title>Survol des proc&#xE9;dures de contestation de validit&#xE9; de brevets (post-octroi) au Canada et au Royaume-Uni (article en anglais)</title><description>Most jurisdictions provide at least some procedures for challenging the validity of a granted patent. Sometimes the process for challenging validity is conducted before a patent office, and sometimes the process is conducted in court before a judge (either as a counterclaim, or as a standalone impeachment or declaratory judgment action).</description><pubDate>Tue, 01 May 2018 15:05:00 Z</pubDate></item><item><guid isPermaLink="false">6f88356f-2228-49e1-a634-ef7addb1e365</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/uk-ratifies-the-upc-agreement</link><title>UK ratifies the UPC Agreement - what does this mean for the UPC? (Sssh - don&#x27;t mention Brexit&#x2026;)</title><description>On 26 April 2018 the UK completed its ratification of the UPC Agreement by depositing its instrument of ratification with the European Council.</description><pubDate>Fri, 27 Apr 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">07a2a365-3d36-479a-b456-d48657591f43</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/from-tpp-to-cptpp-suspensions-to-ip-provisions</link><title>Du PTP au PTPGP : Suspension des dispositions relatives &#xE0; la propri&#xE9;t&#xE9; intellectuelle</title><description>Le 23 janvier 2018, le Canada et dix autres signataires du aujourd&#x2019;hui d&#xE9;funt Partenariat transpacifique (PTP), ont men&#xE9; &#xE0; bien une s&#xE9;rie de n&#xE9;gociations &#xE0; Tokyo &#xE0; propos du projet d&#x27;accord de Partenariat transpacifique global et progressiste (PTPGP). Les &#xE9;l&#xE9;ments principaux du futur accord, qui est n&#xE9; apr&#xE8;s que les &#xC9;tats-Unis se soient retir&#xE9;s du PTP en janvier 2017, ont &#xE9;t&#xE9; accept&#xE9;s par les 11 Parties restantes le 10 novembre 2017 &#xE0; l&#x27;occasion d&#x27;une r&#xE9;union &#xE0; Da Nang, au Vietnam.</description><pubDate>Wed, 25 Apr 2018 17:50:00 Z</pubDate></item><item><guid isPermaLink="false">3972fa58-3cda-4fad-8991-53ae191eac28</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/patent-eligibility-natural-product-can-us</link><title>Deux pays, deux visions : les exigences li&#xE9;es &#xE0; l&#x2019;obtention d&#x2019;un brevet pour des produits naturels au Canada et aux &#xC9;tats-Unis</title><description>Les produits naturels, des compos&#xE9;s chimiques produits par des organismes vivants, sont omnipr&#xE9;sents dans notre quotidien et essentiels pour l&#x2019;&#xE9;conomie des sciences de la vie moderne. Des produits de beaut&#xE9; aux compl&#xE9;ments alimentaires en passant par les produits th&#xE9;rapeutiques pour lutter contre le cancer, la science &#xE0; l&#x2019;origine des produits naturels conna&#xEE;t un essor rapide et nous en r&#xE9;coltons les avantages plus que jamais.</description><pubDate>Mon, 23 Apr 2018 15:33:00 Z</pubDate></item><item><guid isPermaLink="false">8dd95e1e-f1df-43aa-9a5e-45045037a420</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/brexit-implications-for-ip-arrangements-agreed-so</link><title>Incidences du Brexit pour la propri&#xE9;t&#xE9; intellectuelle (pi) : les dispositions prises jusqu&#x2019;&#xE0; maintenant</title><description>Le Royaume-Uni et les pays demeurant dans l&#x27;UE se sont entendus en partie sur le texte d&#x27;un trait&#xE9; qui r&#xE9;gira le processus du Brexit. Ce texte clarifie globalement les dispositions prises relativement &#xE0; la conversion des droits unitaires de l&#x27;UE se rattachant aux marques de commerce, aux dessins industriels et aux obtentions v&#xE9;g&#xE9;tales en droits du R.-U.</description><pubDate>Wed, 11 Apr 2018 19:28:00 Z</pubDate></item><item><guid isPermaLink="false">9e0b5bb6-c97c-4d8e-9965-f000116ec52d</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/understanding-ip-across-multiple-jurisdictions</link><title>Understanding IP across multiple jurisdictions</title><description>Guides to understanding the differences between IP law in multiple jurisdictions.</description><pubDate>Tue, 27 Feb 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">924ccb11-100e-429f-ab69-67831f0b6a31</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/employee-inventor-compensation-annual-patents-re</link><title>Employee Inventor Compensation - Annual Patents Review 2017</title><description>This is the Employee Inventor Compensation chapter of Gordon Harris&#x27; Annual Patents Review 2017. For the other chapters of the review, please follow the links below or download the Annual Patents Review 2017 in full.</description><pubDate>Thu, 15 Feb 2018 10:07:00 Z</pubDate></item><item><guid isPermaLink="false">623b5842-1397-4c2d-ac3a-406dd44fc38f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/competition-law-annual-patents-review-2017</link><title>Competition Law, Settlement and Licensing - Annual Patents Review 2017</title><description>This is the Competition Law, Settlement and Licensing chapter of Gordon Harris&#x27; Annual Patents Review 2017.</description><pubDate>Thu, 15 Feb 2018 10:06:00 Z</pubDate></item><item><guid isPermaLink="false">3f718a74-3f0b-42bf-9c03-2b5c21971e36</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/validity-annual-patents-review-2017</link><title>Validity - Annual Patents Review 2017</title><description>This is the Validity chapter of Gordon Harris&#x27; Annual Patents Review 2017. For the other chapters of the review, please follow the links below or download the Annual Patents Review 2017 in full.</description><pubDate>Thu, 15 Feb 2018 10:04:00 Z</pubDate></item><item><guid isPermaLink="false">c9802ca5-1344-45c0-a9c5-6d5ce14974a2</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/infringement-annual-patents-review-2017</link><title>Infringement - Annual Patents Review 2017</title><description>This is the Infringement chapter of Gordon Harris&#x27; Annual Patents Review 2017. For the other chapters of the review, please follow the links below or download the Annual Patents Review 2017 in full.</description><pubDate>Thu, 15 Feb 2018 10:03:00 Z</pubDate></item><item><guid isPermaLink="false">a022e6c0-ae3b-4b4a-8bf2-d71e385ad9a1</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/annual-patents-review-2017-overview</link><title>Annual Patents Review 2017 - Overview</title><description>Gowling WLG&#x27;s UK intellectual property (IP) team bring you their annual patent review for 2017.</description><pubDate>Thu, 15 Feb 2018 09:57:00 Z</pubDate></item><item><guid isPermaLink="false">be60fd93-4062-4c5f-9460-70c2858e2242</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/technical-matters-annual-patents-review-2017</link><title>Technical Matters and Procedure - Annual Patents Review 2017</title><description>This is the Technical Matters and Procedure&#xA0;chapter of Gordon Harris&#x27; Annual Patents Review 2017. For the other chapters of the review, please follow the links below or download the Annual Patents Review 2017 in full.</description><pubDate>Thu, 15 Feb 2018 01:05:00 Z</pubDate></item><item><guid isPermaLink="false">4e1fbdc7-ba9c-44b6-9a7d-afeeca75c675</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/uk-supreme-court-introduces-doctrine-of-equivalent</link><title>Actavis vs. Eli Lilly: UK Supreme Court introduces Doctrine of Equivalents in Patent Law</title><description>In a landmark decision, Actavis v Eli Lilly [2017] UKSC 48, the UK Supreme Court has re&#x2010;steered the law of patent infringement in the UK, stating that there is a doctrine of equivalents, and expressly permiting recourse by the courts to the prosecution file in appropriate limited circumstances.</description><pubDate>Mon, 22 Jan 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">36bca360-38a0-4e58-a19e-b1a2ac0a8832</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/top-10-differences-patent-litigation-canada-us</link><title>Les dix principales diff&#xE9;rences entre le litige en mati&#xE8;re de brevets au Canada et aux &#xC9;tats-Unis</title><description>Les titulaires de brevets ont de plus en plus tendance &#xE0; faire prot&#xE9;ger leurs droits de brevets hors des fronti&#xE8;res des &#xC9;tats-Unis. D&#x2019;aucuns diraient que le processus de r&#xE9;vision inter partes ainsi que diverses d&#xE9;cisions r&#xE9;centes de la Cour supr&#xEA;me am&#xE9;ricaine ont rendu la protection de droits de brevets aux &#xC9;tats-Unis plus difficile depuis cinq ans au moins. Les titulaires de brevets qui se tournent vers l&#x2019;&#xE9;tranger pour trouver une solution de rechange choisissent principalement l&#x2019;Europe, l&#x2019;Allemagne en particulier. Dans d&#x2019;autres cas, ils jettent leur d&#xE9;volu sur le Japon, et m&#xEA;me la Chine est dor&#xE9;navant prise en consid&#xE9;ration au vu du d&#xE9;veloppement et de l&#x2019;am&#xE9;lioration de son r&#xE9;gime de protection de la propri&#xE9;t&#xE9; intellectuelle (PI).</description><pubDate>Mon, 22 Jan 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">db6f463b-2f3e-4135-a8a8-743c72779351</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2018/canadian-patent-law-2017-year-in-review</link><title>Droit canadien en mati&#xE8;re de brevets &#x2013; Faits saillants de 2017</title><description>L&#x2019;ann&#xE9;e 2017 a &#xE9;t&#xE9; tr&#xE8;s charg&#xE9;e en ce qui a trait au droit canadien sur les brevets. La controvers&#xE9;e doctrine de la promesse a &#xE9;t&#xE9; rejet&#xE9;e par la Cour supr&#xEA;me du Canada dans l&#x2019;affaire AstraZeneca Canada Inc. c. Apotex Inc.; le plus important jugement p&#xE9;cuniaire au Canada a &#xE9;t&#xE9; accord&#xE9; au titre de la contrefa&#xE7;on de brevet dans l&#x2019;affaire The Dow Chemical Company v Nova Chemical; le R&#xE8;glement sur les m&#xE9;dicaments brevet&#xE9;s (avis de conformit&#xE9;) et les R&#xE8;gles sur les brevets ont fait l&#x2019;objet d&#x2019;importantes modifications et le Projet de loi C-30 a introduit la possibilit&#xE9; de demander la restauration de la dur&#xE9;e d&#x2019;un brevet au moyen d&#x2019;un &#xAB;&#xA0;certificat de protection suppl&#xE9;mentaire&#xA0;&#xBB; dans certaines circonstances.</description><pubDate>Wed, 03 Jan 2018 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f03768ef-b2dc-4612-9795-ba4d7146038b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/the-skinny-on-skinny-labels</link><title>The skinny on skinny labels</title><description>In a recent decision of Federal Court (Bristol-Myers Squibb Canada v Apotex Inc., 2017 FC 1061), Justice Lafreni&#xE8;re dismissed the prohibition proceeding brought by Bristol-Myers Squibb Canada (BMS) against Apotex Inc. (Apotex) for a generic version of ABILIFY&#xAE;, which is indicated for several uses.</description><pubDate>Thu, 21 Dec 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e43e4704-8ed9-4195-9634-5aaaa81f416c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/podcasts/2017/design-protection-hindsight-giving-insight</link><title>London Design Festival: Design Protection - Hindsight giving insight</title><description>In this podcast, design lawyer John Coldham is joined by a panel of fellow experts, offering designers advice on protecting their creations.</description><pubDate>Fri, 03 Nov 2017 11:17:00 Z</pubDate></item><item><guid isPermaLink="false">57c74668-1c42-441a-8dd0-670d3cfa3d09</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/government-increases-official-fees-by-rospatent</link><title>Government increases official fees charged by Rospatent</title><description>As of October 6, 2017, administrative fees charged by the Russian Patent and Trademark Office (Rospatent) have been increased by Decree 1151. The decree has also introduced fees not previously charged by Rospatent.</description><pubDate>Wed, 01 Nov 2017 23:00:00 Z</pubDate></item><item><guid isPermaLink="false">6213a015-8910-42bb-aabc-056dbbd33d3b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/pmprb-decision-creates-uncertainty-for-patentees</link><title>PMPRB decision creates uncertainty for patentees</title><description>On September 27, 2017, a two-member Hearing Panel of the Patented Medicine Price Review Board (PMPRB) ruled that the ultra-rare disease drug Soliris&#xAE; (eculizumab), manufactured by Alexion Pharmaceuticals Inc. (Alexion), was excessively priced.</description><pubDate>Wed, 01 Nov 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">032cf7cb-52bd-4075-83b2-c2f716265d8f</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2017/defects-in-pre-patent-issue-process-do-not-render</link><title>Defects in pre-patent issue process do not render a patent void</title><description>In Apotex Inc. v Pfizer Inc. et al, 2017 FCA 201, the Federal Court of Appeal refused to void a patent based on an administrative error made during the prosecution of the patent application.</description><pubDate>Wed, 18 Oct 2017 10:57:00 Z</pubDate></item><item><guid isPermaLink="false">5eec1abd-22e1-415d-b0f9-262d9583ff3e</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2017/mind-the-actavis-v-eli-lilly-gap-please</link><title>Mind the Actavis v Eli Lilly gap please</title><description>Following the Supreme Court&#x27;s decision in Actavis v Lilly, is there a gap between the interpretation of a patent claim for validity purposes and its reach for infringement purposes? If so, what are the practical implications?</description><pubDate>Wed, 18 Oct 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4af2d49e-e7d2-4341-8313-96b673567389</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2017/uk-rewrites-its-law-prohibiting-threats-of-legal-p</link><title>UK rewrites its law prohibiting threats of legal proceedings for IP infringement</title><description>The Intellectual Property (Unjustified Threats) Act 2017 (the Act) entered into force on 1 October 2017, introducing changes to the law in the UK regarding threats of intellectual property proceedings.</description><pubDate>Mon, 02 Oct 2017 07:37:00 Z</pubDate></item><item><guid isPermaLink="false">1844555b-5246-4a0d-ac33-f89a2f4ac6f8</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2017/draft-patent-rules-released-for-public-consultatio</link><title>Draft &#x3C;em&#x3E;Patent Rules&#x3C;/em&#x3E; released for public consultation: Overview of key changes</title><description>The Canadian Intellectual Property Office (CIPO) has released draft revisions to the Patent Rules for public consultation. The draft revisions propose to make extensive changes to the current Patent Rules.</description><pubDate>Tue, 01 Aug 2017 17:15:00 Z</pubDate></item><item><guid isPermaLink="false">9ae272b6-3880-48c4-8401-520928a65aa5</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/certificates-of-supplementary-protection-canada-s</link><title>Certificates of supplementary protection: Canada&#x27;s new &#x3C;em&#x3E;sui generis&#x3C;/em&#x3E; patent term restoration regime</title><description>We previously reported on Bill C-30 (the Act to implement CETA) which made important changes to Canada&#x27;s intellectual property landscape reflecting its commitments under the Comprehensive Economic and Trade Agreement between Canada and the European Union (CETA).</description><pubDate>Mon, 24 Jul 2017 10:02:00 Z</pubDate></item><item><guid isPermaLink="false">946f2e77-8336-43c1-b9a2-1a95b92986e0</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/uk-supreme-court-introduces-doctrine-of-equivalent</link><title>UK Supreme Court introduces doctrine of equivalents in patent law in Actavis v Lilly</title><description>In a landmark decision (Actavis v Eli Lilly), the UK Supreme Court has re-steered the law of patent infringement in the UK, stating that there is a doctrine of equivalents.</description><pubDate>Thu, 13 Jul 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b39aeccb-665c-45f5-832b-8b30be34dabf</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/$644-million-patent-infringement-judgment-is-large</link><title>$644 million patent infringement judgment is largest in Canadian history</title><description>In its decision in The Dow Chemical Company v. Nova Chemicals Corporation, 2017 FC 637, the Federal Court of Canada has awarded the successful plaintiff (Dow Chemical) over $644,000,000, plus interest, as compensation for Nova Chemicals&#x27; patent infringement.</description><pubDate>Wed, 12 Jul 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0b8b5f09-7897-4b3d-87c5-3ed2eae0a176</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/promise-of-the-patent-doctrine</link><title>Supreme Court of Canada rejects the Promise of the Patent Doctrine</title><description>The Promise Doctrine required patentees to establish arguable statements of utility in the patent disclosure or risk losing their patents.</description><pubDate>Fri, 30 Jun 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">aeacb763-1dde-43d8-a399-eb3dbf06f176</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/uk-parliament-continues-legislative-steps-needed-f</link><title>UK Parliament continues legislative steps needed for ratification of UPC Agreement</title><description>With the UK Parliament sitting again, following the drama of the June 2017 General Election, the Government is now continuing with the national legislative steps that need to be completed before the UK can ratify the Agreement on a Unified Patent Court (UPC Agreement).</description><pubDate>Tue, 27 Jun 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6ffc75c4-9ef8-45f4-b52b-1d420e491018</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/patent-exhaustion-in-canada-and-the-uk</link><title>Patent exhaustion in Canada and the UK</title><description>The doctrine of &#x27;patent exhaustion&#x27; provides that once a patentee sells one of its products, it can no longer exercise control over the specific product. In this regard, the patentee&#x27;s patent rights are said to &#x27;exhaust&#x27;.</description><pubDate>Mon, 12 Jun 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7a3ce23a-4961-4505-8939-6737bcf6a53a</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/the-basics-of-patent-law-unified-patent-court</link><title>The basics of patent law: the Unified Patent Court and the Unitary Patent</title><description>Gowling WLG&#x27;s intellectual property experts explain the Unified Patent Court and Unitary Patent, as part of their series of articles titled &#x27;The basics of patent law&#x27;.</description><pubDate>Wed, 17 May 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">168bb5b5-625e-4ad5-a7aa-be2574554c71</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/what-the-supreme-court-of-canada-was-not-told-abou</link><title>What the Supreme Court of Canada was not told about patent utility</title><description>On November 8, 2016 the Supreme Court of Canada (SCC) heard an appeal by AstraZeneca regarding the validity of a patent covering its NEXIUM product.</description><pubDate>Thu, 11 May 2017 15:03:00 Z</pubDate></item><item><guid isPermaLink="false">84bf9f98-f152-463f-89e6-2ac84aa4d8da</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/russia-signs-up-to-international-design-registrati</link><title>Russia signs up to international design registration at long last</title><description>On April 3, 2017, President Putin signed a law ratifying the Geneva Act of the Hague Agreement Concerning the International Registration of Industrial Designs.</description><pubDate>Wed, 03 May 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8d12f41c-5186-4f5b-8a29-bba98355a419</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/basics-of-patent-law-assignment-and-licensing</link><title>The basics of patent law - assignment and licensing</title><description>Gowling WLG&#x27;s intellectual property experts explain assignment and licensing in a series of articles titled &#x27;The basics of patent law&#x27;.</description><pubDate>Wed, 19 Apr 2017 03:34:00 Z</pubDate></item><item><guid isPermaLink="false">fec5f2cb-0507-4e64-9bf4-56c76d3e6013</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/the-basics-of-patent-law-remedies-and-costs</link><title>The basics of patent law - remedies and costs</title><description>Gowling WLG&#x27;s intellectual property (IP) experts discuss remedies available in the UK, as part of their &#x27;The basics of patent law&#x27; series.</description><pubDate>Wed, 12 Apr 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7227c025-992e-4ae3-8b8c-f283d33f3cf7</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/procedure-trial-appeal-and-settlement</link><title>The basics of patent law - procedure, trial, appeal and settlement</title><description>Gowling WLG&#x27;s intellectual property experts discuss litigation procedure, trial, appeal and settlement, as part of their &#x27;The basics of patent law&#x27; series.</description><pubDate>Wed, 05 Apr 2017 06:05:00 Z</pubDate></item><item><guid isPermaLink="false">80f0ac78-2595-4419-b077-2b5adcdde5fb</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2017/revocation-non-infringement-and-clearing-the-way</link><title>The basics of patent law - revocation, non-infringement and clearing the way</title><description>Our IP experts discuss challenges to validity, revocation actions, non-infringement and other procedures to remove the effect of an IP right.</description><pubDate>Thu, 30 Mar 2017 12:09:00 Z</pubDate></item><item><guid isPermaLink="false">465029cc-1d62-4639-bb81-dcd6ff55eaf2</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/evidence-for-establishing-sound-prediction-and-the</link><title>Evidence for establishing sound prediction and the use of trial and error experimentation to establish an enabling disclosure</title><description>The Federal Court of Appeal&#x27;s (FCA) recent decision in Teva v. Leo Pharma addresses important issues related to the doctrines of sound prediction and sufficiency.</description><pubDate>Thu, 30 Mar 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">dd4a9768-c1c6-4c8c-b454-c66951e20dd3</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/the-basics-of-patent-law-infringement</link><title>The basics of patent law - infringement and related actions</title><description>Gowling WLG&#x27;s intellectual property experts discuss infringement and related actions as part of their &#x27;The basics of patent law&#x27; series.</description><pubDate>Wed, 22 Mar 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8e527f98-e34e-4df6-a27c-fe07bf9079da</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/the-basics-of-patent-law-initiating-proceedings</link><title>The basics of patent law - initiating proceedings in the UK</title><description>Gowling WLG&#x27;s intellectual property experts discuss initiating proceedings as part of their &#x27;The basics of patent law&#x27; series.</description><pubDate>Wed, 15 Mar 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0a269b13-ab15-454b-ae35-0e1f39822b5e</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/types-of-ip-protection-for-inventions</link><title>Types of intellectual property protection for inventions and granting procedure</title><description>Gowling WLG&#x27;s intellectual property experts explore the types of intellectual property protection for inventions and granting procedure as part of their series called &#x27;The basics of patent law&#x27;.</description><pubDate>Wed, 08 Mar 2017 05:43:00 Z</pubDate></item><item><guid isPermaLink="false">209ee4ca-28ba-4771-90c2-afabb462eee5</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/new-trade-mark-and-patent-fees-in-singapore</link><title>Your guide to new trade mark and patent fees in Singapore</title><description>The Trade Mark and Patent Registries of the Intellectual Property Office of Singapore (IPOS) has announced a series of fee revisions that will take effect from 1 April 2017.</description><pubDate>Mon, 20 Feb 2017 03:52:00 Z</pubDate></item><item><guid isPermaLink="false">52a2bba2-8dec-4a36-9dae-1f787b91a78d</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/annual-patent-review-2016</link><title>Annual patent review 2016</title><description>2016 was another a bumper year for patent decisions from the UK IP courts.</description><pubDate>Wed, 25 Jan 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">013cec61-119d-4e88-864d-2120beb345c8</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/high-stakes-patent-action-turned-damp-squib</link><title>&#x22;High stakes&#x22; patent action turned &#x22;damp squib&#x22;</title><pubDate>Mon, 23 Jan 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7a8bb04a-c708-449e-8f3d-4bd89e4cdf55</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/canada-adopts-six-new-industrial-design-practices</link><title>Canada adopts six new industrial design practices to improve service and align with international norms</title><description>The Canadian Intellectual Property Office (CIPO) released six new practice changes in relation to industrial designs on January 16, 2017. These practices are effective immediately and are being implemented, at least in part, to improve service and adopt practices or provide benefits available from other jurisdictions.</description><pubDate>Thu, 19 Jan 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2600f646-fab8-4725-a262-f2b2c3feecd1</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2017/canadian-patent-law-2016-year-in-review</link><title>Canadian patent law: 2016 year in review</title><description>This article summarizes noteworthy Canadian patent law decisions and developments from 2016.</description><pubDate>Wed, 04 Jan 2017 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2b7bff2f-20ed-4405-8483-59dcf6b4b950</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/uk-signals-intent-to-remain-in-the-new-upc-system</link><title>UK signals intent to remain in the new Unified Patent Court system</title><description>The United Kingdom&#x27;s Minister for Intellectual Property, Baroness Neville-Rolfe, has announced that the government is proceeding with preparations to ratify the Unified Patent Court Agreement (UPC Agreement).</description><pubDate>Wed, 30 Nov 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7257a67a-3593-48dd-86d7-1ff4ad2cfb15</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/monetary-consequences-for-falsely-alleging-patent</link><title>Monetary consequences for falsely alleging patent infringement</title><description>The Federal Court released a decision on Nov. 17, 2016 regarding two patent actions that were heard together.</description><pubDate>Mon, 21 Nov 2016 14:25:00 Z</pubDate></item><item><guid isPermaLink="false">664dee91-1cc6-4b19-89b9-9abaa0a176ba</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/challenge-to-patentee-s-right-to-elect-between-dam</link><title>Patentee&#x27;s choice, patent infringement</title><description>Which party has the right to choose the patentee&#x27;s remedy after a successful action for patent infringement?</description><pubDate>Thu, 10 Nov 2016 16:26:00 Z</pubDate></item><item><guid isPermaLink="false">f91947db-60d9-4430-b0b5-16d9f760836d</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/changes-to-ip-rights-on-the-horizon-canada-introd</link><title>Changes to IP rights on the horizon: Canada introduces legislation to implement CETA</title><description>We previously reported on important changes the recently signed Comprehensive Economic and Trade Agreement between Canada and the European Union (CETA) requires Canada to make to its Patent Act and Trade-marks Act.</description><pubDate>Fri, 04 Nov 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d10ddd60-6bb9-4b12-a8e0-e1fcf7116465</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/federal-court-of-appeal-grants-minister-of-health</link><title>Federal Court of Appeal grants minister of health the right to be wrong</title><description>In a decision dated October 12, 2016, the Federal Court of Appeal upheld two decisions of the minister of health to issue Notice of Compliances to generic drug manufacturers without addressing the requirements of the Patented Medicines (Notice of Compliance) Regulations.</description><pubDate>Mon, 24 Oct 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3695930a-0112-43b2-93bc-ac039e3e9b0f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/patent-survives-anticipation-attack-based-on-use-i</link><title>Patent survives anticipation attack based on use in phase III clinical trial</title><description>On September 7, 2016, the Federal Court found that Apotex and Cobalt infringed three claims of Bayer&#x27;s Canadian Letters Patent No. 2,382,426. The Court also found those claims to be valid.</description><pubDate>Thu, 22 Sep 2016 11:28:00 Z</pubDate></item><item><guid isPermaLink="false">fbd35eb8-958c-4243-a1d5-3859e638f087</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/can-post-brexit-uk-remain-involved-in-the-up-and-u</link><title>Can post-Brexit UK remain involved in the UP and UPC system?</title><description>An Opinion, by English barristers Richard Gordon KC and Tom Pascoe, has been published considering the effect of Brexit (i.e. departure from the EU) upon the Unitary Patent (UP) Regulation and the Unified Patent Court (UPC) Agreement. Can the UK remain involved in the UP and UPC system?</description><pubDate>Fri, 16 Sep 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">76d146e1-717b-4839-b03a-683b6d33aa40</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/eli-lilly-s-erectile-dysfunction-patent-stands-up</link><title>Eli Lilly&#x27;s erectile dysfunction patent stands up to scrutiny</title><description>The English High Court (Patents Court) has ruled in a patent dispute concerned with the treatment of erectile dysfunction. Actavis and Mylan had commenced &#x22;clear the way&#x22; litigation by seeking to revoke Eli Lilly&#x27;s patent in order to launch generic versions of its CIALIS medicine upon expiry of the relevant SPC protection (November 2017).</description><pubDate>Thu, 01 Sep 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e9c81a5f-b37f-4387-a8e3-cb74723c11a5</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/genentech-herceptin-formulation-patents-invalid</link><title>Court of Appeal confirms Genentech Herceptin formulation patents invalid</title><description>The Court of Appeal has confirmed that two Genentech patents concerning lyophilised formulations of trastuzumab (the active ingredient in Herceptin) are invalid for obviousness.</description><pubDate>Tue, 30 Aug 2016 08:28:00 Z</pubDate></item><item><guid isPermaLink="false">51b1ed66-ea22-4be8-adf6-99fc2d0f5bb5</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/english-patents-court-rules-patent-not-infringed-f</link><title>English Patents Court rules patent not infringed four months after claim filed</title><description>The English High Court (Patents Court) is a world-leading forum for efficient, high quality resolution of patent disputes. Demonstrating again the benefits of the court&#x27;s flexible and adaptable procedure, Mr Justice Arnold has delivered a full first instance judgment in a patent infringement case regarding therapeutic patches less than four and a half months after the claim was filed. This is less time than is needed to obtain preliminary relief in many jurisdictions.</description><pubDate>Thu, 14 Jul 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ddec7782-9795-4326-9cfc-9efeb7f285c1</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/business-as-usual-for-upc-says-chair</link><title>Business as usual for UPC, says chair</title><description>Following the result of last month&#x27;s UK referendum to leave the EU, the Unified Patent Court&#x27;s (UPC) Preparatory Committee has said that preparation for the regime will continue as planned.</description><pubDate>Tue, 05 Jul 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">c8bf5ac5-a10f-48ef-98b6-7c58b15bb9ea</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/changes-to-the-profession-patent-and-trademark-ag</link><title>Patent and trademark agent privilege new governance framework</title><description>On June 24, 2016, by way of statutory amendment, the age-old common law concept of privilege between lawyers and their clients was extended to certain communications between patent and trademark agents (collectively &#x27;agents&#x27;) and their clients.</description><pubDate>Mon, 04 Jul 2016 14:54:00 Z</pubDate></item><item><guid isPermaLink="false">b2025d58-cbe9-414e-9b3a-9ddbf3cba468</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/what-brexit-means-for-the-patents-ecosystem-upc</link><title>Brexit - what the UK&#x27;s vote Leave means for the patents ecosystem and UPC</title><description>On 23 June 2016, in a national referendum, the population of the UK by a narrow majority (52%) voted to leave the European Union (EU).</description><pubDate>Thu, 30 Jun 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9686da05-c5d6-4adf-a064-7d169f38906f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/brexit-what-next-for-intellectual-property</link><title>Brexit - what next for intellectual property?</title><description>The UK has voted to leave the EU. What next?</description><pubDate>Fri, 24 Jun 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d9dd2117-fb78-4b7c-8f8d-8b6218403f94</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/patentability-of-methods-of-medical-treatment-in-c</link><title>Patentability of methods of medical treatment in Canada</title><description>A method of medical treatment is not patentable in Canada. This rule arises out of a concern that granting a monopoly over a method of medically treating a patient could interfere with physicians&#x2019; skill and judgment when treating patients.</description><pubDate>Fri, 17 Jun 2016 09:39:00 Z</pubDate></item><item><guid isPermaLink="false">0dac3b13-8b28-4c9a-8926-178bb0bf07f4</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/post-amazon-com-how-the-canadian-patent-appeal-bo</link><title>Post Amazon.com: How the Canadian Patent Appeal Board has dealt with patent-eligibility of computer-implemented subject matter</title><description>An important consideration for every patentee is that each country&#x2019;s patent system has uniquely evolved to effectively deal with limits of patentable subject matter. For example, the patent systems of Canada, the United States and Europe continue to grapple with striking the necessary balance that leaves any underlying building blocks of an invention &#x2013; such as scientific principles, abstract ideas and laws of nature &#x2013; accessible to all, but extends patent protection to new, useful and innovative technical applications of these building blocks.</description><pubDate>Wed, 15 Jun 2016 15:36:00 Z</pubDate></item><item><guid isPermaLink="false">621d220c-d2d1-482c-9eed-d958ae24f397</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/federal-court-of-appeal-affirms-application-of-pri</link><title>Federal Court of Appeal affirms application of principles of causation, burden of proof and laws of evidence to section 8 proceedings</title><pubDate>Mon, 06 Jun 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a259ad96-4568-4dec-8e8a-c0ecc8c6258f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/what-other-products-federal-court-orders-generi</link><title>What &#x201C;other products&#x201D;? Federal Court orders generic to particularize damages claim</title><description>Unlike other actions, fulsome particulars of generic pharmaceutical damages claims (under section 8 of the Patented Medicines (Notice of Compliance) Regulations) have not always been thought to be necessary. It had been suggested that information in the possession of defendants might define the scope of such claims.</description><pubDate>Wed, 25 May 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">02a3991f-0422-4006-a04f-3c57108578b3</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/federal-court-releases-updated-guidelines-to-gover</link><title>Federal Court releases updated guidelines to govern proceedings under the &#x3C;em&#x3E;PM(NOC) Regulations&#x3C;/em&#x3E;</title><pubDate>Wed, 25 May 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">79d03716-c212-4be1-88d1-de9b755cc341</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/crowded-prior-art-and-narrow-drawings-lead-to-non</link><title>Crowded prior art and narrow drawings lead to non-infringement of industrial design</title><description>Industrial design registrations (or design patents as they are referred to in some jurisdictions) are attractive for a number of reasons, including their low cost and often easy prosecution before examiners.</description><pubDate>Thu, 19 May 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0b42631b-cd4b-437f-b3a4-a5d55d36522f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/demand-letters-are-now-mandatory-in-russia</link><title>Demand letters are now mandatory in Russia</title><description>For the last 20 years, at least, there were no legal conditions that had to be met prior to filing a trademark or patent infringement lawsuit in Russia.</description><pubDate>Thu, 28 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">7f2953bb-56e1-443a-88fa-70ca6891e760</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/eli-lilly-s-cialis-patent-withstands-double-paten</link><title>Eli Lilly&#x2019;s Cialis&#xAE; patent withstands double patenting and utility challenges on appeal</title><description>The Federal Court of Appeal has provided guidance on the law of obviousness-type double patenting in dismissing Mylan&#x2019;s appeal pertaining to Eli Lilly&#x2019;s Canadian Patent.</description><pubDate>Tue, 26 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3e6d2272-af35-45a0-b8d3-19583a0b6e4f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/patent-owner-s-entitlement-to-permanent-injunction</link><title>Patent owner&#x27;s entitlement to permanent injunction in Canada confirmed</title><description>In Uponor AB v. Heatlink Group Inc. et al., 2016 FC 320 (Uponor), the Federal Court of Canada awarded a permanent injunction after a finding that the asserted patent was valid and infringed, notwithstanding that the plaintiff did not practise the claimed invention.</description><pubDate>Thu, 21 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">351a8fc1-b4aa-4852-808c-f8f9769faec8</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/paes-and-seps-patent-enforcement</link><title>PAEs and SEPs: When is patent enforcement anti-competitive?</title><description>In 2015, submissions were invited on draft Intellectual Property Enforcement Guidelines. As a result of the consultation process, the Bureau has updated and finalized the IPEGs.</description><pubDate>Fri, 08 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">187dc7b4-2233-46a4-8f05-ee77868b107c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/guidelines-from-competition-bureau-pm-noc-reg</link><title>Competition Bureau releases guidelines in respect of settlements under the &#x3C;em&#x3E;PM(NOC) Regulations&#x3C;/em&#x3E;</title><description>On March 31, 2016, the Competition Bureau released its updated Intellectual Property Enforcement Guidelines.</description><pubDate>Fri, 08 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6366f05b-1d1d-40f2-ae75-a59096a378cf</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/approvability-of-generic-noc-satisfies-imminence-c</link><title>Approvability of generic NOC satisfies imminence criteria in &#x3C;em&#x3E;quia timet &#x3C;/em&#x3E;proceedings</title><description>The Federal Court in Gilead Sciences Inc v Teva Canada Limited, 2016 FC 336 has clarified the law with respect to the imminence requirement of future patent infringement claims.</description><pubDate>Thu, 07 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">472d43f0-d14a-4782-b6e2-588c474ebc5b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/upc-scenario-3-a-standards-case-from-the-defendan</link><title>UPC scenario 3: A standards case from the defendant&#x27;s perspective</title><description>Our latest Unified Patent Court (UPC) scenario looks at a case involving a standard-essential patent. Michael Carter, Nick Cunningham and David Barron consider a defendant&#x27;s options in the new court system.</description><pubDate>Fri, 01 Apr 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a2506831-4055-4348-a11e-ca01d94e89bb</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/the-final-word-on-the-claim-for-innovator-profits</link><title>The final word on the claim for innovator profits following PM(NOC) litigation?</title><description>Generic pharmaceutical companies have long sought the disgorgement of innovator profits following litigation under the Patented Medicines (Notice of Compliance) Regulations (the &#x201C;Regulations&#x201D;). On January 14, 2016 the Supreme Court of Canada (SCC), once again, denied leave after Apotex appealed a decision of the Court of Appeal for Ontario (OCA) which upheld Eli Lilly&#x2019;s motion to strike these claims.</description><pubDate>Thu, 31 Mar 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">473d5c1d-afb4-41fa-a45a-1ee0822ced78</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/technology-commercialization-forecast-heavy-clou</link><title>L&#x2019;&#xE9;mergence d&#x2019;incitatifs fiscaux de type &#xAB; case de brevet &#xBB; au Canada:</title><description>Le Conference Board du Canada publie r&#xE9;guli&#xE8;rement un rapport intitul&#xE9; Les performances du Canada : Bilan comparatif, lequel porte sur divers secteurs, notamment l&#x2019;&#xE9;conomie, l&#x2019;environnement, l&#x2019;innovation et la sant&#xE9;. Malheureusement, le rendement du Canada en ce qui a trait &#xE0; l&#x2019;innovation a re&#xE7;u la cote &#xAB; D &#xBB; pendant plus de deux d&#xE9;cennies et, en moyenne, a &#xE9;t&#xE9; class&#xE9; au 14e rang sur les 17 pays du groupe de comparaison depuis les ann&#xE9;es 1980. Le Conference Board du Canada d&#xE9;finit l&#x2019;innovation comme suit : (i) la cr&#xE9;ation de connaissances, (ii) la transformation de nouvelles connaissances en produits et services et (iii) la diffusion de nouveaux produits et services dans les march&#xE9;s.</description><pubDate>Mon, 28 Mar 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e14f3905-82c5-4f8c-aefd-62cede2b16aa</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/federal-court-deviates-from-established-tests-for</link><title>Federal Court deviates from established tests for patent listing &#x2014; &#x3C;em&#x3E;Gilead Sciences, Inc. v. Canada (Health)&#x3C;/em&#x3E;</title><description>In the decision summarized below, Apotex successfully obtained a dismissal of Gilead&#x2019;s application for a prohibition order in respect of Canadian Patent 2,261,619 on the basis of improper listing on the Patent Register.</description><pubDate>Tue, 22 Mar 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">73a52988-d8e5-460f-9c8c-08f949bf9523</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/supreme-court-of-canada-to-consider-law-of-utility</link><title>Supreme Court of Canada to consider law of utility in Esomeprazole appeal</title><description>The Supreme Court of Canada has again acknowledged the need to consider the law of utility in Canada by granting Astrazeneca leave to appeal in Esomeprazole. At issue will be the validity of Canadian Patent 2,139,653 (&#x22;653 Patent&#x201D;) covering Astrazeneca&#x2019;s NEXIUM&#xAE; product, which has previously been declared invalid by Rennie J., as confirmed by the Federal Court of Appeal (&#x201C;FCA&#x201D;).</description><pubDate>Fri, 11 Mar 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9c0e7549-9f4d-42eb-87b0-657f18f435f4</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/what-you-need-to-know-about-brand-perception-and-t</link><title>What you need to know about brand perception and trademark applications</title><description>Brand perception has always been important to businesses. Now that social media has become one of the primary ways people access news, brand owners must be aware of how they are perceived across the different platforms that they use to manage their identities.</description><pubDate>Fri, 11 Mar 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1a45a968-156f-4e2e-b298-7b0d4331b4b9</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/ceta-and-canadian-ip-law-possible-changes-ahead</link><title>CETA and Canadian IP law: Possible changes ahead?</title><description>In 2013, an agreement in principle was reached between Canada and the European Union - the Canada-European Union Comprehensive Economic and Trade Agreement (&#x201C;CETA&#x201D;).&#xA0; An official text was released on September 26, 2014, subject to legal review. &#xA0;On February 29, 2016, the federal government announced that a legal review of the English text of CETA is now complete, and published the text of the final agreement.&#xA0; International Trade Minister Chrystia Freeland has said she hopes the deal will be ratified later this year and come into force some time in 2017.</description><pubDate>Thu, 03 Mar 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8b92878f-3ad1-4607-89aa-328d22006b08</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/annual-patent-review-2015</link><title>Annual patent review 2015</title><description>2015 was a bumper year for patent decisions from the UK IP courts. Here Gordon Harris shares his comprehensive commentary of the key developments, in his annual review of the year&#x27;s patent cases.</description><pubDate>Tue, 09 Feb 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">31439126-7796-484b-a6c6-6a9b3a47b6ef</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/canadian-patent-law-2015-year-in-review</link><title>Canadian patent law: 2015 year in review</title><description>Canadian patent law: 2015 year in review</description><pubDate>Tue, 12 Jan 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">87a7a7ba-6cff-4de4-8b2f-cb569bd4e951</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/patent-enforcement-through-the-courts-in-canada</link><title>Patent enforcement through the courts in Canada</title><description>The Federal Court has in-depth knowledge of the substantive and procedural aspects of patent litigation. It has exclusive jurisdiction to hear cases regarding conflicting patent applications and the impeachment of a patent.</description><pubDate>Mon, 11 Jan 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b8a55995-46f9-4d13-9f2a-f34f8ea4e967</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/patents-in-canada</link><title>Patents in Canada</title><description>What are the criteria for patentability in your jurisdiction?</description><pubDate>Mon, 11 Jan 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ea105edc-92eb-4d95-9b02-041cb315f8cd</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2016/patentability-in-canada</link><title>Patentability in Canada</title><description>What are the criteria for patentability in your jurisdiction? In Canada, in order to be patentable an invention must be novel, useful and unobvious.</description><pubDate>Mon, 11 Jan 2016 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1624d386-ee30-4182-9f81-e5006fcc9151</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/bc-court-of-appeal-dismisses-proposed-consumer-cla</link><title>BC Court of Appeal dismisses proposed consumer class action for invalid pharmaceutical patent</title><description>On Dec. 8, 2015, the British Columbia Court of Appeal dismissed a proposed class action by consumers against Pfizer Canada Inc. in connection with Pfizer&#x2019;s now invalid patent which covered its VIAGRA&#xAE; product.</description><pubDate>Tue, 01 Dec 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cb11bf0b-bef0-4259-becb-afc9c25774c9</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2015/company-just-received-a-cease-and-desist-part-one</link><title>So, your company just received a cease and desist letter... (Part 1)</title><description>The first questions that typically come to mind in such events are: Do you have to respond to the letter, particularly if you don&#x27;t know anything about the sender? What are your options for a response? And what steps should you take in formulating a response to such a letter?</description><pubDate>Tue, 01 Dec 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8ac0816b-dced-453c-8680-60ffbe0d44a2</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2015/company-just-received-a-cease-and-desist-part-two</link><title>So, your company just received a cease and desist letter... (Part 2)</title><description>Part 1 of this article summarized the steps that should be taken if your company receives a cease and desist letter that alleges patent infringement.</description><pubDate>Tue, 01 Dec 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">92da0c16-c714-4beb-9099-f1828c08248a</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2015/pharmaceutical-data-protection-in-canada-the-late</link><title>Pharmaceutical data protection in Canada: The latest word from Photocure</title><description>In the recent Photocure decision the Federal Court has once again sided with Canada&#x27;s Minister of Health in denying data protection for a new medicinal ingredient.</description><pubDate>Tue, 01 Dec 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">67392e11-eaba-46fa-87f8-a4ad46a00ffa</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/the-tpp-rights-for-patent-holders-in-canada</link><title>The TPP - New rights for pharmaceutical patent holders in Canada</title><description>The Canadian government released the official consolidated text of the Trans-Pacific Partnership (TPP) agreement on Nov., 5, 2015. This follows the technical summary of negotiated outcomes posted on the Department of Foreign Affairs and Development Canada&#x2019;s website following conclusion of the agreement.</description><pubDate>Thu, 12 Nov 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1ae33f3a-e348-483a-b812-313711b6aad1</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/canada-china-patent-prosecution-highway-program-be</link><title>Canada/China patent prosecution highway program benefits</title><description>As previously reported the CIPO and the SIPO entered into a PPH pilot project agreement that was scheduled to last from September 1, 2013 to August 31, 2015.</description><pubDate>Sun, 01 Nov 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">6acc3fcf-7838-4838-b0d7-9ad513268199</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/federal-court-of-appeal-finds-that-pmprb-extends-t</link><title>Federal Court of Appeal finds that PMPRB extends to generics</title><description>On Nov. 6, 2015, the Federal Court of Appeal issued a rare decision relating to Canada&#x27;s pricing control regime for patented medicines administered by the Patented Medicine Prices Review Board (&#x22;PMPRB&#x22;).</description><pubDate>Sun, 01 Nov 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">208fb197-b9b5-46e0-8332-0873b0ca496f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2015/federal-court-grants-leo-pharma-s-application-for</link><title>Federal Court grants Leo Pharma&#x27;s application for a prohibition order in respect of DOVOBET&#xAE;</title><description>On Nov. 18, 2015, Justice Locke granted Leo Pharma&#x2019;s application to prohibit the minister of health from approving Teva&#x2019;s version of Leo Pharma&#x2019;s patented DOVOBET&#xAE; product until after expiry of Canadian Patent 2,370,565 (the &#x201C;565 Patent&#x201D;).</description><pubDate>Sun, 01 Nov 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1cc7f069-5c52-4279-9bc5-1ca94056ec3e</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/you-and-the-unified-patent-court-survey-findings</link><title>You and the Unified Patent Court - survey findings</title><description>Our IP team surveyed patent attorneys and solicitors in private practice and in-house, seeking views on the UP and UPC - Will it work? Will it change anything? And is it really necessary?</description><pubDate>Thu, 15 Oct 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4769e6ac-a17d-4fbf-b9d7-186606c9c5dd</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/the-trans-pacific-partnership-changes-for-patents</link><title>The Trans-Pacific Partnership: Changes for patents and pharmaceuticals?</title><description>Changes may be on the horizon for Canada&#x27;s legal and regulatory regime for patents and pharmaceuticals.</description><pubDate>Thu, 01 Oct 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">09dc2e4c-8ac3-4d3a-892e-c5b37e7a0043</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/ontario-superior-court-refuses-to-strike-generic-s</link><title>Ontario Superior Court refuses to strike generic&#x27;s damages claim against pharmaceutical innovator based on 400-year-old statute</title><pubDate>Tue, 01 Sep 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">928847cb-5813-4a32-a550-b91c1a1aa8b7</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2015/federal-court-of-appeal-comments-on-standard-of-re</link><title>Federal Court of Appeal comments on standard of review and expert evidence in patent infringement action</title><description>On Aug. 18, 2015, the Federal Court of Appeal dismissed two appeals by ABB Technology AG, ABB Inc., and ABB AG (collectively, ABB) in the context of a patent infringementdispute against Hyundai Heavy Industries Co, Ltd (HHI) related to gas-insulated electrical switchgear assemblies used in electrical power transmission.</description><pubDate>Tue, 01 Sep 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e861f9d0-76f9-4fe2-8f4b-0b217e3fa9bd</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2015/federal-court-of-appeal-reinterprets-product-speci</link><title>Federal Court of Appeal reinterprets product specificity requirements</title><description>On July 17, 2015, the Federal Court of Appeal set aside a judgment of the Federal Court that upheld Health Canada&#x2019;s refusal to list Canadian Patent 2,379,329 owned by Eli Lilly Canada Inc. on the Patent Register maintained under the PM(NOC) Regulations.</description><pubDate>Fri, 17 Jul 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">349edad2-5b3d-47b7-9609-987744276521</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/fca-does-not-address-trial-judge-s-finding-that-th</link><title>FCA does not address trial judge&#x27;s finding that there is no heightened disclosure requirement in cases of sound prediction</title><pubDate>Wed, 01 Jul 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">aa34c578-ee8b-4ab9-b7c9-f95b20071eec</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2015/federal-court-of-appeal-reinterprets-product-speci</link><title>Federal Court of Appeal reinterprets product specificity requirements: Patent listing is determined by patent claims construction and not a word match</title><description>On July 17, 2015, the Federal Court of Appeal set aside a judgment of the Federal Court that upheld Health Canada&#x2019;s refusal to list Canadian Patent 2,379,329 (the &#x2018;329 patent) owned by Eli Lilly Canada Inc. on the Patent Register maintained under the PM(NOC) Regulations.</description><pubDate>Wed, 01 Jul 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cbe6e35b-cb7e-4476-8575-987e45e80c08</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2015/federal-court-grants-accounting-of-profits-and-add</link><title>Federal Court grants accounting of profits and addresses NIA &#x22;Non-Infringing Alternative&#x22;</title><description>The Federal Court recently released a decision accounting for an infringer&#x27;s profits in a pharmaceutical matter.</description><pubDate>Wed, 01 Jul 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f01c7f1d-8aa4-4937-a832-27ffba1c772b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2015/federal-court-grants-interlocutory-stay-in-ip-disp</link><title>Federal Court grants interlocutory stay in IP dispute</title><description>On June 12, 2015, the Federal Court issued an interlocutory stay in the context of a data protection application in Horizon Pharma plc v The Minister of Health et al, 2015 FC 744.</description><pubDate>Wed, 01 Jul 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fe8f8652-e0b9-4693-bbac-1575834ae85b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2015/fca-imposes-could-and-would-test-to-assess-non-i</link><title>Une d&#xE9;cision de la Cour d&#x2019;appel f&#xE9;d&#xE9;rale du Canada d&#xE9;stabilise le droit en mati&#xE8;re de dommages-int&#xE9;r&#xEA;ts</title><description>La Cour d&#x2019;appel f&#xE9;d&#xE9;rale (CAF) a publi&#xE9; ses motifs dans le cadre de l&#x2019;appel de la d&#xE9;cision de la juge Snider en mati&#xE8;re de dommages-int&#xE9;r&#xEA;ts concernant le m&#xE9;dicament lovastatine. La juge Snider a accord&#xE9; &#xE0; Merck 119 millions de dollars, plus des int&#xE9;r&#xEA;ts, &#xE0; titre de dommages-int&#xE9;r&#xEA;ts en raison de la violation par Apotex du brevet de Merck pour son produit lovastatine. La CAF a rejet&#xE9; l&#x2019;appel d&#x2019;Apotex (copie disponible ici).</description><pubDate>Wed, 01 Jul 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0decafe4-fb81-4e07-83fe-0e8e7808010c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/client-work/2015/federal-court-affirms-principle-of-claim-different</link><title>Federal Court affirms principle of claim differentiation in evaluating utility</title><description>Novartis Pharmaceuticals Canada Inc. v. Teva Canada Ltd. and Minister of Health and Novartis AG, 2015 FC 770</description><pubDate>Fri, 19 Jun 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">f01d2d13-8619-476d-bd58-a8d43e9bc33c</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/ip-ownership-for-r-d-companies-cautionary-tales-a</link><title>IP ownership for R&#x26;D companies: Cautionary tales and best practices</title><description>In this presentation, Selena Kim discusses how companies engaged in R&#x26;D can successfully secure title to their intellectual property.</description><pubDate>Mon, 01 Jun 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">5a990cd2-3e4c-4d93-8921-bf9ad6eb2c00</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2015/fca-confirms-that-no-disclosure-of-factual-basis-o</link><title>FCA confirms that no disclosure of factual basis or line of reasoning is required for sound prediction when they would be self-evident to the skilled person</title><pubDate>Mon, 01 Jun 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">a0c76b26-fcd6-42aa-9876-3dcb44614178</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2015/canadian-competition-bureau-issues-draft-update-of</link><title>Le Bureau de la concurrence du Canada publie une mise &#xE0; jour des Lignes directrices sur la propri&#xE9;t&#xE9; intellectuelle</title><description>Le 9 juin 2015, le Bureau de la concurrence du Canada a publi&#xE9; la mise &#xE0; jour de ses Lignes directrices sur la propri&#xE9;t&#xE9; intellectuelle (LDPI), &#xE0; des fins de consultation publique (voir ici). Les LDPI d&#xE9;crivent comment le Bureau traite la relation entre le droit de la concurrence et les droits de propri&#xE9;t&#xE9; intellectuelle, ainsi que son approche en mati&#xE8;re d&#x2019;application de la l&#xE9;gislation quant &#xE0; la conduite li&#xE9;e &#xE0; l&#x2019;exercice de droits de PI.</description><pubDate>Mon, 01 Jun 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ddb201e2-61ac-474f-88c2-2876e4b5bc55</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/industry-canada-seeks-comment-on-proposed-changes</link><title>Industry Canada seeks comment on proposed changes to listing requirements under the PM(NOC) Regulations</title><description>On May 2, 2015, the Governor in Council issued proposed amendments to sections 2, 3, and 4 of the Patented Medicines (Notice of Compliance) Regulations. These amendments specifically address the eligibility of listing patent claims that may not include all medicinal ingredients referred to in the approved drug product for which listing was sought on the Patent Register.</description><pubDate>Fri, 01 May 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">727c22b8-c0a6-4435-add3-e24b6dca00d4</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/cipo-revised-guidance-on-methods-of-treatment</link><title>L&#x2019;OPIC publie des directives d&#x2019;examen r&#xE9;vis&#xE9;es des m&#xE9;thodes de traitement m&#xE9;dical et de r&#xE9;gimes posologiques</title><description>L&#x2019;Office de la propri&#xE9;t&#xE9; intellectuelle du Canada (OPIC) a r&#xE9;cemment publi&#xE9; l&#x2019;Avis de pratique PN 2015-01, lequel traite de l&#x2019;examen de revendications d&#x27;utilisation m&#xE9;dicale. L&#x2019;Avis de pratique assouplit certaines des pratiques d&#x2019;examen actuelles quant &#xE0; la brevetabilit&#xE9; des r&#xE9;gimes posologiques. Dans ces nouvelles directives, les &#xE9;l&#xE9;ments essentiels de la revendication qui ont trait &#xE0; un dosage fixe, &#xE0; un r&#xE9;gime posologique fixe, &#xE0; une sous-population de patients ou &#xE0; un site d&#x27;administration particulier ne sont pas consid&#xE9;r&#xE9;s comme limitant l&#x27;exercice des comp&#xE9;tences professionnelles ou du jugement d&#x27;un m&#xE9;decin, un facteur important dans la d&#xE9;termination de la brevetabilit&#xE9; de l&#x27;objet de la revendication.</description><pubDate>Sun, 01 Mar 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ef678a05-57c5-4f45-baf9-bae4fb663d74</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/re-examination-a-viable-alternative-in-canada</link><title>La proc&#xE9;dure de r&#xE9;examen : une solution de rechange viable au Canada</title><description>La Cour d&#x2019;appel f&#xE9;d&#xE9;rale a r&#xE9;cemment maintenu le rejet d&#x2019;un appel interjet&#xE9; &#xE0; l&#x2019;&#xE9;gard d&#x2019;une d&#xE9;cision rendue par un conseil de r&#xE9;examen de brevet. Ce faisant, la Cour a &#xE9;tabli que la proc&#xE9;dure de r&#xE9;examen peut constituer une solution de rechange viable lorsqu&#x2019;il est question de contester la validit&#xE9; d&#x2019;un brevet canadien.</description><pubDate>Sun, 01 Mar 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d7439779-d6a1-434f-9feb-9b8521f128ea</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/annual-patent-review-2014</link><title>Annual patent review 2014</title><description>2014 was an interesting year in the world of patents in the UK, with some important developments:</description><pubDate>Thu, 12 Feb 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3442adc3-2646-4317-a882-842731c4410a</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/canadian-patent-law-2014-year-in-review</link><title>Revue de l&#x27;ann&#xE9;e 2014 en mati&#xE8;re de brevets</title><description>Le pr&#xE9;sent article fournit un r&#xE9;sum&#xE9; des d&#xE9;cisions notables et des d&#xE9;veloppements de 2014 en mati&#xE8;re de droit des brevets au Canada.</description><pubDate>Sun, 01 Feb 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">e1feddc0-78fe-411b-b7ba-b01287ff946f</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/client-work/2015/federal-court-awards-eli-lilly-106-million-in-pat</link><title>Federal Court awards Eli Lilly $106 million in patent damages</title><description>On January 23, 2015, the Federal Court released its decision regarding the quantum of damages recoverable by Eli Lilly in an action relating to Apotex&#x2019;s infringement of patents related to the manufacture of the antibiotic cefaclor.</description><pubDate>Fri, 23 Jan 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8b7e81ce-2cb5-475d-9fbb-957a1f68d5ba</guid><link>https://gowlingwlg.com/fr-fr/insights-resources/articles/2015/federal-court-determines-minister-s-decisions-gran</link><title>Federal Court determines minister&#x27;s decisions granting NOCs based on administrative ANDSs cross-referencing licensed generics without requiring NOAs are wrong</title><description>On Dec. 19, 2014, the Federal Court set aside a decision of the Minister of Health granting a Notice of Compliance (NOC) to Teva authorizing the sale of its product that referred to Pfizer&#x2019;s Aromasin&#xAE;.</description><pubDate>Thu, 01 Jan 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">b30ead23-9582-4fd4-b44a-2c9caf52a0b3</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2015/federal-court-rejects-nia-defence-and-awards-compo</link><title>La Cour f&#xE9;d&#xE9;rale rejette la d&#xE9;fense NIA et octroie des int&#xE9;r&#xEA;ts compos&#xE9;s sur des dommages-int&#xE9;r&#xEA;ts li&#xE9;s &#xE0; un brevet</title><description>Le 23 janvier 2015, la Cour f&#xE9;d&#xE9;rale a publi&#xE9; une d&#xE9;cision portant sur le montant des dommages-int&#xE9;r&#xEA;ts recouvrable par Eli Lilly (&#xAB; Lilly &#xBB;) dans le cadre d&#x2019;une action concernant la contrefa&#xE7;on, par Apotex, de brevets visant la fabrication de l&#x2019;antibiotique c&#xE9;faclor. Lilly a obtenu des dommages-int&#xE9;r&#xEA;ts y compris ceux qu&#x2019;elle r&#xE9;clamait en lien avec la perte de profits li&#xE9;s &#xE0; la perte de ventes et les indemnisations d&#x2019;int&#xE9;r&#xEA;ts avant jugement calcul&#xE9;s au taux moyen correspondant au taux de profit global de Lilly, compos&#xE9; annuellement pour la p&#xE9;riode de 17 ans s&#x2019;&#xE9;tant &#xE9;coul&#xE9;e entre l&#x2019;introduction de la proc&#xE9;dure et l&#x2019;adjudication d&#xE9;finitive du montant des dommages-int&#xE9;r&#xEA;ts.</description><pubDate>Thu, 01 Jan 2015 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0325f1d5-749d-4b1c-a016-470b60530535</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2014/unitary-patent-likely-to-pass-its-spanish-test</link><title>Unitary Patent likely to pass its Spanish test</title><description>In welcome news for supporters of the Unitary Patent, Advocate General Bot has proposed that the Court of Justice should dismiss both of Spain&#x27;s applications for the annulment of EU Regulations relating to the Unitary Patent package.</description><pubDate>Thu, 20 Nov 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">fdc25965-ee97-44a0-a85a-fb9476d742b9</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2014/canada-prepares-for-hague-agreement-on-internation</link><title>Canada prepares for Hague Agreement on international industrial design registrations</title><description>The Industrial Design Act (the Design Act) is due for an update.</description><pubDate>Mon, 03 Nov 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">bb39ebd1-0ff1-43f9-8b5c-a7d285874863</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2014/canada-prepares-for-patent-law-treaty</link><title>Le Canada se pr&#xE9;pare au Trait&#xE9; sur le droit des brevets</title><description>La Loi sur les brevets sera modifi&#xE9;e par le projet de loi C-43, connu sous le nom de Loi no 2 sur le plan d&#x2019;action &#xE9;conomique de 2014 et d&#xE9;pos&#xE9; &#xE0; la Chambre des communes le 23 octobre 2014. Le Canada respecte ainsi son engagement d&#x2019;adh&#xE9;rer au Trait&#xE9; sur le droit des brevets qui a &#xE9;t&#xE9; adopt&#xE9; le 1er juin 2000 &#xE0; Gen&#xE8;ve et qui vise &#xE0; harmoniser au niveau mondial les formalit&#xE9;s nationales li&#xE9;es &#xE0; l&#x2019;obtention de brevets ainsi qu&#x2019;&#xE0; simplifier les proc&#xE9;dures des bureaux nationaux des brevets et les m&#xE9;canismes de normalisation afin d&#x2019;&#xE9;viter une perte involontaire des droits relatifs aux brevets &#xE0; la suite d&#x2019;un d&#xE9;faut de se conformer aux formalit&#xE9;s et aux d&#xE9;lais prescrits. Toutefois, les modifications entra&#xEE;nent des changements additionnels qui vont au-del&#xE0; des obligations du Canada d&#xE9;coulant de ce trait&#xE9;.</description><pubDate>Sat, 01 Nov 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">9d74a289-af03-484b-9a0e-5564cc03f39b</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2014/leaving-their-mark</link><title>Leaving their mark</title><description>Over the past year, Canadian Federal Courts left their juristic mark on patent law. This article highlights recent patent decisions addressing the idiosyncratic Canadian concepts of &#x201C;promise of the patent,&#x201D; &#x201C;sound prediction,&#x201D; our treatment of methods for medical treatment, and our evolving management of remedies in patent cases. Canadian patent drafting and prosecution tips are also highlighted.</description><pubDate>Mon, 29 Sep 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3007bff9-874c-4491-8a29-facfe8d3727d</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2014/patentability-of-computer-implemented-inventions</link><title>Patentability of computer-implemented inventions: how Canada compares to the United States in view of &#x3C;em&#x3E;Alice Corp&#x3C;/em&#x3E;</title><description>Every patentee must understand that each patent system has evolved a unique way in which to effectively deal with the limits of patentable subject matter.</description><pubDate>Fri, 04 Jul 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">57667228-a3c1-4712-9a58-91ee29ec7bf7</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2014/permanent-injunction-granted-despite-patentee-not</link><title>Permanent injunction granted despite patentee not having a product that practiced the claims of the patent</title><description>On May 22, 2014, the Federal Court of Canada issued an injunction curtailing Janssen Inc.&#x2019;s marketing of its drug ustekinumab (STELARA&#xAE;) in ongoing patent litigation with AbbVie Corporation and related companies. The Court had previously found that certain claims of the patent in issue were both valid and infringed.</description><pubDate>Wed, 18 Jun 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">4be470df-d38a-445f-8ce2-d42858020c30</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2014/experimental-testing-in-patent-actions</link><title>Experimental testing in patent actions: Federal Court issues notice to the profession</title><description>Experimental testing and patent infringement actions: they often go hand-in-hand. With respect to providing notice to other parties of experimental testing, the patent litigation bar has been working under a salutary, unofficial rule since at least the 1960s.</description><pubDate>Thu, 17 Apr 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ce892c1a-9c70-421d-ac89-79670a7e953a</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2014/patents-year-in-review-2013</link><title>Patents year in review 2013</title><description>This article summarizes noteworthy Canadian patent law decisions and developments from 2013.</description><pubDate>Mon, 10 Feb 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d32258c0-6e41-4328-8f62-d6a3c5129d47</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2014/canadian-parliament-tables-five-ip-related-treatie</link><title>D&#xE9;p&#xF4;t de cinq trait&#xE9;s relatifs &#xE0; la propri&#xE9;t&#xE9; intellectuelle au Parlement</title><description>Le 27 janvier 2014, le Parlement du Canada a soumis &#xE0; la discussion cinq trait&#xE9;s internationaux li&#xE9;s &#xE0; la propri&#xE9;t&#xE9; intellectuelle.</description><pubDate>Fri, 31 Jan 2014 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">41b2c4dc-88f9-4c88-a05b-476bc1a5498c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2013/court-grants-largest-patent-infringement-damages-a</link><title>Court grants largest patent infringement damages award in Canadian history</title><description>On July 16, 2013, the Federal Court released its decision granting the largest award of damages for patent infringement in Canadian history. In Merck &#x26; Co., Inc. v. Apotex Inc. (2013 FC 751) (&#x201C;Merck&#x201D;), Justice Snider found that Merck is entitled to over $119 million in damages, plus interest, for Apotex&#x2019;s infringement of Merck&#x2019;s patent for the anti-cholesterol drug lovastatin.</description><pubDate>Thu, 18 Jul 2013 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">8db8430f-d3d3-4a4c-92f6-258946126c27</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2013/everything-you-wanted-to-know-about-software-and-b</link><title>Everything you wanted to know about Software and Business Method Patents but were afraid to ask</title><pubDate>Fri, 15 Feb 2013 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">0120a6ce-b7ab-4f72-9800-0a6347a4eae9</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2013/patents-year-in-review-2012</link><title>Patents Year in Review 2012</title><description>This article summarizes the most noteworthy Canadian patent law decisions of 2012.</description><pubDate>Fri, 08 Feb 2013 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">2152c60e-f722-4491-9111-2bbe6db0787d</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2012/supreme-court-of-canada-addresses-sufficiency-of-p</link><title>Supreme Court of Canada addresses sufficiency of patent disclosure</title><description>The Supreme Court of Canada has unanimously overturned decisions of the Federal Court and Federal Court of Appeal, and held, in the context of proceedings under the Patented Medicines (Notice of Compliance) Regulations [PM(NOC) Regulations], that Pfizer&#x2019;s Canadian Patent No. 2,163,446 for the use of VIAGRA (sildenafil) was void.</description><pubDate>Fri, 09 Nov 2012 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">1246de30-7d19-4dcd-a141-3dda827e61f4</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2012/navigating-the-patent-process-four-hot-tips-for-s</link><title>Navigating the Patent Process: Four Hot Tips for Startups</title><pubDate>Thu, 12 Jul 2012 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d57dee08-1135-42fc-9cd9-3d7a459a3a37</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2012/punitive-damages-award-in-canada-due-to-implied-kn</link><title>Octroi de dommages-int&#xE9;r&#xEA;ts au Canada pour cause de connaissance implicite d&#x2019;un brevet contrefait</title><description>Il est rare que les tribunaux canadiens octroient des dommages-int&#xE9;r&#xEA;ts punitifs dans le cadre de poursuites pour violation de brevet, ce qui rend la r&#xE9;cente d&#xE9;cision de la Cour f&#xE9;d&#xE9;rale d&#x2019;octroyer des dommages-int&#xE9;r&#xEA;ts dans l&#x2019;affaire Eurocopter c. Bell Helicopter 2012 CF 113 d&#x2019;autant plus remarquable. En effet, les tribunaux octroient des dommages-int&#xE9;r&#xEA;ts lorsque la conduite d&#x2019;une partie s&#x2019;est av&#xE9;r&#xE9;e malveillante, opprimante et abusive, qu&#x2019;elle choque le sens de dignit&#xE9; du tribunal ou d&#xE9;roge radicalement des normes ordinaires de comportement acceptable.</description><pubDate>Thu, 05 Apr 2012 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">cc7283a9-f5af-471e-be5b-20d6a3f25363</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2012/amazon-com-s-canadian-one-click-patent-on-the-th</link><title>Amazon.com&#x27;s Canadian &#x22;one-click&#x22; patent on the threshold of issuance</title><pubDate>Tue, 03 Jan 2012 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d2278171-cc4f-46fd-828c-d6fb76e75311</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2011/business-method-patents-how-prepared-are-you</link><title>Business method patents: How prepared are you?</title><pubDate>Tue, 06 Dec 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">358757f8-c42f-440b-8635-be355c915261</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2011/ramifications-of-the-amazon-appeal-decision-on-doi</link><title>Surely business methods are prohibited in Canada? Ramifications of the Amazon appeal decision on doing business (methods) in Canada</title><description>A typical business method patent contains claims to innovative, computer-implemented technology related to the practice, administration, or management of an enterprise, usually involving the processing of data specific to enterprise operations. Industries potentially subject to business methods can include e-commerce, advertising, loyalty and reward programs, insurance and banking and other financial services. In some countries, business method patents are recognised as important assets for small, medium and large corporations.</description><pubDate>Mon, 05 Dec 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">421a47d6-955a-4b15-9498-484630b1f81f</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2011/business-method-as-essential-element-of-valid-pate</link><title>Business method as essential element of valid patent claim: Amazon one-click decision, a Canadian prosecution perspective</title><description>On November 24, 2011, the Canadian Federal Court of Appeal released a vital decision quashing the Commissioner of Patents&#x27; stated &#x27;tradition&#x27; of excluding business methods from patentability.</description><pubDate>Fri, 25 Nov 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">d6c0a6bd-3b45-4d2d-8ec2-c448b405d728</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2011/top-ten-tips-for-dealing-with-business-method-pate</link><title>Top ten tips for dealing with business method patents in Canada</title><description>Will Canada Become a Haven for Non-Practicing Entities to Litigate Their Claims? This list of top ten issues will canvass the law of business method patents in Canada and will consider the impact of the recent Amazon case on your business.</description><pubDate>Tue, 13 Sep 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">3ced0b97-4c23-499c-baac-2bf272a6bb76</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2011/patents-are-like-a-swiss-army-knife-know-to-use-t</link><title>Patents are like a Swiss Army Knife: Know to use them</title><description>Grant W.C. Tisdall&#x27;s presentation, &#x22;Patents are like a Swiss army knife: Know how to use them&#x22;, discusses tools and strategies for patent portfolio development, including how to best leverage both the certainty and uncertainty that patents and patent applications provide and what business considerations are important in selecting which technology to patent.</description><pubDate>Thu, 30 Jun 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">81efa921-08fb-4a6a-bb4c-395edf910a7c</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2011/cipo-accelerated-examination-provision-green-tech</link><title>L&#x27;Office de la propri&#xE9;t&#xE9; intellectuelle canadienne (OPIC) introduit la disposition d&#x27;examen acc&#xE9;l&#xE9;r&#xE9; pour les technologies vertes et modifie les r&#xE8;gles existantes</title><description>Dans les R&#xE8;gles modifiant les R&#xE8;gles sur les brevets (DORS/2011-61), lesquelles sont entr&#xE9;es en vigueur le 3 mars 2011, l&#x27;OPIC a introduit des modifications touchant les articles des R&#xE8;gles sur les brevets qui traitent d&#x27;un processus d&#x27;examen acc&#xE9;l&#xE9;r&#xE9;.</description><pubDate>Mon, 21 Mar 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">ad51bf0f-b572-4a11-aa34-86303bf121a1</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2011/intellectual-property-protecting-what-s-yours</link><title>Intellectual property: Protecting what&#x27;s yours</title><description>This presentation was given on February 16, 2011 at the RIC/OCETA breakfast session, &#x22;Growing Your Business - Intellectual Properly - Protecting What&#x27;s Yours.&#x201D;</description><pubDate>Mon, 28 Feb 2011 00:00:00 Z</pubDate></item><item><guid isPermaLink="false">28e9683d-e607-4f24-8b6c-2e0a7b11a924</guid><link>https://gowlingwlg.com/fr-FR/insights-resources/articles/2011/developments-in-canadian-patent-law-2010</link><title>Key Developments in Canadian Patent Law in 2010</title><description>Over the past year, patent law in Canada has continued to evolve in significant ways. This review discusses seven key developments based on recent Canadian judgments, as well as amendments to the Federal Courts Rules and the Patent Rules.</description><pubDate>Mon, 24 Jan 2011 00:00:00 Z</pubDate></item></channel></rss>